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ABSTRACT 
Riboswitches are short RNA sequences that undergo a structural modification in 
the presence of a specific molecule, regulating gene expression in the process. A 
few examples of riboswitches have been described in eukaryotes, but they are 
present in many species of bacteria. These molecules are of great interest in 
synthetic biology for their inductive regulatory properties, which could be used 
in metabolic studies, or as biosensors in medical, industrial or environmental 
contexts. However, riboswitches are very substrate-specific, creating a problem 
for their use with novel compounds; and current development procedures suffer 
from issues such as being too laborious and not using in vivo conditions. By 
developing strategies based on Phage Assisted Continuous Evolution (PACE) and 
using T7 phage along with a double selection system, we aim to develop a way of 
obtaining riboswitches that show improvements compared to a control sequence 
or with a different specificity. This procedure could even be used to develop novel 
riboswitches not present in nature. Once the method is properly established, the 
strategy could be used not only for the directed evolution of riboswitches, but 
also other types of sensors, such as protein or RNA receptors. Alternative 
evolution strategies based on phage transduction were also tested, along with 
inducible RNA systems based on the phage Qb. These three processes have 
yielded different results, namely a randomised library of theophylline riboswitch 
sequences in phages, a working transduction system, and an inducible RNA 
plasmid, respectively. In the first case, by using a double selection process to 
achieve evolution, we have shown sequence variation within the phage 
populations progressively decreased over time, until a single sequence was 
prominently represented in the population. The sequence showed higher 
activation folds at a lower concentration of the activating molecule than in initial 
generations, taken as an indication that evolution had taken place. This library 
was also adapted into the transduction strategy thanks to the use of a working T7 
phage packaging signal. As for the RNA-based plasmid system, we have shown it 
to be an inducible, transient expression system that could be used as a novel way 
to regulate gene expression and bypass CRISPR systems. This set of results speak 
of the possibilities held by these strategies, not just for their specific areas of 
research, but for synthetic biology at large, from bioremediation to treatment.
  List of abbreviations  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  8 
List of abbreviations 
PFU: Plaque Forming Units   CFU: Colony forming Units 
Amp: Ampicillin    Kan: Kanamycin 
Gent: Gentamycin    Cm: Chloramphenicol 
MOI: Multiplicity of Infection  EOP: Efficiency of Plating 
DNA: Deoxyribonucleic Acid  RNA: Ribonucleic Acid 
cmk: CMP kinase    CMP: Cytidine monophosphate 
trxA: Thioredoxin A    gp5: Gene product 5   
DNApol: DNA polymerase   Rep: Replicase 
RBS: Ribosome Binding Site   SD: Shine-Dalgarno sequence 
MM/F: Methylenomycin/ furans  HR: Homologous Recombination 
NGS: Next GenerationSequencing  qPCR: Quantitative PCR 
PACE: Phage-Assisted Continuous Evolution 
PANCE: Phage-Assisted Non-Continuous Evolution 
LIMS: Laboratory Information Management System 
CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats 
 
  Introduction  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  9 
CHAPTER 1. INTRODUCTION  
The ability to interact with the environment and react accordingly is one of the 
most basic abilities living organisms have (Malmstrom, 2010; Pearce, 2010). The 
biological elements allowing for this to take place are known as biosensors. From 
extremely complex photoreceptive systems allowing animals to see the world 
(Davson & Perkins, 2018), to the bacterial membrane receptor molecules reacting 
to the presence of nutrients or competitors in the environment (Braga, Dourado, 
& Araújo, 2016), these all share one basic trait: they take outside impulses and 
transform them into something the organism can identify and react to (Bhalla, 
Jolly, Formisano, & Estrela, 2016). 
 
The ones that currently have the spotlight are, ironically, the least complex ones, 
working at the molecular level, based on conformational changes or molecule 
binding, who can regulate multiple processes, from metabolite production to 
gene expression, at the transcriptional or translational level. There is an 
exorbitant number of different biosensors in this category, as well as functions 
for them in the natural world (Mehrotra, 2016). They tend to be very specific, 
some are very conserved in evolution (Margoliash, 1963; Serganov & Nudler, 
2013), while others are more specific to a smaller group of species.  
 
The specificity, and in some cases simplicity, of these biosensor systems, have 
made them a very valuable target not just for research, but for uses such as 
industry, bioremediation, or medical treatments (Carpenter, Paulsen, & Williams, 
2018). What’s even more, thanks to synthetic biology, these natural biosensors 
have either been incorporated into organisms that did not originally produce 
them (Ravikumar, Baylon, Park, & Choi, 2017), had their efficiency improved via 
targeted mutations or evolution so that they can be used in alternative 
environments or processes (Bradley & Wang, 2015; Mahr et al., 2015; Stella, 
Wiechert, Noack, & Frunzke, 2019), or served as the base for the development of 
novel sensory circuits (B. Wang, Barahona, & Buck, 2013). 
 
Possibly the most important development is the creation of artificial biosensors, 
using the natural ones as blueprints or examples (Rogers et al., 2015). These 
  Introduction  
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studies have helped not only develop new molecules, or create sensors that 
detect compounds not naturally produced (Ramajani & Sayre, 2018), but have also 
shed light on the relationship between structure and function that lies at the core 
of some of these biosensors (Vallée-Bélisle & Plaxco, 2010); where a mutation can 
eliminate the function, modify its binding efficiency, or even create a specificity 
for other molecules.  
 
Understanding the laws that govern these changes could lead to not just a better, 
deeper understanding of the subject, but also could harbour a completely new 
way of developing sensors with very specific objectives, which could greatly 
benefit research fields like infection treatments or industrial processes. 
 
1.1 RNA. More than a middleman 
 
Nucleic acids are some of the basic elements that comprise living organisms. The 
most well-known one is obviously the double-stranded Deoxyribonucleic acid, or 
DNA. Although not as universally acknowledged as DNA, RNA plays an equally 
important role, being already associated with protein synthesis by 1939 
(Caspersson & Schultz, 1939). Being a single-stranded molecule, and the middle 
ground between DNA and proteins, RNA was initially seen as a mere intermediary, 
but as research went on, more information was obtained on the actual level of 
regulatory control RNA holds in gene expression (Morris & Mattick, 2014). RNA is 
actually highly structured, and able to fold in on itself, thanks to self-
complementary regions (Tinoco & Bustamante, 1999), which can create regions 
of double helix structures. These structural capabilities allow RNA to achieve 
multiple functions (Higgs, 2000), and showcase the fact that there is more than 
one type, with each serving a different, specific function. It is not within the scope 
of this research to delve too deeply into the categories of RNA, but to make 
special emphasis on mRNA.  
 
Messenger RNA, or mRNA, was initially a theoretical concept within Francis 
Crick’s “Central Dogma of Molecular Biology” (First stated 1958, properly 
published in Crick 1970), by which DNA is transcribed into mRNA, and this is then 
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translated into amino acids that form proteins. mRNA was isolated and proven to 
exist in 1958, thanks to research conducted by Hildegard Lamfrom and 
collaborators (Schweet, Lamfrom, & Allen, 1958); which started to unveil the level 
of intricacies within RNA biology, and all the roles its different types played in a 
functional organism. The most relevant one for the purpose of this research were 
its regulatory functions.  
 
In recent times, RNA has, slowly but steadily, become a much-appreciated 
regulatory element to be used in transcription and translation of genetic 
sequences (Erdmann, Barciszewska, Hochberg, de Groot, & Barcizsewski, 2001; 
Morris & Mattick, 2014). Regulatory RNA elements have more than enough 
qualities to stand their ground against protein elements given some of their 
positive properties: 
 
• Lower metabolic cost and higher genomic economy, since regulation is at 
the genetic level. 
• Highly conserved in evolution (Miranda-Ríos, Navarro, & Sobero, 2001) 
• Specific recognition via base pairing. 
• High specificity and orthogonality (Jenison, Gill, Pardi, & Polisky, 1994), 
which does not require high levels of the complementary molecule. 
• Thanks to the above; modification of function is much faster and easier. 
 
And despite some of their negative ones:  
• Easy degradation and instability. 
• Negative side of an easy modification of function/structure. 
• Lower binding affinities than protein molecules. 
 
All these have allowed researchers to adapt RNA molecules in order to form new 
regulatory circuits to be used in vitro or in vivo (Anzalone, Lin, Zairis, Rabadan, & 
Cornish, 2016), or development of new forms of therapy (Wagner et al., 2018) 
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1.2 Riboswitches, the smart way of regulating 
One particular type of RNAs are known as riboregulators (Krishnamurthy et al., 
2015) and comprise a group that includes aptamers (single strand 
oligonucleotides that change their structure in order to bind to proteins) 
(Hermann & Patel, 2000), or the RNA molecules known as riboswitches (Edwards 
& Batey, 2010; Serganov & Nudler, 2013). Riboswitches are regulatory mRNA 
molecules which can modify their structure due to environmental conditions, 
such as temperature changes, or the binding of a specific molecule in a segment 
of their sequence (Sherwood & Henkin, 2016; Tucker & Breaker, 2005). This 
changes the transcription or translation rate of sequences downstream from the 
riboswitch (Roth & Breaker, 2009) and is such a specific binding, that they can 
discern between specific molecules and closely related analogues.  
 
Riboswitch have two distinct domains, an aptamer domain, which detects the 
specific ligand and produces a change in 3D conformation; and the expression 
platform, which affects gene expression based on such changes.  




Figure 1. Riboswitch domains and their function. 
(From Tucker and Breaker, 2005) Common mechanisms of riboswitch regulation, at the 
transcription and translational levels. As shown, in both cases, the structural change in 
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the aptamer domain after binding to a specific molecule affects the expression platform, 
and thus the outcome of the specific process. 
Multiple organisms use riboswitches, mostly bacteria (Nudler & Mironov, 2004), 
but one specific riboswitch, known as the TPP riboswitch, has been detected in 
eukaryotes, such as plants or fungi (Sudarsan, Barrick, & Breaker, 2003). The fact 
that no riboswitches have been detected in mammalians also raises the possibility 
of their use in human therapy, either as antibiotic targets (Blount & Breaker, 
2006), or because research suggests they may not interfere with normal ligand 
interactions present in a mammalian cell environment, due to the very specific 
way in which the ligand binds to the switch (Montange & Batey, 2006). It is 
because of these reasons that riboswitches are not expected to cause any serious 
side effects in humans if used as therapy agents. 
 
All these reasons have made riboswitches a very interesting group of molecules 
to work with, and given them a very promising lead in synthetic biology research 
and development (Machtel, Bąkowska-Żywicka, & Żywicki, 2016; Robinson, 
Medina-Stacey, Wu, Vincent, & Micklefield, 2016). A great deal of research has 
been done not just on the discovery (Bengert & Dandekar, 2004) and 
characterization of riboswitches, but also on their improvement and the 
development of synthetic riboswitches in both prokaryotes and eukaryotes 
(Findeiß, Etzel, Will, Mörl, & Stadler, 2017; Groher & Suess, 2014; Win & Smolke, 
2008). This is due to riboswitches holding much potential for therapeutic 
(Mehdizadeh, Saeid, & Barzegar, 2016), metabolic engineering, or bioremediation 
(Pham et al., 2017) applications, and even for the more novel CRISPR technologies 
(Galizi & Jaramillo, 2019; Makarova et al., 2011) These can be obtained starting 
from a previously known riboswitch (Ceres, Trausch, & Batey, 2013) or aptamer 
that reacts against a specific molecule of interest. Figure 2 shows different ways 
in which artificial riboswitches can affect gene expression in prokaryotes and 
eukaryotes. 
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Figure 2. Mechanism of action of several engineered riboswitches. 
(Modified from Groher, Süß, 2014) Mechanisms of action in bacteria for engineered 
riboswitches in prokaryotes (A-D) and eukaryotes (E, F). 30s represent the ribosomal 
subunit in prokaryotes, SD the Shine-Dalgarno sequence, where the ribosome binds, and 
taRNA stands for trans-activating RNA. RNAP represent RNA polymerase. 40s is the small 
ribosomal subunit in eukaryotes, U1 represents the U1 small ribonucleoprotein, sORF for 
short open reading frame, and dORF for downstream open reading frame. A) represents 
a regulation of translation initiation via the blocking of the SD sequence B) regulation of 
translation initiation via taRNA freeing the SD sequence, C the regulation of transcription 
termination by having the aptamer bind to a complementary sequence); and D), 
regulation of transcription termination via taRNA. In the case of prokaryotes, E) shows 
the regulation via ribosomal shunting, where an aptamer domain is inserted between a 
sORF and a dORF, and ligand binding allows the shunting over to the landing site (LS), and 
reinitiation of translation; and F) is a diagram for regulation of pre-mRNA splicing, via the 
integration of an aptamer into the intron of a eukaryotic mRNA, controlling accessibility 
of l splice elements, like the 5′ splice site (5′SS), the branch point (BP) or the 3′ splice site 
(3′SS). Ligand binding can either inhibit splicing or enhance exon skipping 
 
1.3 Riboswitch improvement: Build-a-switch 
 
Riboswitches are great targets for directed evolution due to their orthogonality, 
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functionality. There are currently two main ways to improve or develop 
riboswitches de novo: Computer model predictions or Directed Evolution. 
 
The first method requires a previously known aptamer as a working base, and to 
choose a specific type of model to work with, which could be organised based on 
the type of data they use for their predictions. Many models use thermodynamics 
and free energy, accounting for what structures would be more plausible under 
certain conditions based on mathematical and computational models (Retwitzer, 
Kifer, Sengupta, & Yakhini, 2015), others use physics and folding mechanisms 
(Borujeni, Mishler, Wang, Huso, & Salis, 2015), while others use RNA and molecular 
kinetics for their predictions (Beisel & Smolke, 2009; Gong, Wang, Wang, & Zhang, 
2017).  
 
This creates predictions for “ideal” riboswitches fitting the criteria, which would 
then be synthesised and tested. But herein lies one of the problems of this 
approach. Computer models are, by definition, incomplete, and also at odds with 
one another more than once. An ideal riboswitch for model A may not be selected 
in model B, or the same sequence may have different predicted structures 
(Barsacchi, Novoa, Kellis, & Bechini, 2016). Even if models agree, the selected 
molecule may not work at the in vivo level, since all the processes happening on 
a living organism were not part of the simulation. They are, however, very useful, 
as they give insight into riboswitch structure and functionality, and can be 
updated in order to take in new constraints as research on the subject develops. 
 
In our laboratory we have developed validated methodologies for the design and 
prediction of RNA interaction circuits in vivo based on the thermodynamics 
approach (Rodrigo, Landrain, & Jaramillo, 2012; Shen et al., 2015), to the point of 
engineering a synthetic riboregulator capable of trans-activating a cis-repressed 
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1.4 Directed evolution: Playing God on a smaller scale. 
 
The second research line within synthetic biology that can be used for riboswitch 
development is known as “Directed evolution” (D.E.). The main concept to grasp 
is a sped-up evolution process towards a specific goal. Experiments are designed 
around the mutation of proteins and genetic sequences in order to evolve and 
reach a desired goal (Chen & Romesberg, 2014; Cobb, Sun, & Zhao, 2013). The 
element of interest undergoes multiple rounds of mutation, selection, and 
amplification, all in order to progressively obtain refined sequences that would 
be closer to the desired function than their parental molecules. 
In the case of novel riboswitch development, D.E. has become a significant player 
in the field, being used to detect new aptamers binding to a specific molecule of 
interest when none are known. This process is called SELEX (Systematic 
Evolution of Ligands by Exponential enrichment) (Stoltenburg, Reinemann, & 
Strehlitz, 2007). The rationale behind the method is to select or “fish” molecule-
reacting sequences out of a random oligonucleotide library bound to a multi-well 
plate, in a high-throughput manner. Non-reacting sequences are eliminated from 
the system, while the ones that do bind to the molecule of interest are amplified 
and go through increasingly stringent iterations of the same process. The final 
result is a highly enriched pool containing the selected oligonucleotides, which 
can then be used to assemble riboswitches.  
 
However, SELEX is not without its caveats (Lakhin, Tarantul, & Gening, 2013; H. 
Liu & Yu, 2018). To begin with, not every molecule of interest can have an aptamer 
developed for it, which reduces the possible target selection; and also the sheer 
amount of random sequences or “sequence space” is massive, and the process 
needs to be overseen by a researcher at several points, which means it is 
laborious and time consuming. Despite all these, one of the biggest issue SELEX 
faces is the fact that it is an in vitro process, meaning that even if some molecule-
binding aptamers are actually obtained by the end of the process, they might not 
work properly in a cell environment. Advances have been taken to deal with this 
issue, developing procedures for in vivo SELEX (Mi et al., 2010; H. Wang et al., 
2018), but even in those cases, the procedure is cumbersome and slow, relying on 
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specific modifications in the RNA for stability, and requiring extra steps of RNA 
purification and PCR in each cycle. 
 
1.5 Bacteriophages: Nature’s most efficient killing machines 
 
Bacteriophages are a group of virus which predate on hosts within the bacteria 
and archaea groups, and represent most ubiquitous and varied group among all 
organisms on Earth (Hendrix, 2003).  First hypothesized at the end of the 19th 
Century (Hankin, 1896), and discovered independently twice (D’Herelles, 1949; 
Twort, 1915), there are currently 19 recognized families within the group 
(Ackerman, 2009), based on structure and different genome organizations. Due 
to their variation, sometimes classification of a particular species is a complicated 
issue, with no efficient answer available (Gibbs, 2013). The use of bacteriophages 
in both applied and basic research fields cover a wide array of applications. These 
include phage display (Smith, 1985; Smith & Petrenko, 1997), a procedure for 
peptide isolation based on their expression on the phage’s capsid and their 
binding to a specific immobilised molecule, which would then be used for their 
purification. Phages have also recently been incorporated as an element used to 
ensure Food safety (Moye, Woolston, & Sulakvelidze, 2018), essentially using 
phages as bio-controlling agents to avoid foodborne illness. 
 
Phages are also a major player in the medical research field, being very relevant 
for the discovery of possible antibiotic compounds (J. Liu et al., 2004), their use 
in diagnostics (Schofield, Sharp, & Westwater, 2012), or one of the most impactful 
lines of phage research nowadays, phage therapy. Phage therapies were first 
started at the beginning of the 20th Century in the Soviet Union (Bunting, 1997; 
Kuchment, 2012), but fell into disuse in Western countries due to, among other 
things, the rapid rise of antibiotics, lack of understanding of the subject, and 
international disinterest in the subject (Kutter et al., 2010). The large scale of the 
current Antibiotic Crisis has once again brought Phage Therapy into the spotlight 
(Golkar, Bagasra, & Gene Pace, 2014), and it has been progressively gaining more 
support and proving useful as a bona fide therapeutic agent (R. Brown, Lengeling, 
& Wang, 2017; B. K. Chan et al., 2018). The final type of research involving phages 
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are evolutionary experiments (Fernandez-Gacio, Uguen, & Fastrez, 2003), which 
take advantage of the phage’s properties for the directed evolution of 
biomolecules.  
 
1.6 The T7 Phage: You’ve heard of him. 
 
One of the most well-known phages is the T7 phage, a member of the T4 family 
of bacteriophages discovered in the early 20th Century (Delbrück, 1946; Demerec 
& Fano, 1945). T7 is an obligate lytic phage infecting E. coli, with a genome of 
roughly 40 kb, coding for 19 different genes (Dunn, Studier, & Gottesman, 1983; 
Studier & Dunn, 1982), which have made it a very useful tool in studies of genome 
economy (L. Y. Chan, Kosuri, & Endy, 2005). Its infective properties, such as a 
short injection and lytic replication time, along with its high replication efficiency 
(approx. 100 offspring per replication) (Molineux, 2005) and the aforemented 
small genome, make it ideal for use in evolutionary experiments (Springman, 
Keller, Molineux, & Bull, 2010). To further support this, a higher mutation rate can 
be incorporated by using an error prone copy of the phage’s own DNA 
polymerase (Friedberg, Fischhaber, & Kisker, 2001).  
 
1.7 Phage-assisted strategies.  
 
T7 was recently used in the renowned evolutionary strategy known as Phage 
Assisted Continuous Evolution (PACE) (Esvelt, Carlson, & Liu, 2011). As previously 
stated, current riboswitch-developing technologies suffer from a common issue, 
the fact that they do not take place in vivo, and this system holds many 
possibilities for the field of riboswitch directed evolution  
 
The high mutation rates and relatively easy manipulation of T7 bacteriophages, 
along with the newer technologies of bacterial continuous culture, allow for a 
more autonomous process of directed evolution that does not require as much 
time and regulation from the researcher as other in vitro processes. The idea at 
the core of this process is that phages lacking a specific, essential gene are used 
to infect cells that provide such a gene in trans, but with its production regulated 
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by the desired evolutionary target, which is contained within the phage. A basic 
schematic of the process can be seen in Figure 3, indicating the way in which the 
phage drives the evolutionary process, keeping mutations away from the 
bacterial strains used.   
 
Figure 3. Overview of PACE process. 
(From Esvelt, Carlson and Liu, 2011) Schematic of the PACE process, showcasing the most 
important elements (library phages and host cells with the accessory and mutagenic 
plasmids), as well as the dynamics between them. Members of the library that do not 
produce working phages get washed out of the system due to the constant flow of cells, 
while surviving phages get progressively enriched in the phage lagoon. 
This means that only phages that are able to trigger the production of the gene 
in trans by having a working version of its regulator will complete their cycle, 
survive, and go on to the next step of the process. As the process undergoes 
subsequent iterations, the desired element will progressively become more 
functionally efficient, due to the stringency of the evolutionary process. The main 
issue of the process relies on the complexity of its bioreactor setup, which can 
represent quite a hurdle initially in order to set it up properly for the correct 
functioning of the experiments.   
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In recent years, several developments have taken place that take directed 
evolution via phages further (Yosef, Goren, Globus, Molshanski-Mor, & Qimron, 
2017b). This particular process started with the assembly of multiple plasmids 
containing leg genes from different phage species, and then transforming them 
into hosts capable of properly regulating their expression. Infecting these hosts 
with WT T7 phages produced new phages expressing the different phage legs, 
which conferred them novel host specificity. This process, based around 
transduction rather than infection, allowed for phages to act as an efficient 
carrier system for DNA that was progressively optimised via directed evolution. 
A schematic of the process can be seen on Figure 4, indicating the main elements 
and steps of the procedure. 
 
Figure 4. Overview of transduction process to extend phage host range. 
(From Yosef et al., 2017b) Schematic of the original transduction process. I) T7 phages are 
used to infect E. coli cell strains carrying specific genes encoding for different phage legs 
(responsible for their tropism). II) Via transduction, some phages incorporate the 
plasmids within their capsid, becoming phagemids, and produce the new legs. III) The 
new phages are used to infect different cells not suitable for T7 replication. If they 
expressed the proper legs, they would be able to enter the cells. IV) If phages were able 
to recognize the specific host and introduce the plasmid they carried, those cells would 
then be able to grow in a plate with specific antibiotic resistance, and the transduction 
calculated. This system was then used to introduce randomized phage leg genes, which 
would be optimised via directed evolution. 
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In my current laboratory, our own continuous culture scheme based on PACE 
was engineered by designing and developing our own bioreactor, allowing us to 
directly evolve bacteriophages containing our sequence of interest. This was 
done by infecting specifically designed selection cells strains in order to select 
for more progressively efficient activities. Our bioreactor could alternate the 
inflow of cells between different selection strains in an autonomous way, while 
maintaining an outflow that ensured cells were not able to replicate within the 
system; all allowing for just the minimal overseeing by the researcher while 
experiments were in process. However, in the cases of a malfunction by the 
bioreactor, the process could be easily done by hand using traditional methods, 
albeit less autonomously, more akin to the Phage Assisted Non-Continuous 
Evolution (PANCE) procedure from Suzuki et al. (2017). 
 
1.8 My project 
 
My research goal was to join both riboswitch development and evolution with 
directed evolution via phages, in order to use the continuous culture of bacteria 
to directly evolve a genetic sequence via bacteriophages; which in this case was 
the previously mentioned T7 virus.  
 
The key to this evolution process lies within phages containing a riboswitch 
sequence of interest; but the process could also be used for the evolution of other 
types of molecules as well. During the course of this project, there was an effort 
to evolve protein receptors using this same strategy, as part of a collaborative 
effort within the Life Sciences department at the University of Warwick. In order 
to do this, we took advantage of previously developed methodologies, assembling 
synthetic riboregulators based on our predictions, and then inserted them in the 
genome of T7 phages via homologous recombination (abbreviated HR in tables) 
(Pires, Cleto, Sillankorva, Azeredo, & Lu, 2016), a natural system by which 2 
distinct DNA sequences flanked by the same homologous regions exchange 
location. By designing specific plasmids containing regions homologous to the 
phage’s genome, we could introduce our sequences of interest and at the same 
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time eliminate specific genes from the phage, allowing us to control it by 
expressing those genes in trans. 
 
In order to select these phages, the homologous recombination process 
exchanged the T7 phage’s gene 5, encoding its DNA polymerase (Molineux, 2005); 
for our gene fragment of interest followed by the gene trxA, which encodes the 
protein thioredoxin A, an E. coli-produced protein essential for the phage’s 
replication cycle, as it works as the processivity factor for the phages DNA 
polymerase (Qimron, Marintcheva, Tabor, & Richardson, 2006). A deletion of this 
gene will directly affect the phage growth, which would impact the phage 
population’s “Efficiency of plating” (EOP), defined by Adams as “the plaque titre 
of a phage preparation, determined by plating under stated conditions, relative 
to some other estimate, usually higher, of the concentration of phage particles” 
(Adams, 1959). 
 
In the case of the directed evolution of a riboswitch, the recombined gene 
fragment contains a T7 promoter, the theophylline riboswitch (Lynch, Desai, Sajja, 
& Gallivan, 2007) controlling the expression of a repressor originating from phage 
l, known as the cI repressor (Fehér, Karcagi, Blattner, & Pósfai, 2012); and 
essential gene trxA. The cI repressor regulates the switch from a lysogenic state 
in the case of phage l, maintaining latency and preventing DNA replication and 
the exit of the phage (Dodd, Perkins, Tsemitsidis, & Egan, 2001). 
 
The rationale behind the use of the phage l cI repressor was that it acts as a 
transcriptional activator, binding to a specific promoter known as the pRM 
promoter (D. Huang, Holtz, & Maharbiz, 2012); and so, its conditional expression 
thanks to the riboswitch could be used to regulate that of subsequent genes, 
using it as a dam of sorts to control the selection process.  
 
A representation of the fragment can be seen in Figure 5, as well as the homology 
regions and gene 5 in the phage’s genome. 
 
  Introduction  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  23 
There were two phage populations used during these experiments. One 
contained an already established working version of the riboswitch (from Lynch 
et al. 2007) which will be used as a control; while the other is a phage library of 
riboswitches containing 8 random nucleotides at the end of the stem (section 
marked “N8” next to the riboswitches in Figure 5). This created a prospective 
library of 6.5536 x 104 different riboswitches to begin the evolutionary process 
with. Over the course of the rounds of selection, the number of variants within 
the population was expected to decrease, making for more homogeneous 
libraries. Initially, the ones that did not work due to basic structural constraints 
would be eliminated, and as the selection went on, conditions could be modified 
to increase its stringency, such as using a lower concentration of theophylline to 
select variants with higher binding rates. Information regarding the production 
of these libraries can be found in Chapter 3. 




Figure 5. Homologous recombination of the sequence of interest into T7 phages. 
General scheme of T7 homologous recombination, showing the T7 homology regions 
flanking the fragments of interest, and the T7 DNApol, which the phage will lose in 
exchange for it. Out of the phage’s offspring, only a small percentage of them will undergo 
this procedure. 
The recombinant phages would undergo 2 different continuous culture 
conditions; a positive selection, where the molecule of interest was present and 
thus the riboswitch selected for an active/ “ON” state, and a negative selection 
where the molecule of interest wasn’t present, and so the selected riboswitch’s 
WT 
HR 
Riboswitch l cI T7 homology T7 homology trxA 
T7 homology T7 DNA pol T7 genome T7 homology T7 genome 
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state should be inactive/ “OFF”. In both selections, in order to find a suitable 
candidate that shows a significant activation fold, multiple combinations of the 
pRM promoter and different Ribosome Binding Sites (RBSs) of variable strength 
had to be tested. Five of these RBSs originate from the iGEM registry of standard 
biological parts (http://parts.igem.org, first described in Weiss 2001) and one 
was obtained via the use of the RBS calculator (Borujeni, Channarasappa, & Salis, 
2013). Both strains also contain the mutation-inducer compound N-methyl-N′-
nitro-N-nitrosoguanidine (NG) to further increase the mutation ratio of the 
system (Sugimura, Nagao, & Okada, 1966), as well as an error-prone version of the 
phage’s DNA polymerase. 
 
The experimental setup was designed in such a way that cells were flowing in and 
getting washed out of the system before they could replicate, but however 
remained for enough time for the phages to do so. That way, any mutations that 
can affect the evolutionary process would only be conserved within the phage 
population.  All details about this procedure can be found in Chapter 4. 
 
These findings could then be used to improve current riboswitch prediction 
models (Gong et al., 2017) by feeding these new parameters into them. Obviously, 
as previously mentioned when regarding any model, there is no perfect one, since 
there are multiple elements not taken into account, due to the difficulties that 
would arise from including too many in the same model, or simply because the 
supported theory does not contemplate them. One of the biggest challenges 
would be the incorporation of the in vivo data into models, something for which 
this research could be helpful. By analysing the resulting riboswitch structures 
after the evolutionary procedure, conclusions could be drawn based on the 
different nucleotides present, not only from a structural, but from a functional 
standpoint as well; which could be included in some of the aforenoted models in 
order to improve their prediction power.  
 
The presented experimental setup was also valid for other types of sensors that 
are trying to be evolved, with the main elements driving the selection being the 
same in all cases. One such alternative evolution is the case of the MmfR/MmyB 
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system, regulating biosynthesis of the molecules known as methylenomycin 
furans (MMF) (O’Rourke et al., 2009), which was tackled as part of a collaboration 
with Dr Christophe Corre at the University of Warwick. 
The mmyB gene codes for a protein regulating the synthesis of MMF, and in order 
to regulate the system, once the concentration is high enough, the MMF 
molecules bind to the MmfR protein encoded in gene mmfR, and repress the 
action of MmyB. All details about this procedure can be found in Chapter 4. 
 
In recent years, as explained previously, my laboratory has also started 
developing a new strategy discussed in the literature (Yosef et al., 2017b) based 
upon the use of “phagemids”; bacterial plasmids containing a sequence of interest 
as well as a phage’s packaging signal and an antibiotic resistance, in order for 
some of the viral offspring to pack it within their virion during the replication 
process (Chung & Hinkle, 1990b). By keeping the riboswitches in a plasmid library, 
rather than recombining them into the phages, a higher activation could be 
achieved, by growing cells with theophylline in the media for enough time to fully 
activate any working variants present. And by eliminating the full phage in favour 
of phagemids, the replication only happens under very specific terms, and can be 
triggered when needed, rather than having to accommodate everything in the 
original seventeen minutes of T7 replication. All details of this procedure can be 
found in Chapter 5. 
 
As a side project throughout the final stretches of this PhD, a different project 
was undertaken, which, however, kept similar beats to the previous work that 
conforms this thesis. The development of an inducible gene expression system 
based upon the genome of the Qb bacteriophage (Gorzelnik et al., 2016). This (+) 
ssRNA phage has a very compact genome with only 4 genes, one of which is a 
well-conserved RNA-dependent RNA polymerase known as replicase (D. Brown 
& Gold, 1996; Kashiwagi & Yomo, 2011). By eliminating one of the phage’s genes 
and substituting it for an antibiotic resistance gene, experiments were designed 
to confirm whether this would be a viable novel system for transient and 
conditional gene expression to be developed. All details regarding this procedure 
can be found in Chapter 6. 
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AIMS AND MAIN OBJECTIVES 
 
RNA regulation is an essential part of gene expression in living organisms, and a 
key player in the advance of synthetic biology systems. The aims of this thesis 
revolve around developing efficient ways in which phages can be harnessed to 
develop new ways to use and improve current RNA regulation systems, as well as 
to create de novo elements for multiple research settings. 
 
To summarise, the main objective of this thesis was as follows: 
 
- To set up a system for the directed evolution of riboswitches using T7 phages 
in a continuous culture scheme, via the development of a phage riboswitch 
library and specific selection strains.  
 
As the project moved forward, secondary objectives arose which were directly 
related to the main one: 
 
- To set up an alternative strategy using phagemids instead of full phages. 
- To test these systems in the evolution of alternative molecules, such as cell 
membrane receptors. 
 
In one case, separated from but following a similar path to all previous 
experiments, the objective was: 
 
- To develop a transient RNA-dependent system for the tuneable expression of 
genes in bacteria by incorporating them on the genome of bacteriophage Qb 
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CHAPTER 2. MATERIALS AND METHODS 
 
2.1 Original cell strains 
 
E. coli DH5α, TOP10, MG1655Z1, from the laboratory’s own stock; and cells from 
the Keio Collection (Baba et al., 2006), namely the parental Strain E. coli BW25113, 
and KO strains for essential phage genes cmk, trxA, and both (CGSC, 
http://cgsc2.biology.yale.edu). The specifics for each of these strains can be 
found in , and all are available in the laboratory’s LIMS. 
 
Table 1. List of E. coli strains used throughout the PhD.  
List of cell strains used throughout the PhD as part of all the different projects. Keio 
collection strains described in  Baba et al., (2006) and found at the Coli Genetic Stock 
Center (https://cgsc2.biology.yale.edu/KeioList.php) 
Strain name Genotype Project & Origin 
E. coli DH5a F– endA1 glnV44 thi-
1 recA1 relA1 gyrA96 deoR nupG purB20 
φ80dlacZM15 (lacZYA-argF)U169, 
hsdR17(rK–mK+), λ–  
P) Initial full phage strategy 
(Discarded) 
O) Lab stocks 
E. coli TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 
φ80lacZM15 lacX74 nupG recA1 
araD139 (ara-leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ- 
P) Initial full phage strategy 
(Discarded), Phagemid strategy 
O) Lab stocks 
E. coli MG1655 K-12 F– λ– ilvG– rfb-50 rph-1 
 
P) Initial full phage strategy, 
(Discarded) 
O) Lab stocks 
E. coli BW25113 lacI+rrnBT14 lacZWJ16 hsdR514 
araBADAH33 rhaBADLD78 rph-1  
(araB–D)567 (rhaD–B)568 
lacZ4787(::rrnB-3) hsdR514 rph-1 
P) Full phage strategy, cloning 
procedures, Phagemid strategy 
O) Lab stocks, SAJ128 





3), λ-, rph-1, trxA732::kan, (rhaD-
rhaB)568, hsdR514 
P) Full phage strategy, 
phagemid strategy 
O) Lab stocks, SAJ130 
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3), λ ,-cmk-734::kan, rph-1 (rhaD-
rhaB)568, hsdR514 
P) Full phage strategy, 
phagemid strategy 
O) Lab stocks 
E. coli BW25113 
∆trxA∆cmk 
F-, ∆(araD-araB)567, lacZ4787(::rrnB-
3), λ ,- trxA732::tet, cmk-734:: kan, 
rph-1 (rhaD-rhaB)568, hsdR514 
P) Full phage strategy, 
phagemid strategy 
O) Lab stocks, SAJ19 
E. coli LEMO21 DE3 fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS/ pLemo(CamR) 
 
P) Qb strategy 
O) New England Biolabs 
E. coli BL21 DE3 E. coli str. B 
F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 
[lacI lacUV5-T7p07 ind1 sam7 nin5]) 
[malB+]K-12(λS) 
P) Qb strategy 
O) New England Biolabs, SAJ733 
E. coli BL21 AI E. coli B F– ompT gal dcm lon hsdSB(rB–
mB–) [malB+]K-12(λS) araB::T7RNAP-tetA 
P) Qb strategy 
O) Invitrogen, SAJ760 
 
2.2 Original phage strains 
 
All phages used throughout this PhD were T7 phages, part of the laboratory 
stocks. Phage Qb is not included as part of this list due to its genome being 
sequenced inside a custom-ordered plasmid, not as a free phage. 
 
Table 2. List of original T7 strains used throughout the PhD  
T7 strains and the projects they were used for during the length of the PhD.  
 
Strain  Project Origin 
WT T7 Full phage strategy, phagemid strategy Lab stocks 
T7 ∆gp5  Phagemid strategy Lab stocks 
T7 ∆gp5 trxA+ Phagemid strategy Lab stocks 
 
2.3 Lysogeny broth media 
 
All bacterial strains were grown in LB unless specified accordingly, with any 
alternative media used only for specific experiments. For 1 L of broth: 1 L H2O, 10 
g Peptone 140, 5 g yeast extract, and 5 g sodium chloride are needed. 
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2.4 Theophylline solution 
 
In order to obtain a stock solution of 25 mM, 225 mg of powdered theophylline 
were diluted in 50 ml of dH2O and vortexed until fully diluted, then aliquoted into 
1.5 ml Eppendorf tubes in order to avoid thawing more than the needed quantity 
for the required experiments at any given time. 
 
2.5 Saline-Magnesium (SM) buffer 
 
Solution used for long-term storage of phages at 4ºC, stabilizes them and avoids 
the risk of contamination by microorganisms. For 1L of SM buffer: 1 L water, 50 
mM Tris-HCl 7.5, 100 mM NaCl, and 100 mM MgSO4. (Based upon the same recipe 
used in Lee, Billington, Hudson, & Heinemann, 2011) 
 
2.6 M9 media 
 
M9 is a minimal media used for fluorometric assays, to measure the expression 
of GFP. For a total of 200 ml, 100 uM of CaCl2, 2 mM of MgSO4, 10 uM of FeSO4, 40 
ml of 5X M9 salts, 3.2 ml of 50% glycerol, 8 ml of 5 % cas-amino acids, 1 µg/ml of 
thiamine, 20 mg/ml of uracil, 30 µg/ml of Leucine, 50 µL of NaOH 8 M and add 




Throughout all experiments described in this thesis, different antibiotics have 
been used in growth media or plates for bacterial culture and are indicated when 
appropriate. Here are the names and stock concentrations of the most used ones. 
 
Table 3. List of antibiotics used throughout the PhD. 
Ampicillin (Amp) Chloramphenicol 
(Cm) 
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All cultures and plates were made with a 1/1000 dilution of the corresponding 
antibiotic or antibiotic mix. E.g. 5 ml of an Amp culture would have 5 µl of Amp 
added to it, while an Amp/Kan would have 2.5 µl of each to keep the same ratio. 
 
2.8 Competent cell production 
 
For transformation purposes, many of the cell lines used needed to be made 
competent at different stages of the project, so two methods were used, one to 
make electrocompetent cells, and another to make chemically competent ones. 
 
2.8.1 Electrocompetent cells:  
Prepared according to the Krantz Lab protocol 
(http://mcb.berkeley.edu/labs/krantz/protocols/electrocomp_cells.pdf).  
10 ml of overnight culture was added to 1 L of LB and grown at 37ºC with shaking 
until the OD600 nm reached exponential culture, between 0.35 and 0.4. These 
exponentially growing cells were kept at 4ºC for the remainder of the process.  
The volume was then split into ice-cold centrifuge tubes and the cells pelleted at 
1000 g for 20 min at 4ºC. The supernatant was discarded, and the pellets 
resuspend in ice-cold sterile water, dividing the number of tubes in half by 
combining the pellets. This procedure was repeated twice more, each time 
halving the number of tubes and the volume of water. After the last pelleting of 
the cells, the cells were resuspended in ice-cold 10% glycerol, halving the volume 
once more. The cells were pelleted, and the supernatant discarded, each pellet 
was resuspended in 1 ml of ice-cold glycerol. 50 µL of the suspension were 
aliquoted into chilled Eppendorf tubes and stored at -80ºC. 
 
2.8.2 Chemically competent:  
10 ml of an overnight culture was added to 1 L of LB and grown at 37ºC with 
shaking, until OD600 was between 0.35 and 0.4.  The cells were then put on ice for 
30 minutes, before being pelleted by centrifugation (3000 g, 4ºC for 5 minutes). 
The supernatant was discarded, and the cells resuspended in 10 ml of 100 mM 
CaCl2. The cells were incubated on ice for 30 min, before the cells pelleted by 
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centrifugation using the same conditions as previously described. The 
supernatant was again discarded, and the cells resuspended in 10 ml of 100 mM 
MgCl2 and incubated on ice 30 minutes. Finally, they were pelleted again, the 
supernatant discarded and resuspended into 2 ml of CaCl2+10% glycerol, ensuring 




Plasmids were transformed into both electrically and chemically  competent 
cells. In the first case, a minimum of 100 ng of DNA were added to 50 µL of 
competent cells and left on ice for 15 minutes, along with a 2-mm gap 
electroporation cuvette from BioRad (BioRad #1652086). The volume was then 
transferred to the cuvette, the cells electroporated using a MicroPulser 
Electroporator from BioRad (BioRad #1652100) and then grown in LB media for 1 
hour, before being plated. For chemically competent cells, the DNA was added to 
the 50 µL of cells, which were left on ice for 30 minutes, then heat-shocked at 
42ºC for 90 seconds, and put back on ice for 10 minutes, before recuperating 
them in LB media for an hour. Cells were then plated on a LB agar plate with 




All plasmids are presented with its original nomenclature and the specific one 
used throughout the project. Presented here are the parental plasmids used as 
template for all others throughout the project. The assemblies were made either 
by enzymatic digestion at 37 ºC and overnight ligation at 20ºC, or using the 
process known as Golden Gate ligation (Engler, Kandzia, & Marillonnet, 2008), 
where indicated as such. The details on each specific variation based on these 
plasmids will be discussed in the relevant chapters. All plasmid maps can be found 
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Table 4. List of parental plasmids used throughout the PhD. 




Figure 6 4226 bp (cmk)  




pMB1 Ori, Cm+. T7 
homology regions 
4.7 & 5.3 flanking 
pT7 followed by 
cmk, cI, & trxA.  cmk 
eliminated via 
digestion with BglII 
and BamHI 
pSEVA631/EG_002 Figure 7 3001 bp 
 
SEVA plasmids 




site, flanked by 
rrnB T1 terminator, 
lt0 terminator, 




Figure 8 7135 bp 
 
EG_002 Same as EG_002, 
with pTyàEP T7 










Figure 9 8677 bp 
 
EG_002 Same as EG_002, 
with pTyàEP T7 
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Figure 6. Parental plasmid 
EG_001. 
Plasmid map of parental 
homologous recombination 
plasmid EG_001, indicating 
the phage recombination 
elements 4.7 and 5.3, 
flanking the lambda cI gene, 









Figure 7. Parental plasmid 
pSEVA631.  
Structure for the pSEVA631 
plasmid, used to assemble 
all other selection plasmids. 
Based upon the European 
standard of SEVA plasmids 
(Silva-Rocha et al., 2013), 
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Figure 8. Positive selection 
parental plasmid EG_002+. 
Positive selection parental 
plasmid, used as a template 
for all subsequent plasmids 












Figure 9. Negative selection 
parental plasmid EG_002-. 
Negative selection parental 
plasmid used as a template 
for all negative selection 
plasmids over the use of 
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2.11 Primers and Gblocks 
 
All gene sequence constructs produced by Integrated DNA Technologies. Melting 
temperatures (Tm) of the primers were calculated using the NEB calculator 
(www.neb.com/external-links/tm-calculator). All primers’ name, sequence and 
designed use can be found in Table 5. 
 
Table 5. List of primers used throughout the thesis. 
List of main primers used throughout the different strategies, divided into newly 
designed primers and pre-existing ones. Specific sub-categories are present in the table. 
For each primer there is its the name, sequence and specific use. 
PRIMER NAME USE SEQUENCE 
  Designed primers 
EG_GG01 











EG_GG03 cI insert + Rd Rbsw Fwd 
aaggtctcccaccnnnnnnnnagacaacaaga
tgagcacaaaaaagaaaccgagaccaa 
EG_GG04 cI insert + Fix Rbsw Fwd 
aaggtctcccaccccgctgcaagacaacaagatg
agcacaaaaaagaaaccgagaccaa 
EG_GG05 cI insert+ Rbsw Rev ttggtctcggtttcttttttgtgctcatcttgttgtc 
   
EG_064 Goldengate presence test Fw tgccgataagaccaacatga 
EG_065 Goldengate presence test Rv gcatcaagacgatgctggta 
EG_068 









EG_096 Detect pifA presence  cggaagaaagagcgcttcaaccggactgccg 
EG_097 Gene 5 Fwd ctcaaggtcgccaaagtgg 
EG_098 Gene 5 Rev gaaggacactttaaatttctttgtcatagcc 
EG_099 
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EG_100 
Change RBS for cmk or pifA in 










Change origin of replication in 




Change origin of replication in 












Gene 5 base addition for insertion 




Phagemid base addition for gene 
5 insertion Rev 
aggtctcatcgagtcagccaaacgtctcttc 
EG_108 
Gene 5 base addition for insertion 
in phagemid plasmid Rev 
aggtctcagtcgacttagtggcaaatcgcc 
EG_109 
Phagemid base addition for gene 
5 insertion Fw 
aggtctcacgacctgcagtaaagcccgcttcg 
EG_112 




Confirmation of plasmid 
presence 1 (Fw) 
ggtttttttgtttgcaagcagcagattacg 
EG_116 
Confirmation of plasmid 
presence 1 (Rev) 
cggggagtcaggcaactatgg 
EG_117 
Confirmation of plasmid 
presence 2 (Fw) 
gtatttagaaaaataaacaaataggggttccgcg 
EG_118 
Confirmation of plasmid 
presence 2 (Rev) 
ttgtgagcggataacaatttcacacagg 
EG_119 
Confirmation of plasmid 
presence 3 (Fw) 
ctggggtgcctaatgagtgagc 
EG_120 
Confirmation of plasmid 
presence 3 (Rev) 
gtcgatttttgtgatgctcgtcagg 
EG_123 
Mid l cI to check for riboswitch 
(Rev) 
gttgtgcttacccatctctccg 
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EG_124 
Addition of overhangs for 





Addition of overhangs for 





Addition of overhangs to GFP for 




Addition of overhangs to GFP for 




Confirmation of GFP plasmid 
presence 1 (Fw) 
caacgatcaaggcgagttacatgatccc 
EG_129 
Confirmation of GFP plasmid 




Confirmation of GFP plasmid 




Confirmation of GFP plasmid 
presence 2 (Rev) 
tgtaactcgccttgatcgttgggaaccggagctg 
EG_132 
Confirmation of GFP plasmid 




Confirmation of GFP plasmid 
presence 3 (Rev) 
gtttgctaacctagggtgcgtatag 
NGS procedure   
EG_NGS 
_Fwd 
Initial NGS amplification primer, 





Initial NGS amplification primer, 










NGS amplification primer Rev 
gtctcgtgggctcggagatgtgtataagagacagc
tttaaggcgacgtgcgtcctc 





Addition of sequence and Eco31I 




Addition of sequence containing 
RBS B0030 and Eco31I site (Rev) 
ttatttggtctcttcatctagtatttctcctctttaat
ctctagacaagatacattgtaaa 
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re_prm31 
Addition of sequence containing 




Addition of sequence containing 




Addition of sequence containing 




Addition of sequence containing 




Addition of sequence containing 




Addition of T7 RBS sequence and 





Addition of sequence containing 
T7 RBS and Eco31I site (Rev) 
ttatttggtctcttcattctctacctccttaatgtgtt
ctattgacgactc 
Diagnostic Binding to:  
seq_pLitGG_Fwd PmB1 Origin of replication gtcgatttttgtgatgctcgtcag 
WR_PR4 Homology region 5.3 
ttggtctctgccatactagcatttcagaagcagca
cc 
WR_PR6 Homology region 5.3 ttggtctctgccacacctgttaagtgtctttcgttc 
WR_PR8 Homology region 5.3 
ttggtctctgccattcatgagtagcctcctgtagtc
g 
PS2_T0Rev T0 region in selection plasmids gcggcaaccgagcgttc 
VF2 
G00100_VF2 annealing site in 
selection plasmids 
tgccacctgacgtctaagaa 
gp5EP_Rev Error prone T7 gene 5 cacggttgagttgcagctta 
Gp5_mtplx_Fwd Error prone T7 gene 5 tcaccgacgttggctatactac 
Gp5_mtplx_Rev Error prone T7 gene 5 ccatcctgcttcttgcagtttt 
PS1_T1Fw T1 region in selection plasmids agggcggcggatttgtcc 
 
2.12 Restriction enzymes 
 
All used enzymes were part of the FastDigest line from Thermo Scientific. All 
digestions were carried out at 37 ºC, using 200 ng of DNA template, 1 µl of 
FastDigest enzymes, and 2 µl of 10x buffer solutions from ThermoFisher in a final 
volume of 20 µL. 
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2.13 Ligation 
 
A mixture of 100 fmol of the corresponding plasmid backbone and 100 fmol of the 
desired insert, along with 2 µl of Thermo Scientific’s 10x Ligase buffer and 2 µl of 
T4 ligase (ThermoFisher #EL0014) in a final volume of 20 µl, was incubated at 25º 
C for 1 h in order for the fragments to anneal, then be purified and transformed. 
 
2.14 Polymerase Chain Reaction 
 
All PCR reactions used for plasmid assembly were done using the 2x Phusion 
High-Fidelity PCR Master Mix with HF buffer from NEB (Wrenbeck et al., 2016) in 
a 50 µL volume, with the corresponding primers and sample.  
In cases where the secondary structure of the sequences produced problems 
with the amplification, different percentages of DMSO were used (3, 6 and in one 
case, 9%) to help with the correct amplification. Diagnostic PCRs from colonies 
or phage samples were done using a 2x Taq or GreenTaq Mix from Thermo 
Scientific (Weyant, Edmonds, & Swaminathan, 1990) and in a 25 µl volume. 
 
2.15 Goldengate assembly 
 
(Based on Engler et al., 2008) Starting from the desired plasmid backbone, 
primers were designed and ordered to Integrated DNA technologies (IDT). These 
primers contain an overhang (a sequence not present in the original template) 
which introduces a BsaI/Eco31I cutting site. Compatible ends are included into 
the tails of the primers used to amplify the fragment to be introduced in the 
backbone. Using 100 fmol of each DNA template, 1 µL of BsaI from New England 
Biolabs (NEB), 1 µL of T4 DNA ligase from Fermentas (Rossi, Montecucco, 
Ciarrocchi, & Biamonti, 1997), 2 µL of 10x ligase buffer and water up to 20 µL, each 
reaction tube underwent the following series of cycles: 2 minutes at 37°C, 5 
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2.16 Agarose gel electrophoresis 
 
Amplified samples were run in gels made of 1% agarose in 1x TAE buffer, in order 
to confirm their size and approximate quantity, at 95 volts for 30 minutes as a 
general rule, with times varying depending on the exact size of the fragment. 
Smaller samples were run in a 2% gel for better discerning of their size. 
 
2.17 DNA fragment purifications 
 
All PCR reactions were purified using the ThermoFisher GeneJET PCR 
purification kit (ThermoFisher #K0701) according to the manufacturer’s 
protocol. In cases where several bands appeared when running the sample in a 
gel, the band of interest was cut and then purified using the GeneJET Gel 
extraction kit from Thermo Scientific (ThermoFisher #K0691) 
 
2.18 Bacterial culture 
 
In order to obtain cell cultures for the various assays, colonies picked from grown 
plates were added to 5 ml of LB, with addition of the appropriate antibiotic where 
necessary, using Falcon 15 ml round bottom tubes. In the cases of positive 
selection strains, to have them ready for assays, 300 µL of 25 mM theophylline 
were added to the 5 ml. Overnight cultures were refreshed the next day and used 
when at OD between 0.2 and 0.3 The remaining overnight culture was used to 
obtain glycerol stocks and minipreps for -80º C storage. 
 
2.19 Phage killing/infection 
 
To obtain phage populations or test their killing efficiencies, phages were added 
to cultures within the logarithmic growth phase (OD 0.2-0.3) of the desired 
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2.20 Lysate filtration 
 
The cells post-infection were pelleted by centrifugation at 3000 rpm/2254 g for 
10 min in an Eppendorf centrifuge 5920 R.  To obtain clean phage samples the 
remaining lysates were filtered through a 2 µm Sartorius filters. 
2.21 Bacterial Growth assays 
 
The wells of a flat bottomed 96-well plate were filled with 180 µL of growing 
bacterial cell culture at an OD of between 0.2-0.3 with the addition of 20 µL of 
the tested phages or controls. Where theophylline was required in the culture it 
was added to the bacterial cells before they were aliquoted into the 96-well plate. 
The plate reader (TECAN SPECTRAFluor PLUS (TECAN #F121005) measured at 
OD600 every 2 minutes after shaking for a duration of 5 hours. The growth curves 
for each strain were plotted using Microsoft Excel to compare differences 
between strains and select the best candidates for the evolution procedure. 
 
2.22 Plaque assays 
 
The efficiency of the phage replication was tested by infecting 300 µL of cells at 
an OD600 of between 0.2-0.3 with 100 µL of phage at several different dilutions. 
This was then mixed with 3 ml of soft LB agar (LB agar was diluted 50% with LB) 
and plated with the corresponding antibiotics. After overnight growth at 37º C, 
clear spots known as “plaques” can be observed in the bacterial lawn of the plate. 
These assays were made both in the presence and absence of 1.5 mM 
theophylline, to assess the leakiness of the system and the activation of the 
riboswitch 
 
2.23 One-Step assay 
 
This procedure was adapted from Ellis, E. L. , Delbruck, (1940). These assays 
follow the same procedure as a plaque assay, but phage samples were obtained 
from infecting a culture, obtaining samples every 4 minutes over a period of 40 
minutes, showing the rise in the number of phages as the infection proceeds. The 
assays were also made in the presence or absence of 1.5 mM theophylline, in order 
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to show a difference not just between the two types of sample treatment, but the 
addition of the molecule to the media. These phage samples were then used for 
plaque assays. Figure 10 shows a diagram of the procedure and sample treatment. 
 
Figure 10. Overview of One-Step plaque assay.  
General diagram of a one-step assay. Once the phages, at a MOI/Multiplicity of infection 
of 10-2 (1 phage/100 cells) have been added to the culture, samples are taken, and undergo 
different treatments. “A” are centrifuged to pellet the cells and obtain the phages present 
in the supernatant, while “B” samples have chloroform added to them, causing bacteria 
to burst and release phages that had not yet exited the cells. In order to eliminate any 
remaining bacterial remnant present in the final samples, chloroform is added again, and 
those phage samples are then used for a plaque assay, where a difference should be 
observable between different samples and time points. 
 
2.24 Next generation sequencing 
 
In order to assess the full sizes of the riboswitch library, several different 
strategies and companies were considered, but finally the in-home genomics 
facility at the University of Warwick was chosen. A 174 bp fragment containing 
the riboswitch sequence was amplified via PCR from libraries in different steps of 
the experimental procedure, creating specific overhangs, that, using a NEXTERA 
XT index kit from Illumina, would be used to specifically tag the sequences of one 
specific library. Using an Illumina MiSeq system (Illumina #SY-410-1003), and 
samples from different stages of selection, the aim was to assess the library sizes 
in each of these steps, and then infer whether or not  evolution has occurred in 
the process, and what that means. 
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3.1.1 The importance of theophylline 
 
As explained in the introduction, riboswitches are a type of mRNA that holds a lot 
of promise in the field of synthetic biology, due to its structural simplicity, 
versatility, and regulatory capabilities. Riboswitches regulate gene expression 
thanks to the conformational changes produced after the binding of a specific 
molecule to their aptamer domain. One of the examples within this group that 
has been most thoroughly researched binds theophylline (C7H8N4O2) (Chi et al., 
2019; Cui et al., 2017; Nakahira, Ogawa, Asano, Oyama, & Tozawa, 2013; Rankin, 
Fuller, Hamor, Gabarra, & Shields, 2006; Suess, Fink, Berens, Stentz, & Hillen, 
2004).  This can be understood due to the fact that theophylline is a small 
molecule with a fairly simple structure, which makes binding easier, and that it is 
used for different medical treatments (Barnes, 2013).  These reasons made the 
theophylline riboswitch an ideal candidate for a directed evolution procedure, 
the main objective of this project, but that could potentially be used in the 
directed evolution of other riboswitches and biosensor molecules.  
 
Previous successful evolutionary experiments have been made with this 
riboswitch at their centre, which further support its use in this case (Lynch et al., 
2007; Lynch & Gallivan, 2009; Topp & Gallivan, 2008). A library of riboswitch 
sequences was constructed as starting point for the evolution. There are many 
ways a genetic sequence library can be assembled, such as via error-prone PCR 
and the lred system (Abou-Nader & Benedik, 2010), end-to-end ligation (Isalan, 
2006) or the use of degenerate nucleotides for cassette-based PCR amplification. 
 
3.1.2 How to get away with evolution 
The way this challenge was finally approached involved introducing the 
riboswitch sequence to be evolved inside a population of T7 phages. Due to the 
difficulties of directly modifying a phage’s genome, the initial step was to amplify 
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the genetic sequences of interest with primers including a randomised region, 
thus assembling a library of riboswitches. This fragment was then cloned in a 
plasmid backbone and transformed into E. coli cells, which were then infected by 
WT T7 phages, some of which incorporated the sequence via the process known 
as homologous recombination (Haber, 2008). 
 
Gallivan and collaborators had already tested a similar approach for the evolution 
of a random riboswitch sequence (Lynch et al., 2007), creating randomised 
libraries of the theophylline riboswitch with different spacer sizes between its 
end and the beginning of the regulated gene, as well as a high-throughput 
motility-based screening to detect optimal riboswitches. This research, along 
with the previously mentioned PACE strategy, are essential influences in the 
development of this project. Previous work (Lynch & Gallivan, 2009) showed the 
possibility of doing the same with a 12 nucleotide (12N) fragment, but given how 
this project was focused on developing the method, such a wide variety of 
sequences was deemed excessive, and the decision was taken to just randomise 
a region of 8 nucleotides.  
 
To help proper regulation, upstream from the riboswitch regulatory elements 
such as a T7 terminator and promoter (Temme, Hill, Segall-Shapiro, Moser, & 
Voigt, 2012) were included, to control the expression of the l phage cI gene (Fehér 
et al., 2012), which will be essential in the selection process the riboswitch 
sequences would have to go through. 
 
Although the project was initially designed with homologous recombination in 
mind, over the course of time an alternative was also considered, via the inclusion 
of a T7 packaging signal. Yosef, Goren, Globus, Molshanski-Mor, & Qimron, (2017) 
showed that by transforming a cell with a plasmid carrying a phage’s packaging 
signal, WT phages infecting those cells were able to pack the plasmid inside the 
virion instead of their original genome. This process creates what is known as a 
phage particle or transducing particle. Their research demonstrated changes in 
host specificity by introducing genes corresponding to phage-host interaction, 
showing that foreign genes can function appropriately in this type of particle. 
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Following their steps, and previous research about T7 packaging signal such as 
Chung & Hinkle, (1990), the approach for the original phage library of 
riboswitches was reconsidered. Instead of undergoing homologous 
recombination to introduce the riboswitch library inside the phage, homology 
regions would be eliminated from the plasmid, and a T7 packaging signal would 
be included along with the library and the control riboswitch.  
By doing so, the theory was that it would allow for some advantages when 
compared to the full phage system, such as a higher efficiency than with 
homologous recombination, in itself an uncommon occurrence. But most 
importantly, it gave the whole system, specifically the riboswitch, more time in 
the presence of theophylline as the cells were growing. 
 
This would translate into higher activation levels of cI expression by the time of 
infection, instead of the more or less 17 minutes it had when present inside of the 
phage. In the latter, the whole process of interaction with theophylline and cI 
regulation had to occur between phages attaching themselves to the cell and 
bursting out at the end of the lytic cycle, a process which showed useful 
differences in activation levels, but that could be improved. 
 
Apart from the introduction of a packaging signal, this new plasmid library 
required an alternative regulation system (since the phage will only be acting as 
a vessel); meaning that the original T7 promoter placed in front of the riboswitch 
had to be exchanged for an E. coli promoter. Due to its already known strength 
and efficiency, the chosen part was J23119 (C. C. Liu et al., 2012). 
 
3.2 Specific Objectives 
 
To obtain an initial plasmid library of randomised riboswitches. The plasmid 
library could then be turned into a phage library via homologous recombination 
or have a T7 packaging signal incorporated into its sequence, to allow packaging 
inside the T7 virion transduced into other cells. 
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3.3 Specific materials and methods 
 
3.3.1 Homologous recombination/Full phage procedure: 
• Vector assembly: 
Using as a template the plasmid EG_001, which contained regions of homology 
with the T7 genome flanking the l cI gene and the essential genes trxA and cmk, 
several of the primers from Table 5 were designed to include, via PCR, a gene 
fragment containing a T7 terminator, T7 promoter, and a truncated riboswitch 
sequence, all incorporated in front of cI, ensuring its expression was regulated by 
the activation of the working riboswitch. Before all this was attempted, cmk was 
removed from the plasmid using the compatible restriction enzymes BglII and 
HindIII, as its presence within the phage would render the designed selection 
process useless.  
 
Once cmk had been eliminated from the plasmid, the assembly of the final desired 
plasmid containing all the elements needed required several intermediate steps. 
Plasmid EG_001 was amplified via PCR using primers EG_GG001 and 
EG_GG002, which stand out from other primers due to their significant length. 
This was done so as to make the cloning procedure easier, allowing for the 
introduction of several elements in one step of cloning.  
 
This amplification created intermediate sequence EG_temp01 (Supplementary 
figure 1A). Furthermore, both primers were designed with cutting sites for 
BpiI/BbsI at the end of their sequence, as shown in Figure 11, so that after 
amplification, both ends of the plasmid could be digested and re-ligated via 
Gibson assembly, as described in the general materials and methods. After this 
procedure, the re-ligated plasmid EG_temp02 was obtained (Supplementary 
figure 1B). This vector contained all the necessary elements for the experiments, 
with the exception of the specific randomised region within the riboswitch that 
will be the base of the library, as well as the fixed version of the riboswitch that 
was to be used as a control. In order to obtain this, the vector had to be cut using 
the incorporated Eco31I/BsaI sites introduced through PCR, and then set up for 
GoldenGate reaction with the desired fragments, as previously described. 
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Figure 11. Initial amplification for HR fragment. 
Detail from the sequence added via the use of primers EG_GG02Fw and EG_GG02Rev, 
which also incorporate cutting sites for digestion enzymes BpiI/BbsI and BsaI/Eco31I for 
further digestions down the working pipeline.  
 
• Primer Overlap: 
In parallel to these procedures, two nucleotide fragments were assembled, using 
three overlapping oligos (EG_GG03, EG_GG04 and EG_GG05) which also 
introduced within the sequence the Eco31I/BsaI sites complementary to the ones 
included within the plasmid. One of the sequences contained the ending 
nucleotides of the 8.1 version of the theophylline riboswitch, from (Lynch et al., 
2007) which had already been shown to be a very effective version of the 
riboswitch, with a high activation rate (EG_GG04 and EG_GG05). The other 
fragment was made using degenerate oligos, containing eight random 
nucleotides (8N) in an even distribution of 25% for each nucleotide, giving a final 
sequence space of 65.536 x 104 different sequences to begin the evolutionary 
process with (EG_GG03 and EG_GG05). To produce these fragments via PCR, 
for the Golden Gate assembly, each of the two different combinations were mixed 
along Phusion High-fidelity PCR MasterMix and went through a specific protocol 
on the Thermocycler, with 5 rounds of 30 seconds at 70ºC + 10 seconds of 
extension at 72ºC. These reactions were then purified using the previously 
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Figure 12.  Fixed and random riboswitch fragments inserted in HR fragment. 
Details from the fragments produced via oligonucleotide annealing of the primer pairs 
EG_GG004 and EG_GG005, and EG_GG003 and EG_GG_005. Both have the same 
length and cutting sites, with the main difference being that the sequence of 04 (A) 
includes a fixed tail for the theophylline riboswitch, while the one from 03 (B) contains 8 
random nucleotides that form the random riboswitch library. The grey squares represent 
the cutting sites for the enzyme Eco31I/BsaI, designed to be complementary to the ones 
present in the plasmid where the fragments will be incorporated. 
 
These two sets of fragments were then incorporated into the plasmid backbone 
of EG_temp02 via GoldenGate assembly, using the complementary BsaI/Eco31I 
cutting sites present in the plasmid and the fragments to introduce the final 
nucleotides of the riboswitch within the plasmid without leaving a digestion scar.  
 
• Homologous recombination:  
The production of a plasmid library, however, is not the main objective of this 
project, since to evolve the riboswitches, they need to be inserted into the 
genome of a T7 phage. In order to do so, these two plasmid populations were each 
transformed into E. coli BW25113 cells which already contained the T7 gene 
A 
B 
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product 5 (gp5: DNA polymerase) in a plasmid backbone carrying Kanamycin 
(Kan) resistance, thus making these cells Kan and Cm resistant.  
 
Once these populations were established, they were subjected to homologous 
recombination (Haber, 2008), being infected with WT phages so that during the 
replication procedure, the regions present in the plasmid which are homologous 
to the phage’s genome allow for the exchange of a fragment between phage and 
plasmid. This exchange produces a subpopulation of phages different from WT 
phages, which will be carrying the fragment previously flanked in the plasmid by 
the phage’s homology arms. 
 
In order to maximize this procedure, there must be enough phages so as to allow 
proper replication and avoid bias in the phage population, while at the same time 
not overwhelming bacteria by completely killing them in one round of replication; 
allowing for several rounds to augment the chances of the recombination 
process. After several tests with different ratios, we arrived at an ideal phage/cell 
ratio of 10-5. This can be seen in Figure 16 in the results section. 
 
Due to the loss of the T7 DNApol in their genome, in order for these phages to be 
obtained, it was necessary for the cells to carry a copy of the previously 
mentioned T7 gp5/DNA pol gene. The presence of this protein is essential to 
ensure the replication of any phage that undergoes homologous recombination, 
as they lose their WT copy of gp5 and thus their ability to replicate when 
incorporating either version of the fragment within their genome.  
 
• Selection of homologous recombined phages: 
The resulting phage lysates obtained from these infections were comprised of 
both WT and homologous recombined phages, so in order to obtain a pure stock, 
they needed to be selected. Selection was achieved by infecting E. coli BW25113 
∆trxA T7gp5+ cells with the lysates, as WT phages would not be able to replicate 
due to the lack of the thioredoxin A gene, while recombined ones carry it as part 
of the fragment of interest. These initial lysates were used for plaque assays in 
both ∆trxA and regular E. coli BW25113 cells, in order to assess the presence of 
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WT and recombinant phages. The plaques formed in the first case were isolated 
and then used to infect liquid cultures of ∆trxA cells. The lysates obtained from 
these infections were formed exclusively of recombined phages, and this 
hypothesis was once again tested via plaque assays in both ∆trxA and regular E. 
coli BW25113 cells, confirming the absence of WT. 
 
• Riboswitch sequencing: 
Sanger sequencing provided by Eurofins Genomics was used at different points 
throughout this process to ensure the presence of the desired riboswitch 
variants. Each sample sent contained on average 400 ng of DNA in a total volume 
of 10 µl, including 1 µl of the specific primer used. Sequencing was done in batches 
after Gibson assembly of the plasmid populations, and after the homologous 
recombination procedures. While multiple bacterial clones and phages were 
individually sequenced and several different nucleotide fragments were found 
within the random region, it needs to be stated for the record that the full scale 
of the variation present in the random riboswitch library was not assessed at the 
initial point of the experimental pipeline. The full scale of variation was 
determined much further down the road, as the proper setup and development 
of the evolution process was prioritised, given that only the Fixed control 
riboswitch sequence was needed in order to properly test the methodology.  
 
3.3.2 Transduction/Phagemid strategy: 
• Packaging signal design: 
Based on the work by Yosef, Goren, Globus, Molshanski-Mor, & Qimron, (2017b) 
and the original T7 packaging signal reference used by them (Chung & Hinkle, 
1990b, 1990a), different packaging signals were designed with the purpose of 
integrating the sequence inside of the riboswitch plasmids EG_cI01 and 
EG_cI02. These sequences were formed of several T7 elements and ordered from 
IDT DNA in the form of readily assembled Gblocks. Such fragments included a T7 
promoter PhiOR (Orlov, Ryasik, & Sorokin, 2018), short repeats from the phage’s 
genome right end (SRR) (Studier & Dunn, 1982), one set of the phage’s terminal 
repeats (TR) (Hoelz, Hickey, & Malkas, 2004) and the short terminal repeats from 
the left side (SRL). The different sequences simply varied in the length of these 
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different elements, with the differences being shown in Figure 13. Only one of the 
two identical copies of the terminal repeat sequence is included within the 
packaging signal so that it would hybridise with the ones present in the phage’s 




Figure 13. Structure of the different packaging signals. 
Different T7 packaging signal sequences designed over the course of the project. In grey, 
each of the elements incorporated as part of the different packaging signals, acting as a 
reference. In red, the parts of each sequence that aligned to the genetic sequence of each 
reference. The middle gap in each of the three sequences represent a bses present in the 
standard that were not incorporated into the novel sequences. Sequences B and C were 
the initial attempts, differing in the inclusion of the left end short repeats (SLR), while 
sequence A was the one that was finally incorporated into the riboswitch plasmid.  
 
• Vector assembly: 
Starting from the plasmid EG_cI02 and using the process of GoldenGate 
assembly, sequence A from Figure 13 was incorporated into the plasmid, 
eliminating all but the last 29 nucleotides of T7 homology region 4.7. Using the 
same technique, gene 5.3 was eliminated, introducing in its place a copy of the 
error-prone T7 DNA polymerase, which would allow, as stated in the 
introduction, for the ∆gp5 phages used in this strategy to replicate inside the cell 
and avoid having to use WT T7 in the process. The plasmid also retained the 
original Cm resistance.  
No modification of EG_cI01 was made, since by this point the ideal selection 
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modification in this process. Because of this, there was no need for a control 
plasmid carrying the fixed version of the riboswitch in this strategy. 
 
This gave as a result the sequence known as EG_Pm01b (Supplementary figure 8. 
A). This plasmid was tested for some phagemid production experiments but was 
discarded and some of its elements replaced due to a basic flaw that had gone 
unnoticed. The remainder of gene 4.7 was eliminated, and the T7 promoter 
included in front of the riboswitch was substituted for the E. coli promoter J23119, 
giving as a result EG_Pm01C (Supplementary figure 8. B) 
 
• Phagemid library production experiments: 
In the initial experiments, to test the procedure, cultures of cells carrying the 
packaging signal plasmid were infected with WT phages until the culture cleared 
out, after approximately 1 h. Then, the tubes were centrifuged at 14000 g for 10 
minutes, and supernatants were filter purified. These supernatants were treated 
as phage lysates, and assays were developed as classical plaque assays, save for 
the absence of soft agar. 300 µl of cells at an OD between 0.2 and 0.3 were mixed 
with 100 µl of the lysate and then plated onto Cm-containing plates, which were 
left to grow overnight at 37º C. If phagemids were present in the lysate and 
managed to infect the cells, colonies would appear on the plate. As a parallel 
assay, in order to assess the presence of WT phages, regular plaque assays were 
done, as previously described. The efficiency of the process was measured by the 
ratio of colonies to plaques in the 2 assays. These assays were eventually carried 
out with multiple types of cell strains and phages, including E. coli strains TOP10, 
BW25113, BW25113 ∆trxA, BW251143 ∆cmk, and BW25113∆cmk∆trxA. The phage 
strains include WT T7 phages, and two types of ∆gp5 T7, one carrying trxA and cI, 
and one carrying trxA. All these combinations were assessed to confirm the exact 
conditions where the transduction process could work, and whether or not the 
absence of the essential genes would impair the function of a phage particle as it 
did in the case of HR phages. TOP10 were used as a negative control of sorts, as 
previous lab experience shows T7 infection is less efficient in this particular strain 
than it is on BW25113.  
 
  Riboswitch library assembly  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  53 
3.4 Results: 
 
3.4.1 Plasmid assembly 
 
• HR_Fix plasmid/EG_cI01: 3569 bp (Figure 14A) 
This plasmid incorporated the same final nucleotides present in the 8.1 version of 
the theophylline riboswitch shown in Figure 14B, (from Lynch et al., 2007). This 
plasmid served as the quality control for the system, carrying a properly 
established riboswitch, and using it to set up the different steps before 
attempting evolution by using the randomised library of switches. 
 
• HR_Random plasmid/EG_cI02: 3569 bp.  
Comprised of the same elements as EG_cI01 (Figure 14A) , but in this construct 
the riboswitch contains a randomized region of 8 nucleotides after the stem of 
the riboswitch and before the RBS (Figure 14C). This means that this is actually a 
plasmid library of riboswitches, containing theoretically 65.536 x 104 variants. 
These will be used for the evolution experiments once the method has been 
properly set up using the fixed version of the riboswitch.  
 




  Riboswitch library assembly  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  54 
Riboswitch-carrying plasmid used for homologous recombination. A) gene map 
indicating elements carried by the plasmid, with the homologous recombination 
fragment present between gene 4.7 and gene 5.3. B) 8.1 version of the riboswitch, which 
showed the biggest activation fold in Lynch, et al., 2007. C) Structure of the theoretical 
library obtained after randomizing the 8 nucleotides following the stem of the riboswitch.  
 
Both plasmids had the exact same size and components, and only differ in those 
8 nucleotides at the end of the riboswitch. Details of the final riboswitch 
sequence between the T7 terminator and the l cI gene are shown in Figure 15. 
 
Figure 15 Final homologous recombination fragment 
Final sequence of the modified region between the T7 promoter (A) and the cI gene (B), 
showing the two final versions of the riboswitch, the Fixed one (C) and the Randomized 
one (D). It is also shown that the pre-existing Eco31R/BsaI sites are gone after the 
GoldenGate reaction took place, which explains why part of the primers used to 
incorporate them (EG_GG2Fwd &Rev) do not bind to the sequence anymore. The full 
sequence of these primers can be found in Table 5. 
 
3.4.2 Homologous recombination procedure:  
A PCR of the same region in the phages obtained at different MOIs showed the 
difference in size between fragments from WT, erroneous HR phages, and 
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Figure 16. Results from HR procedure at different MOIs.  
The bands correspond to the amplification of the homology region between T7 gene’s 4.7 
and 5.3. The image shows the size for the original WT amplification of T7 gp5 (4058 bp) as 
a control, and the results from the HR procedure at different MOIs. Both 10-3 and 10-4 show 
a band at roughly 2000 bp, smaller than the expected size, indicating something went 
wrong in the procedure, while 10-5 shows a fragment of the expected size (3017 bp), 
corresponding to the full fragment of interest. The ladder used was the GeneRuler 1kb 
Plus ladder. 
 
3.4.C Library assembly 
Samples from the different plasmid constructs were sequenced to confirm 
whether or not they contained the correct sequences. After the homologous 
recombination process, 20 phages that appeared to have undergone the process 
were also sequenced to assess if they indeed contained the desired sequence of 
interest. The results from the sequencing of elements from EG_cI01 and 
EG_cI02, as well as these recombinant pre-selection phage populations, show 
the different versions of the riboswitch in both the plasmid and phage libraries. 
The Fixed, non-randomised version of the switch was present in the phage and 
plasmid populations, confirming it remained unchanged. Both the plasmid and 
the phage populations containing the randomised libraries show no repetition of 
sequences, which gives us basis to believe there is no bias in the population, and 
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Figure 17. Sequence variation within obtained plasmid and phage populations. 
Collection of sequences obtained throughout the development of the different libraries. 
A) Riboswitch sequences obtained by Sanger sequencing corresponding to the PCR of 
single colonies carrying plasmids EG_cI01 (Fix) and EG_cI02 (Random). 
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B) Sequences from the PCR of HR phages carrying the fragment of interest, which could 
come from EG_cI01 or EG_cI02. Fix phages were used to set up the evolution procedure. 
The results from the sequencing of EG_cI01 and EG_cI02 are also applicable for 
the alternative method of transduction, as the plasmid library had already been 
established, and the only difference was the addition of the different packaging 
signal sequences to test.  
 
3.5 Discussion of results: 
 
The obtained sequencing results from both plasmid populations confirmed the 
presence of the sequence of interest, both in the case of the fixed riboswitch 
sequence, where it remained constant in all members, and the randomised 
riboswitch library, with no sequence appearing more than once in the different 
samples analysed.  
The subsequent analysis of the recombined phages proved that the populations 
of phages had incorporated the sequences in both cases, and the variation 
present in the case of the randomised phage library indicated no bias. This 
allowed the project to go on to its next stage and use the phages carrying the 
fixed riboswitch to set up the evolutionary process, and then test the random 
phage to evolve the sequence over generations of selection. 
 
Further down the experimental timeline, Next Generation Sequencing 
procedures took place, and samples corresponding to EG_cI01, cI02 and the 
initial phage populations were prepared to be run in an Illumina MiSeq and 
sequenced, in order to further confirm the library variation within each 
population. These results can be seen in Chapter 4 of this thesis.
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4.1.1 T7, the perfect tool for evolution. 
The T7 phage is a member of the T4 family of bacteriophages, and one of the most 
researched and understood phages. This is mainly due to its obligatory fast-
paced lytic life cycle, which covers cell entry, replication, assembly and lysis in 
around 17 minutes, generating around 100 offspring per infection (Molineux, 
2005). Its fully mapped genome is comprised of 40 kb, and the function all the key 
genes are appropriately accounted for (L. Y. Chan et al., 2005).  
 
A schematic of the genome of the T7 phage and its virion are shown in Figure 18A 
and B. The full list of the genes in the T7 genome can be found in in the 









Figure 18. Genome and virion structure of T7 phage.  
A) 
B) 
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A) Schematic diagram for the genetic structure of the T7 phage. The genes are 
progressively transcribed over time, starting from the left of the diagram to the right. 
Promoters are marked with a black arrowhead, while terminators are marked with a black 
circle. Arrowheads below the map represent RNase III processing sites, and the short 
lines between the long, parallel ones represent the beginning and end of each gene, 
marked above by its corresponding number. B) Schematic representation of the T7 
phage’s virion, representing it protein components, encoded by the genes marked as 
“Class III” in A). Both figures were taken from (Molineux, 2005). 
An advantage of studying the T7 phage is that its mutation rate can be regulated 
through the replacement of the gene encoding its DNA polymerase with an error-
prone version (Friedberg et al., 2001). This makes it ideal for a directed evolution 
strategy, such as the one discussed within this thesis.  
 
4.1.2 Riboswitch evolutionary strategy: EvolutiON & EvolutiOFF 
As discussed previously, there were two strategies developed during the duration 
of this project. One, based on the use of T7 phages, and another based on T7-
derived infected particles, or phagemids.  
The main strategy, designed and tested during the project, was based on full T7 
phages and homologous recombination, to achieve the evolution of a riboswitch 
sequence by tying it to the phage’s replication efficiency. After homologous 
recombination, the resulting phages lose their gp5/DNA polymerase in favour of 
the fragment of interest (Figure 15 in Chapter 3). gp5 is essential for the phage to 
replicate and therefore the loss of this gene from the phage genome is a problem. 
This is overcome by expressing the gp5 gene in trans inside the infected cells. 
 
In the fragment of interest, a T7 promoter and the riboswitch regulate the 
expression of l phage gene cI; upstream from the gene trxA, which codes for the 
protein thioredoxin A. this is an E. coli-produced protein essential for the phage’s 
replication cycle, which works as the processivity factor for the phage’s DNA 
polymerase (Qimron et al., 2006). This gene, however, is not the main focus of the 
evolutionary procedures, this corresponds to the riboswitch. 
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Riboswitches have two 3D configurations dependant on the presence of their 
specific activator molecule, which in this case is theophylline. Therefore, 
selection needed to have two steps: 1.  Selection is designed towards an “ON” 
stage of the switch, with the activator present, and 2. Selection towards an “OFF” 
state, with the activator absent. Each of these selections occur in E. coli selection 
strains with their own genetic makeup. In both selection steps, the cells were KO 
for the trxA gene, as it was already included within the T7 phage. In the positive 
selection, the cells also lacked cmk, another T7 phage essential gene.  
Genes trxA and cmk were selected as targets in this strategy due to their large 
impact in the proper replication of the T7 phage. A full list of E.coli genes with an 
impact on T7 replication (from Qimron et al., 2006) can be seen in . 
 
Table 6. List of E. coli genes identified as essential for T7 growth.  
From Quimron, et al, 2006. Table shows the names, gene products and T7’s efficiency of 
plating (EOP, essentially the titre of the phage preparation); both when the gene is 
knocked out and when it is complemented via a plasmid. 
Gene Gene product EOP 
EOP after 
complementation 
trxA Thioredoxin A <10-2  1 
cmk CMK/dCMP kinase 0.05 0.91 
gmhA LPS biosynthesis enzyme <10-2 0.86 
gmhB LPS biosynthesis enzyme 0.30 0.83 
waaC LPS biosynthesis enzyme <10-2 0.80 
gmhD LPS biosynthesis enzyme <10-2 0.16 
gmhE LPS biosynthesis enzyme 0.01 0.88 
waaF LPS biosynthesis enzyme 0.23 0.79 
waag LPS biosynthesis enzyme 0.01 0.82 
galU LPS biosynthesis enzyme 0.29 0.82 
waaR LPS biosynthesis enzyme <10-2 0.79 
 
The cmk gene encodes CMP/dCMP kinase, which catalyses the conversion of 
CMP/dCMP to CDP/dCDP, using ATP as a phosphate group donor. The lack of 
constitutive cmk in the cells is explained by the fact that its expression is what 
controls the positive selection step. When a phage containing a random 
riboswitch sequence infected a bacteria from the positive strain, if the riboswitch 
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attained its “ON” conformation, the transcription of the cI gene would start. The 
repressor would then bind to the pRM promoter in the cell and activate the 
expression of cmk, allowing phages with a working version of the random 
riboswitch to replicate. A schematic of this process is shown in Figure 19.
 
 
Figure 19. Schematic representation of the positive selection process. 
As the aim of this step is to select riboswitches in an “ON” state, theophylline is present 
in the media where cells are grown. 1) If the phage carries a version of the switch which 
is unable to turn on in such a case, the cascade initiated by cI won’t start, and no cmk will 
be produced, thus impairing phage replication and eliminating those members from the 
population. 2) If the switch is able to turn on in this case, however, phage replication will 
occur and those elements will remain in the population.  
 
All phages able to replicate in the positive selection cells would go on to infect 
the negative selection strain. In this case, with the activator molecule absent, the 
objective is to select for riboswitches that remain in an “OFF” conformation. In 
this case, the pRM promoter regulated the expression of the T7-exclusion gene 
pifA. This gene was originally found on the E. coli F-plasmid (Garcia & Molineux, 
1995) and is able to block the  replication of T7 when it is expressed. The 
mechanism by which this process occurs is not well defined, but it is known that 
it is triggered by the co-expression of pifA and T7 genes 1.2 or 10 (Schmitt & 
Molineux, 1991), and that it happens on the surface of the cell (Cheng, Wang, & 
Molineux, 2004). By conditionally regulating the expression of this gene, any 
phage containing a version of the riboswitch with a constitutively “ON” 
1 
2 
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conformation would be eliminated from the system; and only those which are 
“OFF” in the absence of theophylline would be able to replicate and stay in 
subsequent evolution steps. A schematic of this process is shown in Figure 20. 
 
Figure 20. Schematic representation of the negative selection process. 
As the aim of this step is to select riboswitches in an “OFF” state, theophylline is absent 
in the media where cells are grown. 1) If the phage carries a version of the switch which 
remains on in such a case, the cascade initiated by cI will start, and pifA will be produced, 
thus impairing phage replication and eliminating those members from the population. 2) 
If the switch remains off in this case, however, phage replication will occur and those 
elements will remain in the population.   
The presented experimental setup was also valid for the evolution of other types 
of sensors, with the main elements driving the selection (cmk, pifA) being the 
same in all cases. The mmfR/mmyB genes are part of a larger system that 
regulates biosynthesis of the antibiotic molecule known as methylenomycin (Mm) 
in S. coelicolor, and are autoregulated by the presence of molecules known as 
methylenomycin furans (MMF), also produced within the system (O’Rourke et al., 
2009). The mmyB gene codes for a transcriptional activator of the synthesis of 
Mm, and in order to regulate the system, MmfR represses mmyB. However, once 
concentration of MMF molecules is high enough, MmfR repression is blocked.  
 
A simplified diagram of the pathway can be found in Figure 21. 
1 
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Figure 21. Diagram of the interactions between MMF, mmfR and mmyB.  
Genes mmfR and mmyB are part of the regulating system responsible for Mm production. 
mmfR encodes MmfR, which represses the mmyB and thusly, the biosynthesis of the Mm 
compounds. Once the levels of MMF are high enough to repress MmfR regulation, the 
MmyB activator can be produced and Mm biosynthesis starts. 
 
To this end, T7 phages underwent homologous recombination and selection, in 
order to obtain phages containing the 3 different versions of the mmfR 
(transcribed from original gene mmfr (O’Rourke et al., 2009), and mutants 
SAV2270 (Corre, Song, O’Rourke, Chater, & Challis, 2008)  and sgnR (Sidda et al., 
2014). These would be used in the selection process, with a plasmid containing 
the MARE4 gene variant and cmk in the positive selection step, where the 
repressor would not bind and thus the gene will be expressed; and mmyB and 
pifA in the negative selection, where the objective would be to bind the repressor 
and block the production of the exclusion protein PifA.  
 
All information regarding these processes and the results obtained will be 
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4.2 Specific Objectives 
 
The objective of this chapter was the development and further assessment of a 
methodology for the directed evolution of riboswitches using recombined T7 
phages, and to adapt this methodology for the evolution of alternative sensors. 
 
4.3 Specific materials and methods: 
 
4.3.1 Plasmid assembly specifications:  
All the constructs assembled were based on previously available plasmids present 
in the laboratory’s stock. The assemblies were made either by enzymatic 
digestion at 37ºC and overnight ligation at 20ºC, or using GoldenGate ligation 
(Engler et al., 2008), where indicated as such.  
 
•  EG_001: 3490 bp (Figure 6)  
Starting from the backbone of this plasmid, PCR amplifications were done to 
incorporate GoldenGate cutting sites, which would allow for a gene fragment to 
be incorporated, containing a T7 promoter sequence controlling the riboswitch, 
the theophylline riboswitch, and the cI gene. This process was done for both 
EG_cI01 and EG_cI02, in order to have both the control and library populations. 
 
• EG_002+, EG_002-: 7135/8677 bp, respectively (Figure 8 and Figure 9) 
These original plasmids underwent further modifications in order to assemble all 
the positive and negative selection plasmids. All different cargos were introduced 
into EG002 via Goldengate assembly, using the previously mentioned 
GoldenGate cutting sites. 
 
Plasmids specific to the l cI project: 
• HR_Fix plasmid/EG_cI01: 3569 bp. (Figure 14)  
As described in the Library Assembly chapter, this plasmid was based upon the 
∆cmk version of Pr100 pLit Chlor previously described in general methods. Via 
the use of GoldenGate assembly, a gene fragment containing a T7 terminator, a 
T7 promoter, and a version of the theophylline riboswitch with a high-fold 
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activation was introduced directly upstream from the cI regulator from phage l. 
This riboswitch was taken from the literature (Figure 22A, from Lynch, Desai, 
Sajja, & Gallivan, 2007). This plasmid was used as a positive control for the 
efficiency of the method; given that since it carries a properly established 
riboswitch, which we knew turned ON and stayed OFF in the corresponding 
environments.  
 
• HR_Random plasmid/EG_cI02: 3569 bp.  
The same elements as EG_cI01, but the riboswitch contains a randomized region 
of 8 nucleotides after the stem of the riboswitch and before the RBS (Figure 22B) 
creating a plasmid library of riboswitches containing theoretically 65.536 x 104 
variants. These will be used for the evolution experiments once the method has 
been properly set up using the fixed version of the riboswitch. 
 
Figure 22. Riboswitch versions. 
A) 8.1 version of the riboswitch, which showed the biggest activation fold in Lynch, et al., 
2007. B) Structure of the theoretical library obtained after randomizing the 8 nucleotides 
following the stem of the riboswitch.  
 
Positive selection variants:  
Based upon the positive selection plasmid EG_002+, different combinations of 
promoter and RBS were tested in order to select for the ideal construct to use in 
the current experimental design. This would incorporate a combination of 
A) B) 
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promoter and RBS that gave very low production of cmk for a riboswitch in an 
OFF state (without theophylline), and a higher one for an ON riboswitch (with 
theophylline). 8 variants were assembled, 6 of them used test combinations, and 
2 of them used as controls. The plasmid maps, which can be found in the 
Supplementary Material and Methods section, were as follows:  
 
• EG_cI03: (6093 bp, Supplementary figure 2.   
The positive control, which contained a T7 promoter and a strong synthetic RBS 
in control of the cmk gene, ensuring its expression, and so, the proper replication 
of phages, regardless of the presence of theophylline.   
 
• EG_cI10: (6054 bp, Supplementary figure 3)  
The negative control, which contained neither promoter nor RBS in front of cmk, 
so phages wouldn’t be able to replicate under any circumstances.  
 
• EG_cI04-09: (6155 bp, Supplementary figure 4)  
The test variants, which contained the previously described pRM promoter 
followed by 1 of 6 different RBSs of different strengths. These RBSs were known 
as B0030, B0031, B0032, B0033 (Weiss, 2001), B0064 (Modified from Weiss, 2001), 
and B00Syn, obtained via the use of the web server version of the RBS calculator 
(https://salislab.net/software/ from Salis, Mirsky and Voigt, 2009)  
  
Negative selection variants: 
Based on negative selection plasmid EG_002-. Just like in the case of the positive 
selection, 8 variants were tested, 2 of them being controls and 6 of them being 
tests. All the variations are as previously described, except for the plasmids 
containing the T7 exclusion gene pifA instead of cmk.  
o Positive control/EG_cI11: 7635 bp, Supplementary figure 5A 
o Negative control/EG_cI18: 7600 bp, Supplementary figure 5B 
o Test variants/EG_cI12-17: 7700 bp, Supplementary figure 5C 
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Plasmids specific to the Mmfr project 
Homologous recombination (HR) plasmids:  
A secondary set of homologous recombination plasmids was generated to allow 
the evolution of a different set of sensors using our phage strategy. Several 
versions of the plasmid were assembled containing several variants of the gene 
of interest, the transcriptional regulator mmfR (O’Rourke, et al. 2009). These 
variants included the original gene and two of its variants, named sgnR (Sidda, et 
al., 2014) and SAV2270 (Corre, et al., 2008) and were all based on plasmid EG_001. 
 
• mmfR HR plasmid/EG_m01: 3726 bp, Supplementary figure 6A.  
Containing everything previously mentioned for the HR plasmid, but including a 
T7 promoter, the lac operator and an RBS in front of the mmfR gene (649 bp)  
 
• sgnR HR plasmid/EG_m02 3680 bp, Supplementary figure 6B.  
The only difference with the EG_m01 plasmid is the substitution of the mmfR for 
its sgnR variant (600 bp). 
 
• SAV2270 HR plasmid/EG_m03: 3738 bp, Supplementary figure 6C.  
Difference with EG_m01 plasmid is the substitution of sgnR for avaL1 (657 bp) 
 
Selection plasmids:  
As part of the evolution strategy, a selection strategy was also developed. As in 
previous strategies, these plasmids are based upon EG002, with cmk and pifA 
driving the selection. These plasmids contain GFP as a reporter in front the 
regulatory genes, to indicate when gene expression is happening in the system. 
 
• Negative selection A/EG_m04: 6953 bp, Supplementary figure 7A.  
Containing the original operator mmyB, sfGFP and cmk.  
 
• Negative selection B/EG_m05: 6953 bp, Supplementary figure 7B.  
Same as EG_m04, except for the mutated version of mmyB operator, MARE-4.  
• Positive Selection A/EG_m06: 8502 bp, Supplementary figure 7C.  
Containing the original operator mmyB, sfGFP and pifA.  
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Positive Selection B/EG_m07: 8501 bp, Supplementary figure 7D.  
Same as EG_m07, except for the mutated version of mmyB operator, MARE-4.  
 
4.3.2 Experimental procedure for riboswitch evolution: 
The initial aim for the project was to introduce the sequence of the SP6 RNA 
polymerase, which had already been used in directed evolution efforts (Breaker, 
Banerji, & Joyce, 1994), within the homologous recombination plasmids, 
downstream from the riboswitch sequence to be evolved. Due to an inability to 
assemble these constructs correctly, as well as some results from other members 
of the lab that seemed to indicate this strategy was not as efficient as expected, 
it was discarded in favour of the l cI strategy. 
  
After having produced the two riboswitch-containing phage populations, the 
phages containing the fixed version of the riboswitch were tested against the 
positive selection strains, E. coli BW25113∆trxA∆cmk modified from the Keio 
collection transformed with the corresponding plasmids. These tests included 
plaque assays, growth assays, and one-step assays; both in presence and absence 
of 1.5 mM theophylline in the media; working as an indicator of which strains 
offered the highest activation fold when the riboswitch is ON, and whether or not 
the system “leaked”, producing Cmk and allowing the phage to replicate. 
 
Once the positive selection strain was selected, the experiments for the negative 
selection started, by using Keio E. coli BW25113∆trxA cells transformed with the 
plasmid. These cells allowed phages to replicate properly if the riboswitch they 
contained was OFF in the absence of theophylline. If for some reason it turned 
ON, this will activate the pifA gene, and block replication. The procedures were 
done in the same fashion as with the positive selection, but due to much clearer 
results, only some of the assays were made in the case of the negative selection. 
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After both strains were selected, bioreactor experiments could be properly set 
up, with phages being present in a “lagoon”, where different strains were added, 
ideally switching every hour (Times were tentative to improvement). The system 
flushed the cells before they had time to replicate, but after the phages managed 
to do so. This meant evolution only affected phages, as cells were not able to 
maintain any mutations they develop in the system. The lagoon also contained 
the chemical compound N-methyl-N’-nitro-N-nitrosoguanidine (NG) (Sugimura 
et al., 1966) to increase the phage’s mutation rate, making up for the possibly 
smaller size of the factual library compared to the theoretical one. The process 
would go on for several rounds, with samples taken at different time points 
during the experiment; and the multiple phages will be sequenced in order to 
observe the differences in the riboswitch, and its impact on infection rates as 
evolution goes on. A diagram of the bioreactor, as well as schematic version of 
the procedure are shown in Figure 23 and Figure 24. 
 
Figure 23. Schematic representation of the original bioreactor. 
The figure represents the different elements that form the bioreactor: media that is added 
to each of the selection strains to ensure constant growth, two cell vats where each of 
them is grown and their OD monitored, with proper aeration and waste disposal, using 
chloroform to ensure no cell remains in the pool. Each strain will then be alternatively 
added to the phage reactor for infection; with a washout time higher than the phages’ 
replication time, but lower than the cells’, ensuring mutations are only conserved within 
the phage population. 
Theophylline 
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General structure of the originally designed procedure. A) A phage library of switches is 
used to infect the positive strain, containing a positive selection plasmid (blue +). B) In the 
presence of theophylline, only phages with working variants of the riboswitch will be able 
to replicate properly. The system washes out cells before they have time to replicate, 
ensuring phages unable to replicate within that timeframe are eliminated, as well as 
keeping phages as the main driver of variability and evolution in the system. C) These 
surviving phages will then go on to the negative selection step after a time that can be 
regulated according to the need. D) In this case, the absence of theophylline means that 
riboswitches should stay inactive, but in order to eliminate constitutively active phages, 
the pifA gene gets transcribed and those phages are unable to replicate properly. The 
resulting phages will then go back to infecting the positive selection strain after the 
desired time, and then the system will start once again in 1), progressively forcing the 
evolutionary pressure towards functional and improved riboswitches over time. 
 
However, due to technical difficulties with the bioreactor arising in the last year 
of the project, the experiments that had been planned had to be adapted to hand-
made individual assays, using a serial dilution approach. In this case, the 
experiment started with 2 ml of the selection strain being infected at OD 0.2-0.3 
with 20 µl of the phage library of riboswitches, at an approximate MOI of 10-5. The 
infected culture was grown for 1 h at 37º C, after which 1 ml was taken out and 
spun down at 3000 g for 10 minutes; with the resulting supernatant being 
transferred to a new 1.5 ml tube, 10 µl of chloroform added and then vortexed for 
15 seconds. This sample was diluted up to 10-12, in order to develop a spot assay 
and observe the approximate number of phages obtained. These would then be 
used to infect the negative selection, and the process reiterated for as many 
generations as wanted. Sixteen rounds of double selection were made for this 
thesis, with the concentration of theophylline reduced to 1 mM after the tenth 
one. The process is the same for the mmfR project, with the only difference being 
the regulatory elements in this case.  
 
4.3.3 Evolutionary procedure: 
Starting from the initial library of random riboswitches obtained after 
homologous recombination, phages were used to alternatively infect the 
selection strains, starting with the positive selection. 2 ml of infected cultures at 
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an OD600 nm between 0.2-0.3 and an approximate MOI of 10-6/10-7, each time, 
and put in a shaking incubator at 37ºC. One hour after infection, 1 ml of the 
culture was removed, and the cells pelleted by centrifugation at 14,000 g. The 
supernatant was then transferred to a new tube, where 10 µl of chloroform was 
added to lyse any remaining cells. These phage samples were then serially diluted 
12 times, and used in a spot assay, with 3 samples of 3 µl for every dilution. Once 
dried, the plates were grown at 37ºC overnight, and the plaques counted to 
calculate the approximate number of plaque-forming units (pfu) in each sample. 
In some cases, plaque assays were made to ensure a more specific count of the 
pfu/ml of each sample.  
 
Phage samples were then labelled according to their generation number and 
stored at 4ºC. 
 
4.3.4 Next Generation Sequencing preparation 
This strategy was designed following the 16S amplicon sequencing protocol from 
Illumina, using its Nextera XT DNA Library Kit (Illumina #FC-131-001) to prepare 
the samples so they could be run on an Illumina MiSeq. 
PCR was carried out to amplify a 175 bp fragment from the phage genome 
containing the closest elements present upstream and downstream from the 
region containing the 8 randomized nucleotides of the riboswitch (Figure 25A). 
The primers used in this PCR also incorporated sequences necessary to carry out 
the indexing PCR for the sequencing (Figure 25B). Combinations of primers used 
in the Index PCR are shown in the supplementary materials, in Supplementary 
Table 3. 
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Figure 25. Amplification steps for NGS preparation. 
Selected amplicon to be used for the NGS procedures. A) Original amplicon as it is present 
in the recombined phages’ genome, 175 base pairs in size, containing fragments upstream 
and downstream from the random riboswitch sequence. B) Amplicon obtained after the 
PCR, with the desired primers having added the required Illumina overhangs for the 
Indexing PCR. C) Detailed sequence of the final amplicon, indicating the original 
sequences and the overhangs. 
4.3.5 Quantitative PCR assays of samples. 
The Illumina NEBNext Library Quant kit (New England Biolabs #E7630S) was 
used to carry out qPCR to determine the concentration level of each index PCR. 
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The PCR was run for a total of 35 cycles, with the distribution of samples shown 
on Supplementary table 3. 
 
4.3.6 Data analysis of the Next Generation Sequencing results: 
After the results from the MiSeq run, Fastq files for each of the 24 different 
samples analysed in each run were produced using the Illumina FASTQ 
Generation App, V 1.0.0. Each file contained hundreds of thousands of sequences. 
These sequences required several different treatments to enable their proper 
analysis.  
The sequence analysis was approached in two different ways: 
- Via the use of the AptaSUITE program (Hoinka, Backofen, & Przytycka, 2018) 
in order to categorise the variation over generations of phages. 
- Via the use of several independent Bioinformatic tools to trim, align, and 
organise the multiple sequences over generations. 
 
AptaSUITE is an opensource software developed specifically as a way of 
condensing all the bioinformatic workflow necessary to analyse high-throughput 
SELEX data, all within the same framework. AptaSUITE offers the possibility of 
recreating an accurate version of the selection process and cluster the different 
sequences present into each library pool, following their evolution throughout 
the subsequent generations. 
 
Despite all its positives, several issues essentially stemming from a lack of proper 
troubleshooting of the software and computational power, this approach was 
discarded in favour of the more traditional, (albeit slower) use of independent 
bioinformatic tools to extract the relevant data from the NGS sequences. This 
analysis, and the corresponding results shown in Figure 33, were made by Carlos 
Bondia, as stated in the Declaration on page 6 of this thesis. 
 
Due to the lack of computer power, the initial set of analyses were done in a 
fraction of the total number of sequences, approximately 105 per sample. 
Sequence quality control was performed using the FastQC software (Andrews, 
2010). After trimming, all reads corresponding to each sample were aligned to the 
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initial “parent” sequence (as designed and cloned into the initial vector prior to 
selection) using a recursive Needleman-Wunsch pairwise alignment algorithm 
(Rice, Longden, & Bleasby, 2000). 
Once aligned, all reads were trimmed from both ends until only the 8 nt-long 
riboswitch plus 5 bases either side remained. Trimming was performed using 
base R, by finding the 8 nucleotide long “NNNNNNNN” motif in the parent 
sequence and extracting this position (±5bp) for all reads in each sequence. Once 
extracted, nucleotide proportions were calculated by stacking each position and 
counting the number of each nucleotide that was informative (not ambiguous), 
which is considered a Bit. The program doesn’t only count which percentage of 
each nucleotide is present in every position, as there are many reads showing an 
ambiguous read or just a gap in these positions. Hence, in order to account for 
this, it creates a list and only counts the number of times every base is clear, 
represented as an informative Bit, according to information theory. The entire 
process of nucleotide counting and plotting was performed using the R package 
ggseqlogo (Bolyen et al., 2019) 
 
4.3.7 Evolution and efficiency assessment via plate assays 
To quantify the possible evolution of the phage libraries over time, an experiment 
was devised which would compare the replication efficiency of different phage 
libraries of riboswitches at different points in the evolution timeline. Both the 
positive and negative strains were grown at 37ºC in 2 ml of LB culture, in the 
absence and presence of 1 and 1.5 mM theophylline, to see how the phage libraries 
behaved in each selection step, both when the system was expected to be 
functioning and also not functioning. All cultures were infected at a MOI of 10-8 
and grown for 1 h. Such a small MOI was used to allow the phages to replicate for 
such a period of time without fully clearing the culture. After the incubation 1 ml 
from each culture was removed and the cells pelleted by centrifugation. The 
supernatant was transferred to a new tube and 15 µl of chloroform added, before 
the sample was vortexed for 15 seconds to lyse the remaining cells debris. 
 
These samples were serially diluted 9 times each, then used for spot assays with 
∆trxA-gp5 cells, in order to get a rough estimate of their PFUs. After an overnight 
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incubation at 37ºC, and with such an approximation, plaque assays were done 
with the optimal phage dilution, allowing for a much more accurate 
quantification of the resulting PFUs. The PFUs corresponding to each of the 
conditions were represented in order to compare the phages’ efficiency in each 
of them and were then used to calculate the increase ratio of phages from the 
initial numbers used for infection.  
 
Taking the PFU values for both active and inactive states in the positive and 
negative selections allowed for a tentative value named “Activation efficiency” to 
be obtained, indicating the ratio in which the desired state of each selection 
produced phages compared to the undesired state of the same selection.  
 
4.3.8 Evolution assessment via calculation of the Virulence Index 
The selected procedure was the one used by Xie, Wahab and Gill, (2018) and 
Storms & Sauvageau (2019), by which a value known as the virulence factor was 
ascribed to different phages in order to compare them to one another.  
 
The virulence index was obtained via a two-step process: 
 
I. Calculating the local virulence (u1) via the following formula: 
 
    Equation 1: u1=1- !"	!$           
where A0 represents the area under the growth curve of a phage-less cell 
culture up until reaching stationary phase, and Ai the area under the 
growth curve of a culture at a certain MOI until the same timepoint. u1 is 
measured in a range of 0 to 1, with 0 being no virulence whatsoever, and 1 
being the maximum theoretical virulence, instantaneous death.  
 
II. Once the local virulences over a range of MOIs were assessed, they 
were represented on a curve. The area under that curve (Ap) was 
calculated following the formula 
Equation 2: Ap = ∫ u1d(log()*)$"  
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with i being the base10 log of the lowest MOI, which in this case was -6. 
 
III. That value was then divided by the theoretical maximum value (Amax) 
for the same curve, giving the virulence value for a specific phage on a 
specific strain. In this case, this maximum value corresponded to 6.  
 
IV. These values were readily comparable with each other, and were taken 
both as they were, and also to calculate the “Activation efficiency” for 
the riboswitches inside the phages, indicating the fold increase 
between states of the switch in those cases. 
 
The virulence index measurements were made for 5 different phage populations; 
3 at different stages of selection, 1 for the original riboswitch-carrying phage, and 
one for WT T7. Each of these phages was used to infect the positive and negative 
selection strains under three conditions: 0 mM, 1 mM and 1.5 mM theophylline; 
in order to assess their virulence under each of those conditions.  
 




4.4.1 Riboswitch evolution 
In the first step, considered the positive selection step, the objective was to select 
for riboswitches that are able to change their conformation and activate the 
expression of cI in the presence of theophylline. The cI repressor encoded by the 
cI gene would bind to a specific promoter present in the plasmid within the 
positive selection strain, and activate the production of the CMP kinase, ensuring 
the correct replication of the infecting phages. This ensures selection is achieved. 
Unless the phages carried a working version of the riboswitch, they would not be 
able to activate the molecular pathway that leads to their correct replication. 
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4.4.2 Determination of best candidate strain for positive selection step: 
 
As previously stated, eight different strains were developed in order to set up the 
positive selection step of the evolutionary process; and Two of these different 
strains were controls, but the remaining six needed to be assayed in order to 
determine which combination of pRM promoter and RBS would work best in this 
case. This was decided via the use of growth, plaque, and one-step assays, both 
in the presence and absence of 1.5 mM of theophylline; and a comparison of the 
obtained results for each strain. The combination that showed the highest 
activation fold between absence (OFF state) and presence (ON state) of 
theophylline would be selected as the one used in the evolutionary process. 
 
To set up this procedure, the eight different plasmids were designed, constructed 
and transformed into E. coli BW25113 ∆trxA∆cmk cells, each of them carrying the 
same elements except for the promoters in front of the cmk gene, to be used for 
selection. All were put up against the phage population containing the fixed 
version of the riboswitch, originally carried by EG_cI01, in order to determine 
the efficiency of the regulation. The sequences for the different RBS were taken 
from the iGem parts website (parts.igem.org), originally mentioned in (Weiss, 
2001). These RBS were known as B0030 to 33, but also included B0064, which is 
based on the original sequences, and a synthetic RBS obtained using the RBS 
Calculator software from the Salis Lab (Salis et al., 2009) 
 
Plasmid EG_cI03 was used as a positive control, containing the cmk gene under 
the regulation of a T7 promoter and a strong RBS. This ensured that whenever a 
phage infected the cell, the gene would be produced and the resulting phages 
would replicate without further issue. Plasmid EG_cI10 was used as a negative 
control, with neither promoter nor RBS, ensuring no replication of the phages 
could occur regardless of the conditions.  
 
The efficiencies of these strains in phage replication were tested with via killing 
assays, measuring the OD values under different conditions and comparing 
between them in order to find the most suitable candidate. Plaque and spot 
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assays were also carried out, where the number of plaques present in a petri plate 
is directly related to the PFU of the phage sample. All these assays were done 
both in the presence and absence of 1.5 mM of theophylline; and the obtained 
results from each strain were then compared. The combination that showed the 
highest activation fold between presence (ON state) and absence (OFF state) of 
theophylline would be selected to be used in the evolutionary process.  
 
Figure 26 shows the results obtained from the killing assays under these 
conditions. For each of the 8 strains tested, we can see the two growth curves at 
OD600 nm, corresponding to the strain growing in the absence or presence of 
theophylline with a certain value of T7 phages containing the fixed version of the 
riboswitch. These results indicate that among the tested strains, only two of them 
show enough difference due to the presence of theophylline to be considered 
relevant, something that can be blamed on the leakiness of the pRM promoter, 
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T -  T + 
 
Figure 26. Results from cell killing assays in positive selection strains. 
Graphic representation of OD600 over time, showing the killing of each positive selection 
strain, including controls, by Fixed Riboswitch-containing phages at a rate of 1 phage per 
every 104 cells. T- represents the case where theophylline is absent, while T+ represents 
the case where theophylline is present at a concentration of 1.5 mM. The positive control, 
(A) shows no difference in the killing rate regardless of the presence of theophylline; while 
the negative control (B) shows the opposite reaction, with no killing in any case. Each of 
the different test strains (C-H) shows different killing curves, which can be associated 
with the strength of the particular RBS present in front of the cmk gene, as well as its 
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leakiness, based on the difference between the two curves present in each graph. The 
bigger the difference between the presence or absence of theophylline, the more efficient 
the riboswitch’s activation is in that particular case. Error bars in all graphs represent the 
Standard Error of the Mean (SEM) 
Once the number of strains to be tested was lowered, the assays known as One-
step assays took place, as explained in Figure 10 in the Materials and Methods 
section. These assays are essentially plaque assays, where the number of plaques 
is counted and correlated to the number of phages used in the experiment to 
determine an approximate concentration of phages per ml. One-step assays are 
more specific in that measurements are taken every 4 minutes over 40 minutes, 
in order to see the change of phage numbers over time. The result is then 
compared within the different conditions in a more quantitative manner than 
that of OD measurements. For this assay, only four strains were tested, including 
the positive and negative control (Figure 27). 
 
These results show that even though there is a difference between the presence 
and the absence of theophylline in the tested strains, such a difference is higher 
in the case of the strain containing the combination of pRM promoter and RBS 
B0033, making it the best candidate to use for the positive selection step of the 
evolution procedure.  
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Supernatant T- Supernatant T+ Full Sample T- Full sample T+ 
 
Figure 27. Results from One-step assays in positive selection strains. 
Graphic representation of phage production for different cell treatments in the presence 
(T+) or absence (T-) of theophylline. As explained in Materials and Methods, in one set of 
samples cells are spun down and the supernatant taken (Supernatant label), while in the 
other, chloroform is added to the whole sample (Full sample label) both with and without 
the presence of theophylline. A) Phage production for the positive control strain, with 
cmk being regulated by pT7. B) Phage production from the negative control strain, with 
no promoter nor RBS in front of the cmk gene. C) Phage production for a test strain 
containing the combination of pRM promoter and RBS B0032. D) Phage production for 
the test strain containing the combination of pRM promoter and RBS B0033.  
 
4.4.3 Determination of best candidate for negative selection step: 
 
Once the first step was established using the control phage, the same process 
was repeated for the negative selection step. If the positive selection was 
designed to select those versions of the riboswitch that turned ON in the 
presence of theophylline, this one selected for those that remain OFF in its 
absence. Due to the switching nature of the riboswitch, such a step is essential in 
order to eliminate elements within the population that “cheat” their way through 
by being constantly on. In such cases, where the switches are still on even in the 
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absence of the activator, cI will be produced, bind to the pRM promoter and 
activate the expression of the gene pifA, which codes for the T7 exclusion protein 
PifA. The actual molecular mechanism by which the exclusion is happening is not 
fully clear (Cheng et al., 2004), but when such a protein is expressed in a cell at 
the same time as T7 genes 1.2 or 10, the cells shuts down, blocking the replication 
of phages within it (Schmitt & Molineux, 1991). 
 
In order to have an efficient negative selection, a similar set of assays to those 
developed for the positive selection had to be developed, in order to find the best 
possible candidate for phage replication when using the “Fixed riboswitch” phage 
population. Once again, cells were transformed with eight different variants of 
the selection plasmid, EG_cI11 to EG_cI18. EG_cI11 contained pifA under the 
control of the pT7 promoter, ensuring a constitutive production of the protein, 
while EG_cI18 consisted of pifA without any of upstream regulatory element, 
diminishing the production as much as possible. The test strains, EG_cI12 to 
EG_cI17, all contain the same combinations of pRM promoter and RBS that were 
tested in the positive selection, but in this case both the regulated gene (pifA) and 
the genetic makeup of the cell were different. 
 
Cells in this case were E. coli BW25113 ∆trxA from the Keio collection, unlike the 
E. coli BW25113 ∆trxA∆cmk cells used for the positive selection, given that here 
cmk expression does not regulate phage selection, and thus is constitutively 
expressed so phages can replicate appropriately. 
 
Just like in the case of the positive selection, an initial set of killing assays was 
carried out to assess the replicating efficiency of the fixed riboswitch (Lynch et 
al., 2007) phages in the different strains. In this case, however, the results were 
much more straightforward, as seen in Figure 28, since only one of the test strains 
(containing pifA under the control of RBS B0033) showed any indication of phage 
killing. All other strains seemed unaffected by the different phage concentrations 
present in the media, rendering them unusable in the selection procedure. 
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Figure 28. Result from cell killing assays in the negative selection strains.  
Graphic representation of OD 600 over time (in hours), showing the killing of each 
negative selection strain, including controls, by the Fixed Riboswitch-containing phage 
at different multiplicity of infections, including MOI 0/No phage (Cell), MOI 1, MOI 10-4, 
and MOI 10^-9, all in the absence of theophylline. Positive control (A, with a pT7 
controlling pifA expression) shows no killing, while negative control, (B) with no 
production of pifA, shows cell killing.  Each of the test strains has a specific set of killing 
curves, but all of them show phage killing only at the highest MOIs, except for the 
combination including RBS B0033, which indicate the influence of phages is felt even at 
very small MOIs. Error bars represent the Standard Error of the Mean (SEM). 
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Based on these results, it was deemed unnecessary to do one-step assays in this 
case to compare the number of phages being produced in each strain. However, 
the same data was used to calculate the effective growth rate for each strain in 
the presence of phages. This measurement refers to the difference in OD in a cell 
culture between two different timepoints and is calculated as the slope of the 
straight line between point 1 and point 2 in a semi-logarithmic plot, resulting in 
this equation: 
 




with the result being expressed in h-1. Based on the 2011 Miller lab protocol 
(http://miller-lab.net/MillerLab/protocols/general-bacteriology/calculating-
growth-rate/), based on (Neidhart, Schaechter, & Ingraham, 1990). 
 
This equation was used to calculate the growth rate at the steepest point of the 
slope for the strain containing the pRM promoter and RBS B0033 combination 
under multiple MOIs; and then for the same interval of time in the remaining 
strains, in order to compare them to one another in an effective manner, as 
shown in Figure 29, where all test strains show positive values for growth rate 
except for B0033, confirming it is the only case where phages are able to actually 
replicate and lyse the cells.  
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Figure 29. Specific growth rates of negative selection strains. 
Representation of the effective growth rates at different MOI values for negative selection 
strains during the same time period (3000 to 4200 sec) after the start of the experiment. 
The time period was determined by calculating the steepest slope for the problem strain 
and then calculating the slopes corresponding to that same period in all other strains. 
Save for the negative control, where no pifA is produced at all, only the combination of 
pRM and RBS B0033 show some cell killing, confirming the suitability of that strain for 
negative selection. Error bars represent the Standard Error of the Mean (SEM). 
 
This confirmed that the specific combination of pRM and RBS 33 was the best 
candidate to be used for the negative selection process. One further experiment 
was required to assess the efficiency of the system by comparing its behaviour in 
the presence and absence of theophylline. The procedure was the same as that 
carried out for the positive selection, taking samples every 4 minutes for a period 
of 40 minutes and then seeing the increase of phage particles as infection 
proceeds. These assays compared the results between the presence and absence 
of 1.5 mM theophylline; however, the compound would never be present in the 
system in this case. This assay was made in order to confirm the differences in 
the system’s activation levels between both conditions. The results confirmed 
that there was indeed a difference between the two conditions, but much smaller 
than the one showed for the positive selection (Figure 30). 
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Figure 30. One-step assay for the negative selection step. 
Representation of the result from the one-step assays for the negative selection strain 
containing the pRM promoter followed by RBS B0033, under different conditions and 
treatments, as described in Materials and Methods, as well as both with and without the 
presence of theophylline. The graph shows a difference in the cases where only the 
supernatant were used to infect, indicating a slight difference in levels of phages present 
in the supernatant, but more so in the case of full samples treated with chloroform, where 
a more obvious difference can be seen between the two conditions. All of this indicates a 
bigger phage production in the absence of theophylline. As in previous cases, the error 
bars here were obtained by calculating the SEM. 
 
4.4.4 Full evolutionary procedure 
 
Having identified strains for both the positive and negative selection processes, 
the system could now be tested as a whole and its efficiency as a directed 
evolution strategy established. The original plan for the setup of this experiment 
was to use the laboratory’s self-developed bioreactor, in a process similar to the 
one presented in Carlson, Badran, Guggiana-nilo, & Liu, (2014). However, the 
bioreactor suffered a severe malfunction which rendered it unusable therefore, 
classic plaque and spot assays were used as an alternative approach.  
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The procedure was done using the previously described spot assays to roughly 
assess the PFU of each phage generation, so as to keep a similar number of 
infecting phages between every selection iteration. There were cases over the 
procedure in which the spot assays were inconclusive, and so, in such a case, 
both the pre-existing sample and a newly made sample were tested in order to 
keep going.  
 
So far, 16 full cycles of evolution have taken place, which translates to 32 different 
selection steps, some of them with more than one replicate. It is important to 
indicate that all positive selection steps until the 10th generation had a 
concentration of 1.5 mM theophylline, but from that point onwards, the 
concentration was reduced to 1 mM theophylline, in order to further constrict 
the riboswitch selection. It was then considered appropriate to test whether 
some changes to the population of random riboswitches had happened over the 
course of the procedure.  
 
Preparations for a Next Generation Sequencing assay were undertaken, with the 
objective of discerning whether the number of riboswitch variants had changed 
over generations, and give indications of evolution within the populations. 
Sequencing was carried out using a standard Illumina protocol for amplicon 
sequencing and an Illumina MiSeq, the objective of the assay was to determine 
the following: 
 
1) Was the original riboswitch plasmid library obtained after bacterial 
transformation biased in some way? If so, how many of the expected 
sequences did it contain, and which were missing? 
2) How many different riboswitch versions were lost, if at all, in the process 
of homologous recombination to obtain the phage library of riboswitches? 
3) Has there been any decrease in the number of riboswitch variants present 
in the libraries as selection proceeded? 
4) Is there any indication of directed evolution of the riboswitch sequence as 
generations passed? 
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A total of 24 different phage libraries were prepared for each sequencing run. The 
samples included for library preparation incorporated the original plasmid library 
of riboswitches, the original homologous recombination phage population and 
the furthest generations present at the point of analysis. All necessary 
preparations for the experiments are shown in their corresponding subsection. 
The contents and sequence of the amplicon obtained after the first PCR are 
shown on Figure 25, and the indexing primer combinations are shown on 
Supplementary figure 3 of the Supplementary Materials section. 
 
The first sequencing run resulted in no data, due to problems with the 
sequencing procedure. Therefore, a qPCR assay was carried out to determine the 
presence of the specific tags in the samples. The Illumina NEBNext kit for library 
quantification (#e7630) (https://international.neb.com/products/e7630-
nebnext-library-quant-kit-for-illumina#FAQs%20&%20Troubleshooting) is 
specifically designed to detect the tags needed for the Miseq run. The sample 
distribution for this technique is described in the Supplementary Materials 
section, and the resulting amplification curves confirmed the presence of the 
fragments in the samples. () 
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Results from qPCR assays using NGS-prepared library samples. Thirteen different 
libraries were run as part of the assay, at two different dilutions, with three repetitions 
per dilution. Since the qPCR oligos used are specifically designed to only bind to the 
specific tags used to prepare the NGS samples, the increase in fluorescence confirms the 
presence of the tags, and thus affirms the validity of the samples for the MiSeq run. 
Discussion with the manufacturer pointed towards an unexpected issue with the 
sequence of the original set of primers used for the first PCR procedure; which 
prompted a repetition of both this and the indexing PCRs for the samples with a 
new set of primers. The result from running this final set of indexing PCRs on a 
2% agarose gel (due to its small size) shows the band at the corresponding size, 
between 200 and 300 bp, confirming  Indexing amplifications worked. (Figure 32) 
 
Figure 32. Agarose gel of Indexing PCR. 
Agarose gel electrophoresis results of indexing PCR along with a 100 bp plus ladder, 
showing the size of the fragment at the expected range of over 200 bp and under 300. 
The thicker, brighter band at the lower part of each lane can be assumed to be a primer 
dimer, occurring when the primers used in the PCR bind within themselves. 
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This library resulted in a successful MiSeq run, that yielded a total of 2.58 Gbp, 
which, given the size of the fragment, roughly correspond to 107 sequences. These 
sequences were trimmed, aligned, and grouped, in order to determine whether 
there is a change in the variation within the riboswitch library over several 
generations of selection and whether that could qualify as possible evolution. 
 
Due to the sheer amount of data, tackling such an analysis was a very elaborate 
procedure, and different approaches were taken, to various degrees of success. 
In order to get a preliminary idea of what each of the libraries held, a small 
random sample of 105 reads were taken from each of the 24 libraries and the 
sequence variation in each set assessed. This number was considered appropriate 
as it was large enough to encompass the sequence library at its maximum variety 
(65536 bp), and small enough for the data to be managed appropriately. These 
results are shown in the form of diagrams representing the 8 random nucleotides 
flanked by 5 fixed nucleotides on both sides. The larger the size of a particular 
nucleotide, the more represented that particular nucleotide is in that position.  
 
This was done for multiple libraries throughout the evolutionary process, each 
step marked as cmk or pifA depending on whether it corresponded to a positive 
or negative selection step, respectively; and a number to indicate the generation 
since the beginning of the project. These two diagrams, (one set for each 
successful MiSeq run) can be seen in Figure 33, showing the changes in sequence 
distribution over generations, with the corresponding library information in , and 
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Diagrams representing the sequence variation in the samples for each of the libraries. A) 
represents the first successful run, while B represents the second one Information 
regarding the samples can be found in . The bases included within the black square 
correspond to the randomised riboswitch sequences. The larger a nucleotide (AGCT) is 
represented in the diagram, the more represented it is in the sample population. This 
explains the constant size of the flanking regions, with some exceptions, probably due to 
some sequencing issues. In libraries from the beginning of the selection process (Switch-
1 and 2 in A, S1, S2 and S3 in B) we can see no prominence of any sequence in particular, 
exemplified by the empty square, and we see a progressive increase over time towards 
one dominant sequence, which gains representation early in the process. The sample 
used for the first library (Plasmid pool/S0) representing the original plasmid library, was 
wrong due to it probably being the amplification from a single clone, not a full library.  
Another proof of this is that it shows a predominant sequence at the very beginning of 
the selection process, which does not correspond to subsequent libraries. The reason 
why S23 in A, as well as S19, 20, 21 22 and 24 in B shows a much higher variation was 
unclear here, prompting the analysis of the full data sets, rather than just a fragment of 
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Table 7. NGS sample nomenclature.  
Correspondence between the generation number of the different analysed libraries and 
the nomenclature used in the sequence variation diagram. cmk or pifA respectively 
indicated whether the sample corresponded to a positive or negative step in the 
selection, and the number indicated the specific generation. Some generations were 
repeated due to low PFU values, and thus tested to determine any possible correlations 
between this and the riboswitch sequence. “Samples A” correspond to the samples from 
the first successful sequencing, and include a wide margin of sequences, from generation 
1 to generation 14. Based on these results, the second run included samples indicated 
under “Samples B”, with samples used to fill in the gaps from the first set, and show 
consecutive generations until the riboswitch sequences became fixed. 
SAMPLES A NUMBER SAMPLES B NUMBER 
PLASMID Pool S0 Rd Switch 1 S1 
Fix Switch S2 Rd Switch 2 S2 
Rd Switch 1 S3 Rd Switch 3 S3 
Rd Switch 2 S4 cmk1 S4 
Cmk1 S5 pifA1 S5 
cmk2 S6 cmk3 S6 
pifA2 S7 pifA3 S7 
cmk5 S8 cmk4 S8 
pifA6 S9 pifA4 S9 
cmk7 S10 cmk5 S10 
pifA7 S11 pifA5 S11 
pifA9 S12 cmk6 S12 
pifA10 S13 cmk8 S13 
cmk11 S14 pifA8 S14 
pifA11 S15 cmk9 S15 
cmk12 S16 cmk10 S16 
pifA12 S17 pifA11 S17 
pifA12B S18 cmk12 S18 
pifA13 S19 cmk13 S19 
pifA13D S20 cmk15 S20 
pifA13B_8-11 S21 pifA15 S21 
cmk14 S22 cmk16 S22 
pifA14_6-11 S23 cmk2 Amplif. S23 
pifA14 S24 cmk16 Amplif. S24 
 
As can be seen in the figures, starting from a point where no sequence is 
overrepresented (excluding the wrong “Plasmid Pool” sample, corresponding not 
to a library, but a single clone due to a mistake), the variation within each phage 
population seems to decrease over the course of the evolutionary steps, as one 
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single sequence has a progressively prominent presence. This could be taken as 
confirmation of evolution throughout the generations, but in order to assess so, 
a different set of assays had to take place. 
 
Several spot and plaque assays took place to compare the efficiency of replication 
of phage libraries at different points of the evolutionary process. Samples from 
generation two were set up against samples from generation sixteen, both under 
the presence and absence of theophylline, and at the same multiplicity of 
infection, to assess whether there had been any changes in the efficiency with 
which they replicated within the positive and negative selection strains over the 
same period of time. 
 
These evolution assessment assays were detailed in the chapter’s materials and 
methods, apart from the general spot and plaque assays described in the general 
methods. However, this procedure had a significant flaw, namely, the fact that 
the results were not comparable. Despite multiple repetitions, the variation 
within samples was simply too big to consider the assays replicates of each other. 
Possible reasons for this are considered as part of the Discussion chapter. 
 
Because of this, the values of virulence index were calculated, using different 
phage populations, according to the described method in materials and methods. 
The selected phages corresponded to the recombinant phage used as a control 
for the selection process, phage populations from generations 2, 5, and 16; and a 
WT T7 phage population, lacking a riboswitch in its genome. All populations were 
tested in all previously described conditions.  
 
A standard set of results for one of the calculations, showing all the different 
steps, from the OD600 curves in the presence and absence of phages to the 
regional virulence values; can be seen in Figure 34. This set of data was obtained 
after infecting the positive selection strain with phages corresponding to the 16th 




                                                   Recombination-based evolution strategy  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  96 























































































































D) Area under curve 


































pRM33_cmk + 1.5 mM theophyllinepRM33_cmk + Generation16 phage 
(1.5 mM theophylline) 
C) 
                                                   Recombination-based evolution strategy  
Development of Phage-assisted Evolution and Riboregulation mechanisms                  97 
Figure 34. Virulence index example data. 
Standard set of data used in order to obtain the virulence index for a phage population 
infecting a specific strain. A) Killing curves of the cell cultures where phages at different 
MOIs have been added. B) Growth curve of the cell strain without phages. Notice the 
point where it enters stationary phase, where the integration of the curve finishes.               
C) Values resulting from calculating the area under each of the previous curves.                       
D) Representation of the values obtained after using the data from C) in Equation 1, in the 
Specific Materials and Methods section. The area under this curve corresponds to the 
virulence index for that phage in that strain. Error bars represent the Standard Error of 
the Mean (SEM). 
 
Once these calculations have been made for all the different combinations of 
phage, strains, and inducers; the resulting values were grouped and represented 
as columns. Each of the tested phage populations (WT, Fixed Riboswitch, and 
steps 2, 5 and 16 of the evolutionary procedure) were represented for both 
positive and negative selections, in the absence and presence of different 
concentrations of theophylline. These values were then used to calculate the 
riboswitch’s activation efficiency. All these different assessments can be seen in 
Figure 35, which shows no change whatsoever in the case of WT T7, which was 
expected, and a general higher activation fold in the case of the Fixed riboswitch 
sequence. Different phage generations show changes in their virulence, which 
don’t necessarily correlate to an increased activation fold of the riboswitch.  
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Figure 35. Virulence index comparison between 
populations. 
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Virulence index values for the different phage populations (WT, Control/Fix riboswitch, 
and after 2, 5, or 16 cycles of selection) when infecting the positive and negative selection 
strains in the presence and absence of different concentrations of theophylline. The 
higher the bar, the higher the virulence of that particular phage population in that 
particular strain, with a range between 0 and 1. A) Virulence indexes for the 5 different 
phage populations after infecting the positive selection strain in the absence and 
presence of theophylline. In this case, virulence should be higher in the presence of 
theophylline, as the riboswitch changes to an ON conformation in its presence and allows 
for the expression of cmk. B) Virulence index for the different phage populations when 
infecting the negative selection strain in the absence and presence of theophylline. In this 
case, virulence should be higher in the absence of theophylline, as the riboswitch stays in 
an OFF state. Once theophylline is being added and the switch turned ON, pifA is 
expressed, blocking efficient T7 replication. C) Representation of the fold increase in 
virulence in both the positive and negative selections, for the two different 
concentrations of theophylline used in each. In the positive selection the virulence values 
in theophylline+ cultures were divided by the value in theophylline- cultures, with the 
opposite being done for the negative selection, as indicated in the figure’s legend. Error 
bars represent the Standard Error of the Mean (SEM). 
 
4.4.5 Protein receptor evolution strategy 
 
Based on this same strategy, and in collaboration with Dr. Christophe Corre 
(University of Warwick), a second evolutionary project was devised; however, 
instead of riboswitches, the objective in this case was to evolve specific cell 
receptors working as part of the mmfR/mmyB system. This set of genes regulates 
the biosynthesis of an antibiotic molecule known as methylenomycin (Mm) 
(O’Rourke et al., 2009), with the mmyB gene regulating the activation of of Mm 
synthesis, and the mmfR gene doing the same for the repressor protein MmfR, 
that blocks mmyB until the autoregulating molecules methylenomycin furane 
(MMF) reach a high enough concentration. (Figure 21) 
 
The elements involved in the evolutionary processes for this strategy were the 
same as in the main project, with the difference of the evolutionary target and its 
regulators.  
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The project considered two possible evolutionary procedures: 
- The evolution of a repressor that would only bind to mmyB in the absence of 
the ligand, but never in its presence, essentially increasing the specificity and 
orthogonality of the system, much akin to the riboswitch’s evolution strategy. 
 
- The second strategy is aimed towards the evolution of mutant homologue 
versions of the mmf repressor mmfR, named sgnR (Sidda et al., 2014) and 
SAV2270 (Corre et al., 2008). Both versions would be presented with mmyB 
and a version developed by the Corre group, coded by a mutant gene labelled 
MARE4, which differs in just a few nucleotides from the original. All done in 
order to evolve the repressors toward only recognizing the original version of 
the protein, even when differences are minimal. This was the strategy 
selected to move forward due to the interests of the collaborating group. 
 
As with the riboswitch evolution procedure, the sequences of interest were 
introduced inside the phages via homologous recombination and subsequent 
specific selection. Three different phage populations were obtained, containing 
the three different versions of the mmfR gene previously described. All three 
versions would undergo the selection procedure, just as described previously, 
using cmk in the positive step and pifA in the negative step. However, in this case 
the dynamics change with respect to the original evolution strategy. 
 
The positive selection plasmid carried cmk under the regulation of the MARE4 
mutant, meaning the repressor wouldn’t bind in this case, allowing for the 
expression of the gene, and thusly the replication of the phage. As for the negative 
selection plasmid, in this case, pifA was under the regulation of MmyB, meaning 
that the repressors which worked would bind to it and block pifA’s expression, 
ensuring the correct replication of the phages carrying them.  
 
All four different constructs were assembled for the selection procedures and 
transformed into E. coli BW25113 cells and E. coli BW25113 ∆cmk cells. These cells 
also contained the plasmid with the original mmfR gene, in order to test the 
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baseline repression efficiency of the system in each condition. Since mmfR is 
regulated by the Lac operon, two sets of experiments were done, with and 
without IPTG. All these plasmids can be found in Supplementary figure 6 and 
Supplementary figure 7. 
 
A preliminary version of these results, showing the difference in mmfR activation 
with and without IPTG between different strains as it correlates to GFP 
expression, is represented on Figure 36. 
 
Figure 36. GFP activation in the mmfR-mmyB/MARE-4 system. 
Preliminary results of the GFP/OD values for the mmfR-mmyB/MARE4 repression 
systems in E. coli BW25113 and E. coli BW25113 ∆cmk cells, in the presence and absence 
of IPTG. In red, the cases where IPTG is not added into the media, and the Lac operon 
remains OFF, not producing mmfR. In green, the same strains in the presence of IPTG, 
with an active Lac operon and by extension, mmfR production. The values are obtained 
by determining the steepest point of the growth curve for each strain and dividing the 
GFP and OD values corresponding to those same timepoints. The selection plasmid 
present in each case is shown under each set of columns.  
These experiments, however, were lacking the presence of T7 phage, which is 
why another set of tests were conducted to assess their efficiency when infecting 
and killing the different strains under different conditions; which was done in the 
form of OD growth curves. Figure 37 shows the results from these assays, 
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indicating the differences between the control and test strains in the positive and 
negative selections, with the MARE4 strain showing faster killing due to less 
binding by the repressor, but negative selection in general showing no major 
difference at all in most cases. This could be used to confirm the leakage of the 
system and thus it is possible to use along with the T7 phage in order to produce 
the desired evolution. Out of the eight strains used, 4 would work as a control, 
while the others would be used for the selection procedure. All of the 
investigations were carried out in the presence of IPTG, to activate the Lac 
operon and thus the mmfR production.  
Figure 37. T7 infection of mmyB/MARE4 strains. 
Results from the T7 infection of the different strains 
designed to be used in the mmfR evolution 
procedure and as controls. The legend indicates the phage dilution corresponding to each 
element of the plot. The strains used for the actual evolution are surrounded by red 
dotted lines, while the other ones would be used as controls. In the strains used for 
positive selection testing (A, B, C, D) different levels of killing are observed. A) and B) show 
the difference between E. coli BW25113 ∆cmk and E. coli BW25113 cells carrying plasmids 
EG_m01 and EG_m04.  C) and D) show a similar situation, except that in this case the 
plasmids carried are EG_m01 and EG_m05, so cmk repression is lower than in A and B 
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due to the presence of the MARE4 mutant. E), F), G), and H were used as a way to test 
regulation in the negative selection step in a similar fashion. 
After the testing of the selection strains, the following step was to use 
homologous recombination to introduce different mmfR variants within the 
genome of the T7 phage, using cells transformed with plasmids EG_m01, 
EG_m02 and EG_m03. This would allow us to produce recombinant phages 
carrying variations of the mmfR gene, and therefore, evolve three different 
sequences with the same objective, which would be interesting not just from an 
experimental point of view, but also as an exercise in possible convergent 
evolution, structural analysis and gene function. 
 
These phage populations were indeed produced through homologous 
recombination, but due to several mechanistic issues with the bioreactor, 
laboratory organization and time constraints of the PhD, the project was not able 
to move forward and the phages remained unused.  
 
4.5 Discussion of results: 
 
Throughout this chapter, the procedure by which a strategy for riboswitch 
directed evolution was developed and tested have been discussed, including the 
different ways this evolution was assessed, via the use of sequencing and 
virulence index assays. Moreover, the adaptation of this process for the evolution 
of alternative biosensors was also discussed, with some preliminary data 
showcasing the main elements within this alternative strategy. 
 
4.5.1 Riboswitch evolution 
Using a library of recombinant T7 phages carrying randomised riboswitch 
sequences, the aim of the strategy was to develop a selection system that would 
allow for the evolution of the riboswitch sequences, which regulated the 
expression of the l phage cI repressor. The development and setup of this 
strategy was arguably the main aim of this PhD, where most time has been spent. 
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Furthermore, some of the results obtained in this case set up the ground for the 
development of several other strategies described throughout this thesis. 
 
Results for this strategy can be easily divided into 2 main groups: 
The setup of the double selection process, containing a Positive Selection, in 
which the selected riboswitch sequences are in an “ON” state in the presence of 
the activator, theophylline; and a Negative Selection, in which they are selected 
in an “OFF” state in the absence of theophylline. 
 
Once these two selections were tested and properly assembled, several rounds 
of alternative selections took place, with the objective of evolving the 
riboswitches. This led to a set of assays used to confirm whether or not Evolution 
had occurred. This was done via two parallel methods, the analysis of Next 
Generation Sequencing data, and the calculation of the Virulence factor for phage 
populations at different moments in the Selection process. 
 
4.5.2 Selection process 
The setup for the selection process was based on several elements that had 
already been well established in the literature.  
- A working theophylline riboswitch obtained by directed evolution, from 
Lynch et al., 2007, to act as a control switch to set up the procedure. 
- The cI repressor from phage l(Fehér et al., 2012), and the pRM promoter 
it binds to (D. Huang et al., 2012) to regulate gene expression 
- RBSs of different strengths (Weiss, 2001) to further regulate gene 
expression. 
  
The results shown in Figure 26 very clearly indicate which of the combinations of 
pRM promoter and RBS are better than others at allowing the production of cmk, 
but from the beginning there is a very obvious issue, and that is the “leakiness” of 
the pRM promoter (L. Huang, Yuan, Liu, & Zhou, 2015). Except for the two 
controls, with either a T7 promoter or no RBS, this is easily seen in all cases, 
where even in the absence of theophylline to activate the riboswitch (therefore 
producing cI, which binds to the pRM promoter), there are still phages being 
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produced, as indicated by the loss of OD600, representing cell killing. At this 
point, the objective became finding the one combination that gives the highest 
activation when in presence of theophylline.  
 
This condition eliminated most combinations, save for pRM_32 and pRM_33, 
where some significant differences were seen. This was the reasoning for the 
experiments shown on Figure 27. In the positive control, we can see that the 
graph corresponding to the PFU of total phage (phages present in supernatant 
and inside cells) “jumps” earlier than free phage (phages present in supernatant). 
That time difference, known as the “Eclipse period” (Adams, 1959; Hyman & 
Abedon, 2009) roughly corresponds to the time where phages are being 
assembled inside the cells. Since in the total phage count, cells have been 
forcefully burst to release the phages present inside them, that explains the 
reason behind the delay between both cases.  
 
Between both test strains, we can see that there is a significant difference in the 
number of produced phages when theophylline is present or absent, but due to 
the fact that the difference was much higher in the case of the pRM_33 
combination, it was decided that it would be the most suitable candidate. In both 
cases a difference between the total phage and free phage can be seen, but it is 
merely a difference in number, not so much in time, unlike in the positive control. 
This could mean that the eclipse period in this case is shorter than the 4 minutes 
between measurements, so by the time the measurement happens, most phages 
have already been released into the media, explaining the differences in PFU but 
the same timeframe.   
 
Strain selection was much more straightforward in the case of the negative 
selection, since all strains save for one (plus the negative control) produced levels 
of pifA that were low enough to allow the recombinant phages to kill the cells, as 
seen in Figure 28. Because of this, initially One-steps assays were not considered 
necessary in the same way they had been for the positive selection, and the 
effective growth rate was calculated as further proof that this particular 
promoter and RBS combination would be the most suitable for the selection.  
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Despite this apparent simplicity in identifying the ideal strain when compared to 
the positive selection, when one-step assays were eventually done, it was obvious 
that the difference between the presence or absence of theophylline was not as 
large as in the previous step. (Figure 30) 
There is an issue with the use of the pifA gene that needs to be addressed. Despite 
it being the ideal gene for an experiment such as the one described, wherein its 
production will hinder the replication of the T7 phage; the fact of the matter is 
that the mechanism in which its protein product does so is not known as of this 
thesis. Pieces of the puzzle are known, such as the necessity of either T7 gene 1.2 
or 10 to be expressed in the same cell expressing pifA (Schmitt & Molineux, 1991), 
the fact that the translocation of the phage’s genome into the cell is affected 
(Garcia & Molineux, 1995), or that exclusion happens at the membrane (Cheng et 
al., 2004). Cells expressing PifA shut down without exploding, a process that could 
have evolved to avoid a larger-scale infection of the colony. 
 
This leaves enough room for speculation, or in this case, unknown effects that 
may be influencing the experiment, unbeknown to us. According to the literature, 
the phage is able to introduce a percentage of its genome without an issue, but 
after a certain point if pifA is expressed, the remainder is aberrant. Some phages 
manage to enter, possibly even replicate, before the cell shuts down, but they are 
trapped inside. All these experiments analysed pifA as part of the sexual F 
plasmid. It is possible that the presence of the gene in this environment affects 
the production of the pifA protein, and thusly, the phage exclusion procedure.  
 
That, along with the leakiness of the pRM promoter, could be a possible reason 
for the differences between the total phage count and the free phage count. In 
cells with a higher expression of pifA due to the activation of the riboswitch, the 
amount of phages being able to properly enter the cell and replicate before the 
shutdown is lower than in the ones where the switch is off. However, the 
leakiness of pifA makes such an impact that the difference between the two 
conditions is much smaller than it should be. By bursting the cells, phages 
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trapped inside get released into the media, to re-infect again, which would 
explain the higher numbers in those cases.  
 
Despite this, it was considered that the combination of both steps of selection 
would be a good test for whether or not the system works as intended. 
 
4.5.3 Riboswitch evolution experiments: 
The virulence factor calculations provided a comparative measure of the 
different efficiencies for each of the different phage populations, in a much better 
way than directly using growth curves.  
 
The WT T7 was used as a control, essentially, since the whole purpose of the 
process was to measure the activation of the switch and how that affected the 
virulence. Hence, that explains why in this case the value remains at around 30% 
efficiency. The other control, the fixed riboswitch-containing phages that were 
used to set up the procedure, work as expected, with an increase of 20 and 17% 
for the positive selection, and showing essentially no difference in the negative 
selection. Given the commented issues with the negative selection, this result, 
although negative, it’s not entirely unexpected.  
 
This riboswitch sequence could then be considered the “golden standard” for the 
experiment. But at the same time, it can help draw the wrong type of conclusion. 
The evolution of the phage populations can cause increased virulences, but that 
does not necessarily mean better riboswitch sequences. It is important to make 
that distinction, and the reason why the “activation efficiency” metric can give 
more insight into the actual workings of the riboswitch. 
 
For the actual test populations, two out of three are better at infecting than the 
golden standard/Fixed riboswitch phage, but that does not necessarily mean 
better riboswitch sequences, as evidenced by the activation efficiency in both 
cases. Phage populations with worse riboswitch sequences can have a higher 
virulence, and it is important to take that into consideration when assessing the 
efficiency of riboswitch activation based on that data. At this point, it is important 
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to remember the fact that the all phage populations before generation 10 were 
selected with 1.5 mM theophylline, while every generation afterwards was 
selected with 1mM. This is actually visible in the positive selection, as generations 
2 and 5 are worse than 16 when infecting at 1mM, while the opposite happens at 
1.5 mM. 
 
Regarding the negative selection, as seen before in previous assays, there was a 
larger variation in the experiments. But the results show the phages that were 
selected at 1.5 mM have a better activation rate than the gold standard switch, 
while the one selected at 1mM does worse than all others. But at 1 mM, while the 
1.5 mM populations were once again less efficient, population 16 shows the 
biggest activation rate, with an increase of 28%.  
 
These results seem to indicate there is a difference between subsequent 
generations, and that even within the selection process, further changes, such as 
concentrations of the activator, can be considered within the strategy, allowing 
for more specific riboswitches to be obtained.  
 
To fully assess this, the next generation sequencing of different libraries took 
place. Based on the initial set of sequences analysed, it seems that indeed each 
generation has been marching towards a dominant sequence from a sequence 
space where no particular one was overrepresented, as seen in Figure 33. 
 
There are, however, some not-so-obvious implications for the relationship 
between riboswitch sequence and specificity that can be drawn from these 
results, especially given the efficiency of phage population 16 at in cells grown 
with 1 mM theophylline.  
 
The reduction of theophylline concentration occurred after generation 10, and 
the results indicate that the tested population works best at that concentration 
than at a higher one. However, when that is considered along with the data from 
Supplementary table 2 and Figure 33, we can see that by that point (marked as 
S12 in the figure), one sequence is already overly represented in the population.  
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Is it possible that a sequence can change its 3D structure to work better at a 
specific concentration? We do not have all the necessary data to confirm this 
hypothesis, but this could be a way of explaining the obtained results. One 
possible way of addressing this would be to test the virulence of another phage 
population after generation 10. 
 
4.5.4 Conclusion and future improvements 
So, in conclusion, these two sets of selection data, when taken together, seem to 
confirm the following: 
1. Directed evolution has indeed taken place using this strategy. 
 
2. Phage virulence does not directly correlate to riboswitch efficiency, as 
some phages have increased the virulence over subsequent generations, 
despite carrying less efficient riboswitch sequences. 
 
3. The obtained riboswitches have managed to improve upon the previous 
generations, and in certain circumstances, a switch ratified by the 
literature, used in order to set up the system. These improvements 
include a more efficient functionality at a lower concentration of 
activator when compared to the initial generations, and a better 
efficiency rate for the negative selection step. 
 
4. There is room for improvement in the double selection, such as reducing 
the leakage of the selection genes via the promoter, so the full activation 
fold of the switch is more discernible. 
 
5. We acknowledge the fact that the mechanism of the PifA protein is still 
not fully understood. This could mean some effects may be overlooked in 
the selection and cause a larger variation between results than in the case 
of the positive selection. 
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4.5.5 Protein receptor evolution procedure: 
This project was developed on the back of the cI repressor strategy, the mmfr 
strategy was considered a good way of determining whether a T7-based system 
could be applied to the evolution of not just RNA switches, but also different 
protein receptors. 
Despite the full strategy not coming to fruition, there are still some relevant sets 
of data that can be discussed within the frame of this thesis. 
 
As before, the selection genes used were cmk and pifA, but the whole 
promoter/repressor system is completely different in levels of complexity. The 
regulation still occurs at the translational level, with the riboswitch turning 
ON/OFF, but the evolutionary objective is a protein receptor, which adds levels 
of regulation that may be affecting the process. So far, we have no data directly 
indicating if protein production was hindered by the process. 
 
Based on the results shown in Figure 36, the regulation seems to differ between 
∆cmk cells and regular E. coli BW25113 cells as the GFP/OD values are higher on 
average in the second case. But despite that, in both cases all strains containing 
the mutated MARE4 version produce higher levels of GFP, which could be a sign 
of less binding by mmfR in those cases, according to our objective. 
The second set of experiments, this time in the presence of T7 phage to test its 
impact in the different strains used for selection, was once again done in all the 
previously used strains, but only in the presence of IPTG, to activate the Lac 
operon.  
 
Each set of selection strains had four strains, two of them tests and two as 
controls, as explained in Figure 37. As seen here, since the Lac operon is activated 
in both, MmfR is being produced and binding to mmyB, thus repressing Cmk 
production, cells in B still provide cmk in their genome, allowing for the phages 
to infect and kill. The results in A show lower killing rates which can be attributed 
to leakage, as the system is not 100% tight and some Cmk is still being produced 
and allowing proper phage replication. The constitutive lack of cmk in C affects 
killing rates the same way as in A, but lower regulation due to MARE4 presence 
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allows for faster killing, and the same occurs in D when compared to plot B. 
(Figure 37) 
 
The negative selection is where the biggest issue arises, as no killing whatsoever 
occurred in either Figure 37 E, G or H,  only in F, which was acting as one of the 
controls. And even then, the killing rates were much slower than in any of the 
previous cases. This is possibly due to PifA levels blocking any phage replication 
in all other cases. This can be interpreted as an excess of laxity from the system, 
and that the levels of PifA protein being produced even in these cases are more 
than enough to affect the strains in this fashion. In order to check whether PifA 
levels have been affected, the ideal thing would be to assess via western blot, 
which could also be useful to determine the minimum concentration needed for 
repression of T7 replication to take place. 
 
4.5.6 Conclusion and future improvements 
In conclusion, this preliminary set of data can tell us the following: 
 
1. The MARE4 mutated variant of gene mmyB has a lower binding efficiency 
to the repressor MmfR. 
 
2. The use of a T7-based evolutionary procedure for this system holds 
potential but needs to be further regulated. 
 
3.  Tests for the positive selection step of the procedure showed promise, 
with differences in growth curves in the presence of T7 phage; but not so 
much for the negative selection step, where the system requires further 
optimization and regulation in order to be usable in this context. 
 
4. Some of that optimization would involve western blot assays to 
determine the different levels of protein production under each of the 
conditions, which could help shed a light on the threshold that 
determines where phage killing starts occurring, especially in the context 
of the negative selection step. 
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Viruses have evolved as an obligatory parasite, and as such require the molecular 
machinery of other organisms in order to replicate, whether they undergo lytic 
or lysogenic cycles. However, as with all replication processes, nothing is without 
flaws. In the same way some viruses can integrate within the genome of their 
host, in some cases bacteriophages can incorporate DNA fragments from their 
into their genome. This creates a subpopulation of viral offspring which will then 
transfer that DNA into whichever new hosts they infect, in a process known as 
transduction, first described by Zinder & Lederberg (1952) 
 
Traditionally, 3 main types of transduction are considered to exist: 
• Generalised transduction 
• Specialised transduction 
• Lateral transduction 
 
Of these three, only the first two are considered relevant in this case, as they both 
involve bacteriophages (Griffiths, Miller, Suzuki, Lewontin & Gelbart, 2000). 
 
In the case of generalised transduction, the bacterial DNA introduced in the 
capsid is essentially random and is just present in a low percentage of the 
obtained offspring. This can be due to the phage integrating itself in the bacterial 
genome and taking some bacterial DNA fragment via recombination; or because 
of some phages’ “Headful packaging” mechanism (Alam et al., 2008). Phages that 
use this mechanism, such as the T4 family (which includes the T7 phage) establish 
their capsid and proceed to fill it up with genetic material, which, in some cases, 
can include the host’s DNA. The start of this process can be determined by the 
phage’s nuclease detecting a specific pac site, or can start randomly (Garneau, 
Depardieu, Fortier, Bikard, & Monot, 2017) 
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Once these fragments are inside the virion, these viruses are known as 
“prophages” or “phagemids”, and will transfer them to their next host, where 
several things can happen: 
• The DNA is broken down by the host. 
• The DNA happens to be homologous to the host’s and recombination is able 
to occur. 
• The DNA was originally a plasmid and re-circularizes in the host. 
 
In the second type of specialised transduction, specific genetic sequences get 
included within the phage, depending on the position where the phage integrated 
itself into the genome of the bacteria. One example of a phage that undergoes 
this process is the l phage (Snyder, Peter, Henkin, & Champness, 2013). 
This ability of phages to act as a movable element that can be used to deliver 
specific DNA fragments into a host has been taken advantage of not only in 
bacteria, but even in mammalian cells, as a way to deliver and facilitate gene 
therapy (Naldini et al., 1996; Rubinson et al., 2003). All this sets transduction as 
the mechanism responsible for the horizontal transfer of genes, and thus, a very 
active and relevant player in the process of evolution at the molecular level. 
 
Precisely, the use of a transduction strategy enabled Yosef, Goren, Globus, 
Molshanski-Mor, & Qimron (2017) to develop a way to increase the host range of 
the T7 phage by using a specific packaging signal (Chung & Hinkle, 1990b), giving 
the system a much-needed versatility, and enabling the development of an 
efficient system for DNA transfer along the way. These experiments served as 
inspiration for an alternative strategy developed in this thesis, as part of the 
directed evolution of riboswitches that represents its core.  
 
Despite all its positives, such as high speed and number of phages produced per 
cycle, there are several points where the original riboswitch evolution strategy 
via T7 could theoretically be improved: 
 
• Homologous recombination: The process of homologous recombination is, at 
its core, a rare occurrence, hence why the ideal ratios of phage to cell need 
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to be calculated. This is then followed by an amplification step of the 
recombined phages. But the most important issue is that this process could 
also cause a bias on the phage library when compared to the original plasmid 
library, decreasing the theoretical number of variants available and effectively 
reducing the library size. 
  
• Activation time: In the full phage strategy, phages carrying the different 
riboswitch variants infect cells that have been grown in the presence or 
absence of theophylline, and the riboswitch has approximately 17 minutes to 
activate and allow the proper replication of its carrier, given this is the 
approximate time it takes for phages to enter, replicate and burst out of a cell. 
It could be argued that this time constraint may affect the viability of different 
versions of the riboswitch during the selection process, giving a wrong 
estimation of the switches that are able to survive each selection step.  
 
Such were the objectives of this alternative strategy. By keeping the riboswitches 
in a plasmid library, rather than recombining them into the phages, we could 
ensure their activation by growing the cells with theophylline in the media for 
enough time to fully activate any working variants present. And by eliminating 
the full phage in favour of infective particles/phagemids, we make sure that the 
replication only happens under very specific terms, and can trigger it when 
needed, rather than having to accommodate everything in the original seventeen 
minutes of T7 replication. 
 
The starting T7 phage population in this case is already a KO for DNApol, and 
again includes trxA as a marker, but not as part of a recombinant sequence of 
interest as it was before.  In this case, the initial infection is carried by these 
defective phages, and the process occurring is phage transduction (Zinder & 
Lederberg, 1952). This process can make for higher efficiency than homologous 
recombination, pack our plasmid of interest inside the phage’s virion; and 
decrease the chances of WT T7 contamination, since there were no WT phages 
present at any point in the system. 
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This strategy requires a new, less automatic experimental setup, as well as cells 
transformed both with plasmid containing the T7 packaging signal, the riboswitch 
library and the cI repressor; and the specific selection plasmid. This tentatively 
gives the researcher higher control of the selection process as a trade-off, as the 
riboswitch can be induced for longer than the ± 17 minutes it takes for the phage 
to replicate. 
Unlike the first strategy, phage replication in this case is regulated from within 
the bacterial strain, eliminating any issues arising from using WT phages from the 
beginning, using ∆gp5 T7 phages instead. The T7 DNA pol will be supplied by the 
cell, and the switch’s activation will regulate the proper replication of phages, 
following the same design from the 1st strategy. Phages infecting cells containing 
a working version of the riboswitch will be able to replicate, and a percentage of 
their offspring will package the plasmid containing it, creating the infective 
particles or phagemids. 
 
In order to detect these phages and continue the process, a bacterial strain 
containing the selection plasmid for the next step will be infected with the 
obtained phages and plated in media containing a specific antibiotic. The gene 
conferring resistance to this antibiotic is encoded inside the phagemid’s plasmid, 
meaning that unless these cells have been infected by the ∆gp5 T7 phages and 
transduction has occurred, they will not be able to grow. 
 
These cells will then be infected again by a new population of ∆gp5 T7 phages, 
setting the process in motion once again. As indicated before, all this makes the 
system have lower automation than the initial strategy, sacrificing it for a higher 
efficiency on the first bottleneck of the process, the size of the initial phage 
library. 
 
All the elements needed for this strategy were developed and partially tested, but 
due to time constraints, no double selection procedures were carried out, and 
thus, its efficiency as a directed evolution method has not been tested. 
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5.2 Specific objectives 
 
To develop and assess a transduction-based procedure founded on the use of the 
bacteriophage T7. Such procedure would be used for the directed evolution of 
riboswitches and possibly modified for the evolution of alternative biosensors. 
 
5.3 Specific materials and methods 
 
5.3.1 Packaging signal design 
As previously stated, based on the research by Yosef et al., (2017) and the 
packaging signal articles by Chung & Hinkle, (1990), several different versions of 
the packaging signal were designed, and eventually synthesised. Their sequences 
differed in size, due to the different fragments taken from the short and terminal 
repeats of the T7 phage’s genome. In the end, three different packaging signals 
were designed, but only 2 were produced. Their general structures and individual 
differences are shown on Figure 38. In the end, the used sequence contained 
fragments from both left and right short repeats, as well as terminal repeats. 
 
Figure 38. General structure of packaging signals 
Structure of the different packaging signals designed for the project. In red, the ones that 
were actually synthesized, in blue, the one that didn’t make it past the design stage. As 
the figure indicates, all three were very similar to one another when aligned (filled arrow 
fragments), with some differences regarding the length of certain sequences (empty 
arrow fragments). The main difference between the two synthesized packaging signals 
was the inclusion of the left-end short repeats (SRL) at the end of its sequence. The part 
that shows up as not aligned is essentially the same, given that the terminal repeats on 
both left and right sides have the same sequences. 
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5.3.2 Plasmid Assembly 
Plasmid assembly specifications:  
Given that there was only one main modification in order to carry this strategy, 
and that is the addition of a T7 packaging signal, most constructs for this strategy 
remain the same as in the case of the full phage one. Selection plasmids remain 
the same in both cases, and no comparison between the different RBSs is needed 
in this case, as those were already carried out previously and the same results 
would be applicable here.  
 
That being the case, there was only one new construct for the cI strategy, based 
on the riboswitch library plasmid EG_cI02, but its assembly required different 
steps, and further modifications occurred as time went on and the definitive 
version was obtained. Following that same idea, new constructs were also 
designed for the mmfR strategy, but were not properly cloned. All the assemblies 
were made via GoldenGate ligation (Engler et al., 2008), and the final products 
can be seen in Supplementary figure 8.  
 
• EG_pm01a (3916 bp, Supplementary figure 8. A):  
The initial modification consisted on the elimination of most of gene 4.7, part of 
the homologous regions), in order to include the packaging signal in its place. As 
a result of this, this plasmid was obtained. However, further modifications were 
needed, as both genes 5.3 and trxA were still included as part of the sequence of 
the plasmid. 
 
• EG_pm01b (5594 bp, Supplementary figure 8. B):  
The second step in the assembly, eliminating both the other end of the homology 
region, gene 5.3, as well as trxA, in order to introduce the sequence of the T7 E.P. 
gp5. 
 
• EG_pm01c. (5582 bp, Supplementary figure 8. C):  
The definitive version of the plasmid, eliminating the remaining fragment of gene 
4.7, as well as the T7 promoter located in front of the riboswitch, exchanging it 
for E. coli promoter J23119 (C. C. Liu et al., 2012). 
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5.3.3 Production of infective particles/phagemids 
An overnight culture of cells transformed with the previously mentioned plasmid 
was refreshed into 5 ml and grown at 37ºC until it reached logarithmic growth 
phase (OD600 0.2-0.3). At that stage, it was infected with T7 phages and kept at 
37ºC with shaking until the culture became clear. The cultures were then pelleted 
by centrifugation at 3000 rpm/2254 g for 10 min in an Eppendorf centrifuge 5920 
R. To obtain clean samples, lysates were filtered through 2 µm Sartorius filters. 
50 µl of chloroform were added and the culture was vortexed in order to fully 
eliminate any possible remaining cell debris. This lysate, however, contained both 
phages and phagemids, which have incorporated the plasmid and need to be 
isolated. 
 
5.3.4 Transduction assay 
In order to confirm the presence of transducting particles in the lysate, the 
culture to be infected needed to be grown until OD600 0.2-0.3, before 300 µl of 
the culture were mixed with 100 µl of the lysate and plated on an LB agar + Cm 
plate. If transducing particles were present on the lysate and infect the cells, 
colonies would appear, as the cells would have acquired the plasmid contained 
within the phages and obtained the necessary antibiotic resistance.  
 
Initial transduction assays were made with cells that only contained the 
packaging signal plasmid, as the objective was to measure the efficiency of the 
packaging. The objective was that eventually, the procedure would happen with 
cells carrying either the positive or negative selection plasmids. 
 
5.3.5 Plaque assays  
Regular plaque assays took place in parallel with the transduction assays, so as to 
confirm the presence or absence of full-genome-carrying phages in the lysate. 
The procedure was as described in the regular materials and methods, with 300 
µl of the cells that are to be infected + 100 µl of the phage lysate. This is then 
mixed up with 3 ml of soft agar and poured onto a plate with the original 
resistance carried by the cells. The number of PFUs in the lysate is then compared 
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to the number of phagemids/CFUs obtained from transduction, and an 
approximate ratio of efficiency for the packaging signal can be obtained. 
 
5.3.6 Colony PCR  
When colonies were able to grow on the Cm-containing plates, single-colony 
PCRs were made so as to assess the presence of the packaging signal plasmid in 
those cells and then run on a 1% agarose gel. Positive PCRs were purified using 
the Thermo GeneJET PCR purification kit and sent to Eurofins Genomics for 
Sanger sequencing in order to confirm the presence of the packaging signal. 
 
5.3.7 Strain selection for Evolution procedures  
Given that these experiments were already done in the original full phage 
strategy, and the selection plasmids suffer no modification for this one, it was 
considered unnecessary to repeat those, and such, the same strains used in one 
case were applied for the other. 
 
5.3.8 Evolution procedure 
As seen in the previous chapter, the experimental evolution procedure was 
originally devised as an automated process, following on the concept of PACE 
(Hubbard et al., 2015). However, this strategy, following up on (Yosef et al., 2017b) 
requires extra steps for the transduction due to the use of phagemids, since these 
cannot be automated using the bioreactor.  
Once the packaging signal was proven to work, and following the results obtained 
from the evolution strategy using recombined phages, a new procedure was 
derived for the directed evolution of riboswitches using infecting 
particles/phagemids. In this case, the plasmid carrying the packaging signal is 
introduced inside the selection strains, which are then grown and eventually 
infected with ∆gp5 T7 phages, to avoid any WT contamination. These phages 
would be able to replicate and pack the riboswitch-containing plasmid thanks to 
2 distinct elements present in the cells: the T7 DNA polymerase, which allows for 
the replication of the phages, and the riboswitch, whose activation will regulate 
the expression of the specific gene corresponding to the current selection step. 
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The main difference here for riboswitch function would be the fact that, while in 
the recombination strategy the activation of the switch and transcription of the 
downstream genes had to happen in the time it took the phages to infect and 
burst out of the cell; in this case the switch can be activated for hours before the 
infection occurs, ensuring the expression or lack thereof of the necessary genes. 
As explained before, the selection procedure would be regulated by the same 
genes. 
 
In the positive selection, where an “ON” state of the switch is selected, the 
essential gene cmk would be produced, allowing for the replication of the phage 
and packaging of the plasmid in those cells containing a working riboswitch 
sequence in the presence of theophylline. 
In the next step, the negative selection, where the “OFF” state is selected, T7 
exclusion gene pifA is produced in the cases where riboswitch sequences still 
manage to remain in an “ON” state despite the absence of theophylline. This way, 
only those containing an “OFF” state switch will be able to replicate and package 
properly. 
 
Lysates obtained from each of these selection steps would then be used for 
transduction assays using the next selection strain, in a reiterative manner that 
would allow for the selection of riboswitches over time. In this step, the phagemid 
particles that have packed the riboswitch-containing plasmid are used to infect 
the next selection strain and transduce those plasmids into the cells. Doing so 
confers these cells an antibiotic resistance (chloramphenicol) and allows for their 
selection on plate and subsequent growth. 
 
A schematic diagram of how this procedure would be carried out, with an 
overview of the main elements and steps involved is shown in Figure 39. 
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Schematic representation of the different steps needed as part of the planned 
evolutionary procedure using infecting particles. As indicated, the ∆gp5 trxA+ phages 
would infect an E. coli BW25113 ∆cmk∆trxA strain (A), containing both a positive selection 
plasmid (blue circle), and a riboswitch library plasmid with the packaging signal (PM), all 
this in the presence of theophylline, to turn the riboswitch into its “ON” conformation. 
Phages infecting cells containing functional riboswitches will then be able to activate the 
expression of cmk, and thus allow for phages to replicate/package properly (B). The 
obtained lysate will then be used to infect E. coli BW25113 ∆trxA cells carrying the plasmid 
for the negative selection and then plated (C). Cells incorporating the plasmid will be able 
to grow in cm plates, then grown and be infected once again with the same phage strain 
(D). In this case, due to the absence of theophylline, the selection is aimed towards the 
“OFF” state of the riboswitch. If any riboswitch is in an “ON” state, T7 exclusion gene pifA 
would then be expressed and phage replication will be hindered (E). The corresponding 





5.4.A Packaging signal assessment 
The initial set of experiments carried out for this alternative strategy were 
essentially aimed at determining the efficiency of the packaging signal sequence 
included within the plasmid. As a way of determining it WT T7 was used as an 
initial test, and if results were positive, eventually other phage populations would 
be tested for the transduction procedure.   
 
• WT T7, as previously said, acted as an initial test and control for the process, 
since having a full genome meant any problem in the process could solely be 
blamed on the packaging signal. 
Eventually, some of the other phage populations used included:  
• T7 ∆gp5 trxA, to determine if the presence of gp5 in trans affected the 
process, and because this was intended as the phage strain that would be used 
once the evolution procedures were started. It was used to infect E. coli 
BW25113 cells. 
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The packaging signal plasmid was transformed into two different bacterial 
strains, conferring them chloramphenicol resistance. These cells were then used 
for the production of transducting particles, as explained in the materials and 
methods. 
 
• E. coli BW25113, as a control with all essential genes needed by the phage. In 
the case of infection with WT, ideally there should be production of both “full” 
phages carrying the whole genome, and phagemids, carrying the plasmid. In 
the case of ∆gp5 phages, since the plasmid carries a copy of the gene, there 
may be differences, but both phages and phagemids should also be produced. 
 
• E. coli BW25113 ∆cmk, to assess the impact of the absence of cmk in packaging. 
This is a very relevant test, as cmk is one of the elements used in the selection 
procedure, specifically in the positive selection; and ideally should affect all 
phage strains. Ideally, no phage nor phagemid production should occur in this 
case, due to the essential role of the gene, which allows the phage to break 
down the cell’s chromosome in order to be able to use its nucleotides for its 
own replication (Qimron et al., 2006). 
 
After growing for 1 hour in the presence of the phage, the different cultures were 
pelleted and filtered, and the obtained lysates then used for their own sets of 
transduction and plaque assays.  
 
For each lysate, the assays were carried out with several strains of E. coli, to 
determine the effect certain genes had on phage transduction and replication. 
Each of the selected strains were chosen for their differences in allowing proper 
phage replication. Being tested in that case, the same strains were also tested for 
possible effects on transduction, although ideally, no significant differences 
should occur in that aspect, as the process merely involves the introduction of 
the genetic material carried within the phage into the cell.  
 
E. coli BW25113, as a control with all essential genes needed by the phage.  
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• Plaques: In this case only plaque assays with WT phage lysate should show 
any clear spots, as the other populations lack the presence of T7 DNA 
polymerase.  
• Transduction: There should be no impact, as the phage merely introduces the 
plasmid inside the infected bacteria. 
 
E. coli BW25113 ∆cmk, to assess the impact of the absence of cmk in transduction.  
• Plaques: Ideally, no plaques should appear with any of the lysates. 
• Transduction: possible colony presence may be affected due to the gene 
product’s function, as it interferes with the cell’s chromosome  
 
E. coli BW25113 ∆trxA, testing whether the absence of trxA affects the process.  
• Plaques: The impact should be felt in all three phage strains, as WT lacks the 
essential gene, while the other two carry it in their genome, but don’t have T7 
gp5/DNA polymerase.  
• Transduction: Not much effect would be expected, as the gene product does 
not affect the host directly. 
 
E. coli BW25113 ∆trxA gp5, essentially to confirm whether phages carrying trxA in 
their genome can function if there is a supplied copy of T7 DNA polymerase.  
• Plaques: Only WT plaque formation should be affected in this case.  
• Transduction: Colony formation results should be similar to the previous 
case. 
 
TOP10: To confirm if there is a difference between the efficiency of the process 
between E. coli strains, as the genotype varies between them, with TOP10 being 
rec-, which may have an impact on the transduction efficiency. Previous 
experience in the lab has shown TOP10 to be less susceptible to T7 infection. 
• Plaques: In theory, only the lysate obtained from WT phages should produce 
plaques, the same way as with E. coli BW25113, but accounting for the 
possibility of them being lower in number. 
• Transduction: No impact, but as with plaques, there is the possibility that the 
number would be lower than with E. coli BW25113. 
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The results from the initial packaging signal efficiency assays are shown on Figure 
40, where the number of Colony forming units, which correlates to the number 
of infective phage particles, is shown after infection for each E. coli strain and 
lysate. It shows that the number of CFUs produced after transduction varies 
between the different strains infected with the lysates, but most importantly, that 
the production efficiency of infective particles is highly affected in E. coli BW25113 
∆cmk cells, as barely any CFUs were produced when that lysate was used, 
indicating a lower number of them present in the lysate. 
 
Figure 40. Number of colonies after transduction assays.  
Preliminary results from the transduction assays using lysates produced after the 
infection of WT T7 phages into different E. coli strains containing the packaging signal 
plasmid. The blue bars, corresponding to the infection of E. coli BW25113 cells with the 
WT phage, shows the highest number of colonies in all the different transduction cases. 
The orange bars represent the cases where the initial infection took place in a ∆cmk cell 
strain, showing a very significant decrease in the number of colonies. The values 
represented were obtained from 3 independent replicates and the Y axis is represented 
on a log 10 scale. Error bars represent the Standard Error of the Mean (SEM). 
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Figure 41 shows the number of Plaque forming units/Phages produced after 
infection for each E. coli strain and lysate, and how viable phage production varies 
in each of the infected strains, but also, that essentially no phages were produced 
in lysates obtained from E. coli BW25113 ∆cmk cells. 
 
Figure 41. Number of PFU after plaque assays with alternative lysates. 
Preliminary PFU values for the different lysates obtained after the infection using WT T7 
into different E. coli strains containing the packaging signal plasmid. The blue bars 
represent the lysate obtained from infecting E. coli BW25113 cells containing the plasmid, 
while smaller or non-visible orange columns represent the PFU number present in lysates 
obtained from E. coli BW25113 ∆cmk cells. The most accurate value for the PFU content 
corresponds to the one obtained when using the lysates to infect E. coli BW25113 cells, as 
there is no impediment present that could hinder the proper replication of the T7 phage. 
The values represented were obtained from 3 independent replicates, and the Y axis is 
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Given these results, and as previously explained, a second set of assays took place 
to confirm the transduction efficiency of ∆gp5 trxA+ phages. These results can be 
seen in Figure 42, indicating the number of colonies produced after transduction 
assays using lysates obtained from the infection of E. coli BW25113 by either WT 
or ∆gp5trxA+ T7 phages. In all cases, it seems the phagemid production is 
impaired in the second case but would still be usable in the desired strategy.  
 
Figure 42. Number of CFU after transduction assays with alternative lysates. 
Initial results from the transduction assays using the lysates obtained from the infection 
of E. coli BW25113 cells with either WT T7 phage (blue) or a ∆gp5 trxA+ T7 phage population 
(orange). The numbers show a lower efficiency in this case than with WT phages, but still 
colonies are formed, which indicate these phages can be used for the evolutionary 
procedure once set up. These results were obtained after 5 replicates, and the error bars 
represent the Standard Error of the Mean. Error bars represent the Standard Error of the 
Mean (SEM). 
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5.5 Discussion of results 
 
5.5.1 Packaging signal efficiency 
Based on the results displayed in Figure 40 and Figure 41, the first conclusion that 
can be drawn is that infecting particle production is in no way close to phage 
production. This poses a problem for the strategy, but one that can be dealt with 
by improving the efficiency of the system. There is always the possibility of 
developing a new packaging signal and a new set of assays to test it, and 
improving the transduction plasmid, making it smaller and easier to include 
within the T7’s virion. Given the results from Figure 42, the first step in that 
direction could be the elimination of gp5, as it is also present within the selection 
strains and its absence doesn’t seem to affect packaging. A set of transduction 
assays with that new plasmid to confirm whether or not phagemid production is 
impaired would be a good test for future developments of this strategy. 
 
Another plausible conclusion that can be taken out of these results is the fact that 
packaging is indeed affected by the absence of genes essential to the phage, such 
as cmk. While in the case of regular E. coli BW25113 cells the numbers of both PFU 
and CFU vary between the different cells infected by the lysate, there are enough 
to formally assess their presence and confirm that the infection of cells 
containing the packaging signal plasmid is working to a certain degree. However, 
the same cannot be said when the lysate used has been obtained from a ∆cmk cell 
strain. cmk encodes for the dCMP kinase, responsible for the conversion of the 
host’s nucleotides into nucleosides that would be used to assemble the phage’s 
DNA, as a substrate for the T7 DNA polymerase (Qimron et al., 2006).  
 
This can explain the differences seen when compared with regular E. coli 
BW25113 cells. The literature already showed that KO cells for cmk grew slower 
than regular ones, but most importantly, did not allow for the replication of 
phages, since the phages were not able to properly utilise the host’s genome to 
replicate themselves. 
This is one of the issues that make cmk such a good element for the positive 
selection in the evolution of the riboswitch. Unless it is present, phages won’t be 
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able to replicate, and it should only be present when the riboswitch is able to shift 
to an “ON” state in the presence of its activator, theophylline. 
  
Now, this still does not deal with the inefficiency of the packaging signal when 
compared to regular phage replication. Despite this difference, however,  
produced colonies indicate the selected packaging signal was working, and 
producing enough number of colonies so that, in theory, the evolutionary 
strategy could be carried forward.  
 
5.5.2 Conclusion and future research:  
 
Due to several reasons, chief among them the time constraints of a PhD and the 
development of the main evolutionary strategy, there is still quite a significant 




1. The development of another packaging signal sequence, to increase the 
phagemid-to-phage ratio of the original packaging signal, thus increasing 
the overall efficiency of the evolutionary strategy. 
 
2. Fully test the selection procedure. This is the most relevant element of the 
strategy, and ironically, the one that was not able to be tested properly. 
This could be done through the transformation of the positive and 
negative selection strains with EG_pm01c. These cells would then be 
grown in liquid culture in the presence and absence of theophylline, and 
infected with the ∆gp5 trxA+ phages. Since the riboswitch is present in the 
cells under an E. coli promoter in this case, there should be more than 
enough time for those cells carrying a working variant of the riboswitch 
in the positive selection and a constitutively “ON” riboswitch in the 
negative to produce the corresponding selection genes, and 
support/hinder T7 replication. In the end, if the process is successful, 
there should be a visible difference between the cultures grown in the 
presence or absence of theophylline in both cases. 
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CHAPTER 6. Qb PHAGE INDUCIBLE RNA SYSTEM  
 
6.1 Introduction: 
The discovery of the CRISPR system has ushered a new era in molecular biology, 
challenging what was thought to be feasible until now in genetic modification and 
allowing for very specific genetic changes in multiple different settings (F. Jiang 
& Doudna, 2017; Makarova et al., 2011). Its understanding has also shed some light 
onto some of the ways bacteria respond to the many mechanisms  by which 
external DNA is forcefully introduced (Hille et al., 2018). These responses can 
make certain types of research cumbersome and frustrating, or even eliminate 
the possibility of some strategies, as the genetic material can get degraded once 
inside the cells (W. Jiang et al., 2013; Marraffini & Sontheimer, 2008). It is because 
of these reasons that the development of an RNA-based system that could 
potentially bypass CRISPR would be interesting, moreover, one which could be 
relevant for many research groups at different levels of bacterial genetic 
research. It could even be an alternative on a therapeutic level, eliminating the 
obstacles CRISPR-Cas systems pose in these particular contexts (Galizi & 
Jaramillo, 2019; You et al., 2019). 
 
To develop this such a system, the best starting point would be the organisms 
that evolved to be able to introduce their genetic material inside of bacteria and 
overcome their defence mechanisms: bacteriophages. Not just any bacteriophage 
would work in this situation,  they need to have an RNA genome for the strategy 
to work. 
 
The enterobacteria phage Qb is a phage of the Leviviridae family, and one of the 
smallest known phages (Gorzelnik et al., 2016), with a capsid diameter of 28 nm, 
and a small linear ssRNA genome consisting of 3 Open Reading Frames (ORFs) 
coding for 4 proteins: a maturation protein, major and minor capsid proteins 
(contained within the same sequence, but with a frameshift event, in a great 
exercise of genome economy), and a replicase (D. Brown & Gold, 1996; Kashiwagi 
& Yomo, 2011). Due to the (+) ssRNA structure, the genome of these phages is not 
affected by the CRISPR system, which as far as it is known, shears dsDNA 
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sequences in order to disrupt them. This is what makes the Qb phage an 
interesting and novel vector for the insertion of genetic material into bacteria in 
a semi-permanent way. Using the phage’s strategy to introduce exogenous 
genetic material into the bacteria, we hope to obtain a vector that would allow 
for inducible, CRISPR-resistant gene expression, even after the elimination of the 
original vector and the inducing compound. A schematic version of this process 
and its main steps can be seen in Figure 43. 
 
Figure 43. Qb  phage-based strategy overview. 
Schematic representation of the experimental process. A) External and genomic 
structure of the Qb phage, indicating the three ORFs it carries in its genome, encoding 
for the Major and Minor maturation protein, Coat protein, and Replicase. B) The 
Chloramphenicol (Cm) Acetyltransferase gene is introduced inside it, instead of the gene 
for the Major Coat protein, in a reverse sense. This is then contained within a commercial 
vector carrying Ampicillin (Amp) resistance and transformed into specific cells carrying 
an inducible T7 RNA polymerase gene. C) Once plated, cells were grown on Amp plates to 
be selected, and then induced. Induced cells would grow both on Amp and Cm plates; but 
over the course of generations of selection, they would gradually lose the ability to grow 
in Amp plates, due to the loss of the original vector, but retain the Cm resistance. 
To test this hypothesis, we designed and synthesised a fragment consisting of the 
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place, we incorporated the sequence corresponding to the Chloramphenicol 
acetyltransferase gene from Staphylococcus aureus (Shaw & Brodsky, 1968) in a 
3’-5’ sense, opposed to the rest of the phage’s genome. The entire fragment was 
placed downstream from a T7 promoter, inside a generic IDT pUC plasmid 
carrying an ampicillin resistance; and transformed into E. coli strains containing 
an inducible promoter controlling of the expression of the T7 RNA polymerase 
gene. A schematic map of the construct can be seen in Supplementary figure 9. 
 
The transformation of such a construct conferred one antibiotic resistance to 
bacteria prior to induction (Amp), and a second one afterwards (Cm). Moreover, 
this resistance was conserved throughout subsequent generations of cells 
without further need of induction. After multiple cell passages solely in the 
presence of Cm, the original ampicillin resistance seemed to disappear, while the 
induced one remained. But this resistance was also eventually eliminated after 
several passages with no antibiotic present, proving it was not a fixed condition. 
 
6.2 Specific Objectives:  
 
To develop and test a procedure for the inducible and transient expression of 
genetic material in bacteria based upon the use of the Qb bacteriophage.  
 
6.3 Specific materials and methods 
 
6.3.1 Cell strains 
Three cell strains were initially used for this procedure, all of which contained an 
inducible T7 RNA polymerase. This induction was regulated by IPTG in the case 
of strains BL21 DE3 (NEB #C2527) and LEMO DE3 (NEB #C2528H), and by 
arabinose in BL21 AI (Invitrogen #C607003). 
 
6.3.2 Constructs specific to the Qb project  
Maps of all constructs can be found in the Supplementary Materials section. 
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• pUC-cat plasmid: 6767 bp, Supplementary figure 9. 
A standard pUC plasmid from IDT carrying an ampicillin resistance was used as a 
carrier for the sequence of interest, containing the Qb phage’s replicase, minor 
coat protein, and maturation protein on a 5’ to 3’ sense, as well as the sequence 
for the Chloramphenicol acetyltransferase from S. aureus in the opposite 
direction. Specific primers were designed in order to amplify fragments of the 
plasmid, so as to check its presence on the cells after transformation, as well as 
along the curation process. These primer sequences can be found in the 
corresponding table in the General Materials and Methods Section. 
 
• pUC-gfp: 6851 bp, Supplementary figure 10.  
As a second stage of the research, a different construct was assembled based on 
the pUC-cat backbone, which contained all the different elements of the 
previously described plasmid, but the cat gene was exchanged for gfp in the same 
orientation. This was done via PCR amplification of the backbone and the gfp gene 
with the addition of appropriate restriction enzyme sites. After the restriction 
digest, both fragments were ligated and transformed into BL21 AI cells, which 
were then grown on LB plates (Amp). The presence of gfp was confirmed via 
Sanger sequencing using primers EG_128 to EG_133, as seen in the 
corresponding table in the General Materials and Methods Section. 
 
• Gene fragment T7-rGFP-rRBS-3’UTR: 980 bp, Supplementary figure 11 .  
This gene fragment was developed to enable testing in parallel in the PURE 
system with the full plasmid construct, to confirm the production of GFP in a cell-
free environment. It contained a T7 promoter in 5’-3’ sense upstream of the 
sequence for gfp, RBS B0034 (Weiss, 2001), and a 3’-UTR. This fragment will not 
produce any protein alone, but if dsDNA from pT7-RBS-rep is added to the mix, 
it will produce the replicase, which will bind to the rev3’UTR_MDV1 and lead to 
the production of GFP. 
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6.3.3 Primers   
Multiple primers were designed for the assembly of the different constructs, as  
well as the confirmation of the presence in the cell via colony PCR. All can be 
found in Table 5, in the General Materials and Methods section. 
 
6.3.4 Induction 
The cell cultures were grown at 37º C until reaching an OD of roughly 0.4, when 
inducers were added at a concentration of 400 µM in the case of IPTG, and 0.1% 
w/v arabinose in 5 ml cultures. The cultures were induced for 2 hours and then 
plated in 20 ml LB agar plates with either Amp or Cm. 
 
6.3.5 Curation procedure 
In order to force the elimination of the plasmid’s antibiotic resistance, the 
procedure was based on growing cells in media without selective pressure, where 
the genes to be cured were not necessary for the cell’s survival, and over several 
generations, would be eliminated. In the first set of experiments, induced and 
uninduced cells were plated on LB agar plates with Amp or Cm.  
From the colonies that were able to grow on Cm plates, single colonies were 
picked and grown again in 5 ml of LB Cm and plated once more. The repetition of 
this procedure over time lead to the eventual disappearance of the original 
ampicillin resistance carried on the plasmid; while at the same time leading to 
the conservation of chloramphenicol resistance carried within the genome of the 
Qb phage. 
 
Once chloramphenicol resistant strains had been obtained, a similar procedure 
took place, with the difference that in this case, cells were grown in the absence 
of antibiotic, plated in both chloramphenicol and no antibiotic plates, and grown 
once more from the latter ones. This led to the disappearance of the 
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6.4 Experimental procedure and Results: 
 
6.4.1 Qb-Cat experiments 
After the correct assembly of the plasmids containing the Qb genome along with 
the CAT sequence, the three different strains were chemically transformed, 
according to the procedure described in materials and methods. After the 
transformation and plating of the different transformed strains in ampicillin-
containing plates, several colonies were able to grow, hinting at the presence of 
the plasmid. Diagnostic PCR on those colonies using specific primers amplifying 
the plasmid backbone, confirmed the presence of the plasmid in some of them, 
















Figure 44 . Diagnostic PCR for Qb presence. 
Results from the PCR amplification of several of the plated colonies post-transformation 
of the plasmid construct, using specific primers designed to amplify a fragment of 1157 bp 
from the backbone. When compared to the sizes of the different bands present in the 
used Ladder, we could confirm the presence of the desired band, and thus, the presence 
of the plasmid in those colonies. The ladder used corresponded to the GeneRuler 1kb Plus. 
Ladder Picked colonies 1-5 
Ladder Picked colonies 6-13 
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Out of the colonies shown to contain the plasmid, one was selected for each 
strain, grown overnight and then refreshed into separate liquid cultures both 
with and without their corresponding inducers. Following that, all cultures were 
plated in both Amp-LB agar plates and Cm-LB agar plates.  
 
The promoters present in these strains were induced by either IPTG in the case 
of BL21 DE3 (Briand et al., 2016), or by arabinose in the case of BL21 AI (Guzman, 
Belin, Carson, & Beckwith, 1995). A third strain, LEMO DE3, was also used, with 
the difference that although it was induced by IPTG, it had tuneable levels of 
expression via the use of L-rhamnose, which regulates the expression of the lysY 
gene, coding for a specific T7 DNA pol inhibitor. The induction procedure is 
discussed in the material and methods section.  
 
From this initial set of plates, only BL21 AI was able to grow on ampicillin in both 
cases, but not on chloramphenicol unless induction had happened. LEMO DE3 
showed growth on both ampicillin and chloramphenicol despite not being 
induced, while BL21 DE3 showed no growth in chloramphenicol even when 
induced. After several repetitions, including the addition of various 
concentrations of L-Rhamnose to the LEMO DE3 strains; this was indeed 
confirmed to be the case, meaning that only one of the three strains (BL21 AI) was 
actually inducible enough to be used for this type of experiments. A diagram of 
these results is represented in Figure 47. These results eliminated these strains 
from further use in the strategy, meaning that only BL21 AI was used from this 
point onwards, as it showed growth in chloramphenicol only after induction. 
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Figure 45. Induction results. 
Representation of the results after the induction of different strains transformed with the 
Qb plasmid, indicating whether or not the cells were able to grow in different conditions. 
 
From the BL21 AI cells, those induced colonies which were able to grow on 
chloramphenicol plates were then grown overnight into 5 ml of LB with 
chloramphenicol, and plated again on chloramphenicol plates, showing the cell’s 
ability to grow in the presence of the antibiotic even without undergoing 
induction a second time; something that was not initially considered. 
After several iterations of this process of culture and plating, the growth of the 
liquid cultures and plates containing ampicillin started to show differences with 
the ones containing chloramphenicol. One possibility for this behaviour could be 
the cells “curing” themselves of the transformed plasmid, due to the ampicillin 
resistance gene not being needed any more, but the chloramphenicol resistance 
remaining within the genome of the Qb phage, in the form of RNA.  
 
 
Strain          Inducer 
LEMO DE3     IPTG  
BL21 DE3         IPTG  
BL21 AI        Arabinose 
puCIDT Amp-R 
pT7 
Uninduced, Cm Un/Induced, Amp Induced, Cm 
LEMO 
DE3 
Uninduced, Cm Un/Induced, Amp Induced, Cm 
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After 10 rounds of plating, there came a point where some of these colonies were 
able to grow on chloramphenicol plates but unable to do so on ampicillin, possibly 
indicating a full curation of the plasmid. In order to confirm this, a new set of 
PCRs were carried out to confirm the presence of the Cm resistance gene.  
 
34 colony PCRs for the whole Qb fragment with the chloramphenicol resistance 
gene (4715 bp) were run using colonies from different experiments and while in 
some of them a band does appear, in several of them no band appears, indicating 
that the plasmid is no longer present in the cell, but despite that, the resistance 
somehow remains, further supporting the possibility that it does so in in the form 
of RNA, although we cannot rule out other possibilities, such as a spontaneous 
mutation. 
 
The results from this assay and a comparative between the colonies can be seen 
in Figure 46. Some of these selected colonies were made into glycerol stocks and 
kept at -80 ºC for the laboratory’s stocks, under the names SAJ738 for the original 
transformed strain and SAJ739 for the curated one. 
 
Figure 46. Colony growth and diagnostic PCRs for Qb presence.  
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Comparison of eight different BL21 AI colonies grown in both Amp (red) and Cm (green) 
LB + agar plates. As seen in A), the growth in Amp is much sparser than in Cm plates, 
corresponding to a possible loss of Amp resistance over subsequent passages. B) Shows 
the result from PCR amplification of the same fragment of 4715 bp, corresponding to the 
set of genes from Qb, in each of the different colonies. While some of them (mostly in the 
Amp plate) show a band at the expected size, the PCRs corresponding to the Cm-grown 
plates do not produce one. In some case PCR samples are labelled “a” or “b” since two 
different colony morphologies were present, and were tested independently. 
In order to confirm the transitory nature of the cells’ newly acquired 
chloramphenicol resistance due to the Qb phage, a similar experiment was 
devised, so as to eliminate it over the course of several generations.  
 
Cells would once again be cultured in liquid broth under two conditions; the 
presence of chloramphenicol and the absence of any antibiotics, and then 
cultured in 5 ml of LB in the absence of any antibiotics. The cells grown in the 
latter case would then be plated into regular LB agar plates and cultured once 
again in 5 ml of LB + Cm and just LB. Despite the cells being able to grow in both 
conditions for the first plating rounds, showing similar types of growth in both 
cases, by round 9 the bacteria seemed to have fully lost their ability to grow in 
presence of chloramphenicol. This was assessed both via plating and liquid 
culture, with the difference being easily discernible in both cases. 
 
Glycerol stocks of all of the different steps were obtained and then used to 
estimate the number of colony-forming units (CFU) for each plating step under 
the two different conditions (presence and absence of chloramphenicol) at the 
same OD values. Multiple repetitions of this showed a much higher number of 
CFU in the absence of chloramphenicol, which in itself could be understandable, 
since the resistance is an exogenous gene and there is no antibiotic stress for the 
cells; but the ratio of CFU in the absence of chloramphenicol/CFU in presence of 
chloramphenicol greatly increases as the plating steps go by, coming to a point 
where there are essentially no colonies forming in the presence of the antibiotic.  
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These results, indicating the number of average CFUs per generation and their 
growth on LB agar plates can be seen in Figure 47. It indicates how the number 
of CFUs remained similar between the LB agar and LB agar + Cm media until a 








Figure 47. Comparative growth of generations of Qb-expressing cells.  
A) Average CFU values of the induced strains throughout the “curing” process of the 
Chloramphenicol Acetyltransferase gene carried within the Qb phage’s genome; when 
plated in the absence of antibiotics or in the presence of chloramphenicol.  Error bars 
represent the SEM. B) Streaks from each of the different colonies in LB agar plates (left) 
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6.4.2 GFP experiments 
In parallel, our collaborators at Sorbonne University in Paris assayed GFP 
expression via in vitro assays using the Protein synthesis Using Recombinant 
elements system, or PURE (Shimizu et al., 2001). This is a cell-free translation 
system containing a high-purified mixture of all necessary factors for protein 
synthesis, and which allows for a high purification rate of the obtained product. 
In this case, the assay took place using a new construct based upon our original 
Qb plasmid, in which the cat gene was substituted for the gfp gene. This construct 
is described in Supplementary materials’ Supplementary figure 10. Via qPCR, the 
preliminary measurements of GFP production were taken, and can be seen in 
Figure 48 comparing between a control sample with no GFP production and two 
different concentrations of the Qb-GFP plasmid. The figures represent very early, 
preliminary data, and show that the plasmid constructs do indeed produce GFP, 
but at a slow rate, which stops at a certain point, indicating that the system needs 
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Figure 48. Qb-GFP plasmid expression.  
A) Fluorescence curves from qPCR representing preliminary results for GFP production 
in a PURE system by measuring fluorescence signal in AU (Y) over time in minutes (X). 
The different curves represent the PURE system without the plasmid (yellow), with DNA 
encoding for GFP as a control (green, which had issues rendering it unusable), and with 
different concentrations of the pUCIDT+Qb+GFP plasmid (blue and violet). B) Second 
repetition of the assay, with a correct control DNA encoding for GFP (green), the PURE 
system without the plasmid (yellow), and once again, the two samples with different 
concentrations of pUCIDT+Qb+GFP plasmid (blue and violet), which in this case show 
lower activation than in the previous assay.  























No plasmid (-) 
GFP DNA 1 nM (+)  
0.5 nM construct 
1 nM construct 
No plasmid (-) 
GFP DNA 2.5 nM (+)  
0.5 nM construct 
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6.5 Discussion of results 
 
6.5.1 Qb-cat experiments 
The initial set of transformations made for these experiments worked in all cases, 
as each of the different strains was able to grow properly in the presence of 
ampicillin, and PCR confirmed the presence of the plasmid. However, the 
induction showed that each of the strains had a very different response to 
chloramphenicol. The different results between strains meant the elimination of 
two of them, as they were not responding properly to the induction (Figure 45) 
Both strains (E. Coli BL21 DE3 and LEMO DE3) had something in common, and 
that is their DE3 designation, which meant they contained the λDE3 lysogen, 
carrying the gene for T7 RNA polymerase under control of the lacUV5 promoter, 
requiring IPTG to maximally induce expression. The only difference between 
them is the presence of the T7 lysozyme in LEMO DE3, designed to downregulate 
the expression of T7 RNA pol if needed, in cases where a specific protein was 
toxic for the cell.  
 
This makes the results even more vexing, because LEMO DE3 shows more 
expression of the chloramphenicol resistance gene than BL21 DE3, despite having 
one extra level of regulation, the T7 lysozyme. If in both cases the induction 
system is the same, it is unclear why in one of the cases it does not seem to turn 
ON, not activating the antibiotic resistance,  while in the other one it does the 
opposite, with the same resistance not being turned OFF, even when the T7 RNA 
polymerase is supposedly repressed by the lysozyme. Given this situation, and 
since the remaining strain (BL21 AI) seemed to work as desired when induced, it 
was then decided to use it for the remainder of the experiment.  
 
This led to the results shown in Figure 46, where after several culture passages, 
the resistance to chloramphenicol is maintained, even when the original plasmid 
containing the gene encoding Cm resistance is not detectable via PCR. Our 
theory is that, given how the Qb phage is a (+) ssRNA phage, the corresponding 
genetic information encoding chloramphenicol acetyltransferase is maintained 
in the form of RNA in the cytoplasm of the cell, not in plasmid form, as it was 
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previously. Coupled with the Qb’s own replicase, which helps form an RNA-
dependent RNA pol capable of replicating both (+) and (-) RNA strands, this 
creates a way for the information to remain unaffected by the bacterial defence 
system that is CRISPR, and ensure its presence in the cell, carried as part of the 
Qb phage’s genome.  
 
In order to confirm that this resistance was only temporary and would only be 
present as long as it was needed, the same procedure used to eliminate the 
original plasmid was taken once again, (Figure 47). In here, the results indicate a 
slight difference when the cells are gown in the presence of the antibiotic, instead 
of in the absence of it, which could be explained by a possible deviation of 
resources to resistance production, but from the 5th pass onwards, we see a 
decline in number of CFUs, until a total disappearance in the final steps. This 
could be associated with either a decrease in the number of copies of the 
sequence carrying the resistance information, or in the production of the protein 
itself.  
 
As further proof of the progressive disappearance of the chloramphenicol 
resistance, a retro-transcriptase qPCR assay was designed to properly assess the 
quantity of RNA present in each of the plating steps, in an attempt to associate 
those levels with the CFU results. Sadly, due to time constraints, such an assay 
did not take place in the end. However, it would be very relevant to do such an 
assay in order to elucidate the reason, and based on its results, decide on which 
assays would be more relevant afterwards. 
 
6.5.2 Qbeta-GFP experiments 
The most important issue with this set of data is the fact that it is at a very early 
stage, and thus has several flaws and requires improvement. Our collaborators at 
Sorbonne University tested the GFP production of our Qb-GFP plasmid at 
different concentrations in a PURE system against a control with no plasmid 
present, in order to assess the level of expression from the plasmids in the 
system, and provided us with the diagrams represented in Figure 48. The green 
curve acting as a positive control, failed to work in the first case due to an error 
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in the sample, but showed a very fast initial activation which then slowed down, 
but kept increasing over time. Meanwhile, the samples have different activation 
levels in the two experiments, but are both slow, weak, and seem to stop after 5 
hours. One way to tackle this has been the increase of DNA concentration in the 
samples, to levels more comparable to the positive control. Sadly, no results are 
available as of yet. The gene fragment designed as a parallel experiment should 
also be present in these graphs both by itself and with the addition of the 
dsDNA pT7-RBS-rep. Doing this would show the differences in GFP expression 
once the replicase is produced and binds to the rev3’UTR_MDV1. This should, in 
theory, produce GFP levels at a slower rate than the Qb-GFP plasmids, and would 
act as a lower threshold control of sorts for the expression of the plasmid system. 
 
This could also open the door to the question, why not use this system with a 
replicase in trans in an in vivo system instead of an in vitro one? Such a 
development would be interesting from a mechanistic point of view, and would 
certainly make things easier when designing systems, but it would be 
contradictory to the idea that spurred this project in the first place. Having a 
plasmid based around RNA and have it work only in bacterial strains that contain 
a replicase/RNA-dependent RNA polymerase would severely undercut the 
possibilities this system holds and its uses. Thus, we believe that, despite it 
making the system more complex, the current setup is a sufficiently effective way 
for inducible and transient gene expression that could exist outside the realm of 
current CRISPR systems, making a significant impact in the field of synthetic 
biology at large. 
 
In conclusion, this data seems to confirm the following: 
1. We have developed a working inducible system for transient gene 
expression based on the RNA phage Qb, which regulated and maintained 
antibiotic resistance several generations after induction occurred. 
2. More experiments are needed to improve and fully assess the workings of 
the system, including further repetitions of the GFP experiments, and RT-
qPCR assays to properly assess the quantities of RNA in the system over 
generations after induction occurs. 
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CHAPTER 7. OVERALL CONCLUSION & FUTURE DEVELOPMENTS 
 
The main focus throughout the length of this thesis was the development of a 
procedure for the directed evolution of regulatory molecules via the use of T7 
phages. While this procedure was focusing mainly in evolution of RNA elements, 
more specifically riboswitches, other alternative molecules have been presented 
in which such a strategy could be of use, such as proteins. The creation and 
testing of these different strategies have been recorded, along with the 
discussion of results dealing with their main strengths and possibilities, as well 
as current limitations.  
 
Regarding the Main objective of the thesis, which revolved around setting up a 
system for the directed evolution of a riboswitch using T7 phage, many aspects 
need to be addressed to determine whether or not this has been achieved. 
 
The starting point, as explained previously, was the development of a riboswitch 
library and its subsequent incorporation into plasmids and phages for their use; 
which was dealt with in Chapter 3. Next, it was the assembly and testing of strains 
used for the positive and negative selection of these riboswitches, and their use 
to assemble an evolutionary system using all these elements, which was 
discussed in Chapter 4. Chapter 4 also deals with the results from the direct 
evolution of riboswitches using the newly created system.  
 
7.1 Development of a phage riboswitch library 
 
The results obtained in Chapter 3 confirm that the library-assembling strategy 
used did indeed allow for the creation of a library of 8N randomised riboswitches, 
which was introduced into a T7 phage population via homologous recombination. 
Theoretically, a library of eight-nucleotide fragments means 48, that is 65536 
different variants. 
 
This was then fully confirmed via the Next Generation Sequencing results present 
in Chapter 4, which at the same time confirmed an absence of bias in the library, 
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since the obtained results show no particular sequence has prominence when 
compared to others.  
 
This gave us enough certainty to assume all different riboswitch variants 
containing the random 8N sequence were present in the initial library before the 
evolutionary process started. 
 
7.2 Development of strains for positive and negative selection of riboswitches 
 
The positive and negative selection strains, whose development was described 
within Chapter 4, were tested appropriately, via plaque, spot, one-step and 
growth assays, in order to identify the best candidate for each selection step. 
However, both candidates for the positive and negative selections required 
improvements in order for their selection threshold to be optimal, insofar as it 
would only be regulated by the activation or inactivation of the riboswitch. 
 
The first element that should be addressed regarding the flaws of the selection 
process is the promoter leakage. The structure of the pRM promoter itself allows 
for multiple different ways where leakage happens, (Vilar & Saiz, 2010), and this 
certainly impacts the efficiency of selection. There is a difference between the 
presence or absence pf theophylline in the system in both the positive and 
negative selections, but the degree in which that difference is caused solely by 
the activation of the riboswitch is not properly known, as the leakage of the 
selection genes influence the results. Leakage levels need to be decreased in 
order for selection to be more stringent and efficient. 
 
Although leakage affects both selection strains, the negative selection step shows 
a much smaller difference between the ON and OFF states of the riboswitch. The 
cause of it is unclear and is also what drives home another big limitation of this 
study: the number of unknowns in the process by which the T7-exclusion protein 
pifA blocks T7 phage replication. In order to improve the negative selection step, 
more information needs to be obtained about the molecular pathways pifA is 
involved in. Since this falls outside the scope of the project, another possibility 
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could be the measurement of pifA protein levels both when the riboswitch is OFF 
and when it is ON. This could be done using different protein measuring 
techniques, such as a western blot to detect pifA levels specifically, or a Bradford 
assay to detect overall cell and T7 protein concentrations in the sample and 
assess any differences. The first technique would allow us to more accurately 
measure the difference in pifA production between both states, and possibly 
correlate that to riboswitch activation. 
 
7.3 Development of an evolutionary system 
 
The development of the evolution system using all these elements changed 
throughout the development of the project, mainly due to the technical 
difficulties arising after the breaking of the laboratory’s in-house-developed 
bioreactor, which forced the need to produce an alternative procedure that was 
not as automatic as the original one. If fixed, it would be interesting to compare 
the results obtained via the originally planned procedure with the ones obtained 
throughout this PhD and consider any differences and their relation to the 
method used in that particular case. 
 
7.4 Direct evolution of a riboswitch 
 
Regarding the considered main interest of the project, that is, the directed 
evolution of the riboswitch, the data presented in Chapter 4 can argue in favour 
of that, since the NGS data indicates a drastic reduction of sequence variation 
over subsequent generations, going from a state where no sequence has 
prominence over the rest to one where one sequence is substantially 
overrepresented in the population. Virulence factor experiments could be used 
to support this conclusion, as we can see that the values change over generations 
and theophylline concentrations; but again, the separation between a phage 
population’s virulence and riboswitch activation needs to be taken into account. 
Further assessments into the production levels for each of the proteins managing 
the selection could help clear out this issue. 
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Despite its shortcomings, this project has managed to reach the objectives it set 
out to fulfil, and although it can be improved in several aspects, this should not 
overshadow the impact that such a strategy could have in the field of riboswitch 
development and improvement, and tentatively, biosensor research at large. As 
far as we know, this research represents the first instance of a riboswitch 
evolution strategy via the use of T7 phage, and the first time a working riboswitch 
has been included in the genome of a phage. 
 
7.5 Secondary objectives: 
 
As for the secondary objectives, due to time constraints, several unanswered 
questions remain, but the way to follow through is clear:  
 
Regarding the evolution of alternative sensors, the system needs to be improved, 
and in order to do so, once again, the issues with pifA need to be addressed, 
probably with the same protein production measurements recommended for the 
main objective. The evolutionary procedure should be fully tested in the same 
manner as the riboswitch strategy, with the presence or absence of the molecule 
of interest, confirming over generations whether or not the system manages to 
sway the protein of interest towards the desired objective, an improved protein 
receptor with higher orthogonality. 
 
As for the alternative strategy for evolution based on the production of phagemid 
particles, the main issues correspond to the fact that the evolutionary procedure 
needs to be setup properly in order to confirm whether or not it works over 
generations.  
 
If it does indeed work as expected, it would be certainly interesting to compare 
these results with the ones obtained from the full phage strategy and assess if the 
same sequences were selected. If this were not the case, comparing the resulting 
sequences and understanding how they came to be selected could deepen our 
knowledge about the system by which riboswitches are selected, based on their 
structural-functional characteristics. 
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Finally, the results obtained from the development of the Qb phage-based 
inducible system seem to be ones that work according to what was expected, 
showing a working inducible activation that remains over several generations but 
can be eliminated when it is not necessary anymore. The possibilities that such a 
system offers could make a big impact in the field of microbiological research, 
with possible uses including more tightly regulated industrial processes, 
bioremediation applications, or even possible uses in gene therapy.  
 
7.6 Closing Remarks: 
 
As a closing statement, over the course of this PhD, the main research goal was 
concerned with the development of a system starting from a known riboswitch 
with a randomised fragment, but it could even lead to the evolution of new 
switches from random sequences. New switches that could bind known 
molecules and teach us more about the structural basis for their function, or even 
switches that react to newly developed compounds, with all the possibilities that 
offers. 
 
This system itself evolved, serving as a starting point for different alternatives 
that, while working with different structures, ultimately have the same objective, 
the development and improvement of biosensor molecules in an in vivo 
environment. 
 
Strategies like this could mean improvements not just at a basic research level, in 
the form of future riboswitch structure and development research, but in the 
applied research level as well. The development of improved or novel receptors 
could spearhead the development of new, more efficient processes such as the 
production of industry-relevant compounds with increased efficiency and yield, 
personalised medical treatments and a new way to fight the current antibiotic 
crisis. Even the possibility of developing new biosensors and microorganisms for 
bioremediation strategies, capable of degrading contaminants in the 
environment in an efficient way and shut down after fulfilling their objective.  
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As this thesis is being written, the proverbial bricks for some of these projects are 
just being laid, with years standing between us and the point where they will 
become a reality and bear fruit, being able to help society. But that does not mean 
work like this is any less important because of it.  
 
While applied research is important and gives faster benefits; basic research, 
despite its waiting, meandering, its non-profitability, and its difficulty, lays down 
the foundations for it. It opens up the road to further scientific innovation, and 
towards new possibilities we can’t yet see. 
 
Including, hopefully, a better future. 
 
 
,  : A journey of a thousand miles starts beneath one's feet 
 
“It's a dangerous business, Frodo, going out your door. You step onto the road, 
and if you don't keep your feet, there's no knowing where you might be swept off 
to.” (Tolkien, 1954) 
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8 SUPPLEMENTAL MATERIALS: 
 
All plasmids described throughout this thesis are described in this section and 
can be found in the Laboratory’s LIMS database and sample collection. 
 
Supplementary figure 1. Intermediate recombinant plasmid constructs. 
Temporary sequences produced from the modification of EG_001 in order to obtain a 
plasmid library of riboswitch variants. A) Map of the plasmid resulting from the 
amplification of EG_001 with primers EG_GGFw and EG_GGRev, incorporating several 
genetic elements between gene 4.7 and the l cI gene. B) Map of the resulting plasmid 
produced after BpiI/BbsI digestion and Gibson assembly, which will be used for the 
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Supplementary figure 2. Positive control 
plasmid for positive selection.  
Map of plasmid EG_cI03, with the most 
relevant elements for the positive 
selection indicated by name. T7 
promoter regulating expression of cmk 






Supplementary figure 3. Negative control 
plasmid for positive selection. 
Map of plasmid EG_cI10, with the most 
relevant elements for the positive 
selection indicated by name. No 
promoter nor RBS regulate the 
expression of cmk gene, ensuring 








Supplementary figure 4. Test plasmid 
structure for positive selection. 
Map of plasmid EG_cI05, with the most 
relevant elements for the positive 
selection indicated by name. Although 
this map corresponds to the map 
carrying RBS B0033, all other test 
plasmids have the same structure, with 
just a different RBS, differing in 
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Supplementary figure 5. Negative selection plasmids 
Maps corresponding to the plasmids used for the negative selection testing, problem 
plasmids as well as controls. A) Positive control plasmid EG_c11, with a T7 promoter 
regulating pifA expression. B) Negative control plasmid EG_cI18, with no promoter 
nor RBS regulating pifA expression. C) Test plasmid EG_cI15, used as an example for 
all 6 test plasmids of the same size and structure. 
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Supplementary figure 6. Homologous recombination plasmids for mmfR variants. 
Plasmids map for the homology recombination procedure in the mmfR strategy 
showcasing the different elements present, especially the ones within the homology 
region, which are to be introduced within the phage for the evolution process. A) Map of 
plasmid EG_m01, containing the original mmfR sequence. B) Map of plasmid EG_m02, 
containing the alternative sgnR sequence. C) Map of plasmid EG_m03, containing the 
alternative avaL1 sequence. 
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Supplementary figure 7. Selection plasmids for the mmfR strategy. 
Backbones designed for the projects’ selection procedures. A) Negative selection plasmid 
A, carrying the WT mmyB operato regulating sfGFP and cmk expression. B) Negative 
selection plasmid B, carrying the mutated MARE4 version of the operator regulating the 
same genes. C) Positive selection plasmid A, carrying sfGFP and pifA under the control of 
the WT mmyB operon. D) Positive selection plasmid B, carrying the same genes, with the 
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Supplementary figure 8. Phagemid plasmid versions. 
Plasmid maps of the three different constructs gradually assembled as part of the strategy. 
As shown, pm01a is very similar to the plasmid used for the homologous recombination 
strategy, but gene 4.7 has been substituted by the synthetic T7 packaging signal sequence. 
Pmb01b includes the addition of the error-prone gp5, and pmb01c finally eliminates the T7 
promoter in front of the riboswitch in favor of an E. coli one, as well as eliminates the 
remnants of the homology region from gene 4.7. 
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Supplementary figure 9. 
Original Qb IDT plasmid. 
Map of the IDT-assembled 
construct pUC_cat, formed 
of 67667 bp, with a pUC 
plasmid backbone from IDT 
and the Qb phage’s genes in 
the 5’-3’ orientation, as well 
as the chloramphenicol 







Supplementary figure 10. 
Qb-GFP plasmid. 
Map of the lab-assembled 
construct pUC-gfp, based 
upon and with the same 
elements as pUC-cat, but 
with a gfp gene in a 3’-5’ 
orientation, making it 
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Supplementary figure 11 . 3’UTR gene fragment for PURE experiments. 
Structure of the gene fragment assembled by IDT, containing an adapter, a T7 promoter 
in a 5’-3’ sense, and a 3’UTR, RBS and GFP sequence in 3’5’ sense. 
 
Supplementary Table 1 .  List 
of T7 genes 
From (Molineux, 2005). Full 
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Supplementary Table 2. Primer combinations for each NGS sample. 
Matrix indicating which primers correspond to each specific phage library in each of the 
two repetitions. The 6x4 matrix gives the possibility of separating between 24 samples at 
once, each of them with their own specific signal, thanks to the specific indexes present 
in each of the 2 primers used for the amplification. The different denominations for each 
library are based on the selection step they were obtained from, followed by the number 
of the generation. If there are multiple libraries corresponding to the same generation, a 
letter or date is included after the denomination. E.g. Sample cmk11 corresponds to the 
phage library obtained after the 11th positive selection step in the evolutionary process. A 
and B correspond to the 1st and 2nd set of sequenced libraries, respectively. B is not 
currently represented in the results due to a lack of time but will 
 be present in the final version of this thesis. 
 





Riboswitch Rd Switch 1 
Rd Switch 
2 Cmk1 cmk2 
S503 pifA2 cmk5 pifA6 cmk7 pifA7 pifA9 
S504 pifA10 cmk11 pifA11 cmk12 pifA12 pifA12B 





B) N701 N702 N703 N704 N705 N706 
S502 Rd1 Rd2 Rd3 Cmk1 pifA1 cmk3 
S503 pifA3 cmk4 pifA4 cmk5 pifA5 cmk6 
S504 cmk8 pifA8 cmk9 cmk10 pifA11 cmk12 
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Supplementary Table 3. qPCR plate distribution of samples. 
Distribution of library and standard samples in the qPCR plate. 13 out of all the 24 PCR-
amplified samples were taken in order to check the presence of to specific Illumina tags 
required for MiSeq detection. Each sample was represented in the form of two dilutions, 
except for the first one, which had three to make the most use of the plate. Each dilution 
consisted of three repetitions in order to ensure statistical significance of the results. 
 
 1 2 3 4 
A Standard 1 10pM Standard 1 10pM Standard 1 10pM Library 2 10^-4 
B Standard 2 1 pM Standard 2 1 pM Standard 2 1 pM Library 2 10^-5 
C Standard 3 0.1 pM Standard 3 0.1 pM Standard 3 0.1 pM Library 3 10^-4 
D Standard 4 0.01 pM Standard 4 0.01 pM 
Standard 4 0.01 
pM Library 3 10^-5 
E NTC NTC NTC Library 4 10^-4 
F Library 1 10^-3 Library 1 10^-3 Library 1 10^-3 Library 4 10^-5 
G Library 1 10^-4 Library 1 10^-4 Library 1 10^-4 Library 5 10^-4 
H Library 1 10^-5 Library 1 10^-5 Library 1 10^-5 Library 5 10^-5 
 5 6 7 8 
A Library 2 10^-4 Library 2 10^-4 Library 6 10^-4 Library 6 10^-4 
B Library 2 10^-5 Library 2 10^-5 Library 6 10^-5 Library 6 10^-5 
C Library 3 10^-4 Library 3 10^-4 Library 7 10^-4 Library 7 10^-4 
D Library 3 10^-5 Library 3 10^-5 Library 7 10^-5 Library 7 10^-5 
E Library 4 10^-4 Library 4 10^-4 Library 8 10^-4 Library 8 10^-4 
F Library 4 10^-5 Library 4 10^-5 Library 8 10^-5 Library 8 10^-5 
G Library 5 10^-4 Library 5 10^-4 Library 9 10^-4 Library 9 10^-4 
H Library 5 10^-5 Library 5 10^-5 Library 9 10^-5 Library 9 10^-5 
 9 10 11 12 
A Library 6 10^-4 Library 10 10^-4 Library 10 10^-4 Library 10 10^-4 
B Library 6 10^-5 Library 10 10^-5 Library 10 10^-5 Library 10 10^-5 
C Library 7 10^-4 Library 11 10^-4 Library 11 10^-4 Library 11 10^-4 
D Library 7 10^-5 Library 11 10^-5 Library 11 10^-5 Library 11 10^-5 
E Library 8 10^-4 Library 12 10^-4 Library 12 10^-4 Library 12 10^-4 
F Library 8 10^-5 Library 12 10^-5 Library 12 10^-5 Library 12 10^-5 
G Library 9 10^-4 Library 13 10^-4 Library 13 10^-4 Library 13 10^-4 
H Library 9 10^-5 Library 13 10^-5 Library 13 10^-5 Library 13 10^-5 
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